data_1i16_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i16 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.387 0.613 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.444 ' N ' HG11 ' A' ' 30' ' ' VAL . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 112' ' ' ILE . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.699 ' CE1' ' CZ3' ' A' ' 99' ' ' TRP . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.646 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HB2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 98' ' ' ALA . 2.1 mp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.504 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.622 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 . . . . . 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.494 ' O ' HG23 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.586 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD3' ' OE1' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 94' ' ' THR . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.699 ' CZ3' ' CE1' ' A' ' 44' ' ' PHE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.633 ' CG2' ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 99' ' ' TRP . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.277 0.561 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.554 ' CA ' HG11 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 7.4 tptt . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.599 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.599 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.586 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.6 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.6 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.368 0.604 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 77' ' ' GLN . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CD1' HD13 ' A' ' 61' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 81' ' ' GLU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.497 ' NE2' HG23 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 44' ' ' PHE . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.618 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.49 ' OE1' ' HG ' ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.635 ' N ' ' OE1' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.571 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.618 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG11 ' CA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.497 HG23 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 80' ' ' ASP . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.503 ' CG ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 112' ' ' ILE . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.639 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' CG ' ' HB ' ' A' ' 110' ' ' VAL . 5.8 mttt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 ' CD1' ' CD2' ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.504 HD23 ' CD1' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.631 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.631 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.533 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' C ' ' CD ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.522 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 111' ' ' THR . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.622 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.622 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 86' ' ' GLY . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.542 HG23 ' CD1' ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.453 0.644 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.492 ' SG ' ' CD1' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.636 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HG2' ' CD2' ' A' ' 42' ' ' LEU . 21.3 mtmt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.546 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.605 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.642 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.533 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.642 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.435 0.636 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.471 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 61' ' ' ILE . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.605 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.623 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.576 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.524 ' HA ' ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.558 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.541 ' CB ' ' SD ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.623 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.636 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.579 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.477 ' HG3' HG21 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 . . . . . 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 7.4 mttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.446 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.532 ' HB2' ' CG ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.643 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.643 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.484 ' O ' HD22 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.572 ' CD1' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.679 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.465 ' C ' ' CD ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 94' ' ' THR . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.529 ' HA ' HD11 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.679 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.624 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.544 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.544 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.524 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.604 ' CB ' ' CG ' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.652 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.652 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.446 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.492 ' CD ' ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.513 HD12 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 90' ' ' MET . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.469 ' O ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.662 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.604 ' CG ' ' CB ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 97' ' ' GLU . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.548 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.558 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.569 ' CB ' HD23 ' A' ' 59' ' ' LEU . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.52 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 68.2 m-20 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.662 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.629 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.538 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.303 0.573 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.501 HG21 ' CG ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.611 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.617 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.594 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 8.1 mp0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.595 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.617 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.617 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.531 ' HA3' ' CG ' ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.694 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.595 ' HG2' ' CB ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HA ' HD11 ' A' ' 102' ' ' ILE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.694 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.611 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' OE1' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.501 ' CG ' HG21 ' A' ' 30' ' ' VAL . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.538 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm . . . . . 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.608 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.51 ' CD2' HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 11.7 mp0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.487 ' CD2' ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.625 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.493 ' N ' HG21 ' A' ' 64' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.489 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.517 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HB3' HG23 ' A' ' 88' ' ' THR . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.453 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 92' ' ' GLY . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.558 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.481 ' HA ' HD11 ' A' ' 93' ' ' LEU . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.612 ' CD1' HG22 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.504 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.537 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.456 ' HB2' HG21 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.443 ' CG ' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.617 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 105' ' ' LEU . 2.8 tptp . . . . . 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.649 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.649 ' CE2' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.568 ' HB3' ' NH1' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 . . . . . 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.571 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 6.5 mp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 . . . . . 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.295 0.569 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.526 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 90' ' ' MET . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.641 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.571 ' CE ' ' HB2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 91' ' ' GLN . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.568 ' NH1' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.596 ' CB ' ' CD2' ' A' ' 93' ' ' LEU . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.476 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.505 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.636 HD11 ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG22 ' OE1' ' A' ' 84' ' ' GLN . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.505 HG23 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.498 ' O ' HG21 ' A' ' 61' ' ' ILE . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE1' ' ND2' ' A' ' 62' ' ' ASN . 17.8 mt-10 . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HB2' ' HG3' ' A' ' 90' ' ' MET . 1.6 mp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG2' HG12 ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 47' ' ' GLU . 1.9 m120 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.599 HG12 ' CG2' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.278 0.561 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.5 ' CD ' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.532 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.545 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.691 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.555 ' HE2' ' CD2' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.507 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.564 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.467 ' HA ' HD11 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.691 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.624 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.501 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.532 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.507 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.524 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.546 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.591 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.555 HG12 ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 . . . . . 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.249 0.547 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.531 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.561 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.499 ' NE2' HG22 ' A' ' 113' ' ' VAL . 1.3 pm0 -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.689 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 82' ' ' ILE . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.3 mm100 -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.556 ' CD1' HD12 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.482 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.539 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 93' ' ' LEU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.689 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' OD1' ' CD ' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' NE2' ' A' ' 84' ' ' GLN . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 114' ' ' ILE . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.473 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.632 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.605 ' CD1' HG12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 95' ' ' ARG . 2.2 mp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.321 0.582 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 44' ' ' PHE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.532 ' N ' HG21 ' A' ' 61' ' ' ILE . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.589 ' CG1' ' HB2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.183 0.516 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.477 ' O ' HD22 ' A' ' 35' ' ' LEU . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.547 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.553 HG12 ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.667 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.583 ' CE ' ' CB ' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 90' ' ' MET . 12.9 mm-40 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' CB ' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.407 ' CE2' ' HE3' ' A' ' 103' ' ' LYS . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.667 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.628 HD11 ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.551 ' N ' HD23 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.494 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.553 ' CG2' HG12 ' A' ' 82' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 31' ' ' CYS . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.516 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.514 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 1.9 mp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.623 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.623 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' N ' HG21 ' A' ' 64' ' ' ILE . 1.2 m-85 . . . . . 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.573 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' NE2' HG23 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HB2' HG23 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.551 ' HA2' ' CG2' ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 105' ' ' LEU . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.688 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.557 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.559 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' CD2' ' A' ' 59' ' ' LEU . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.568 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.688 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.551 ' CG2' ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.479 HG23 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' CD1' ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.455 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.335 0.588 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.526 ' CG ' HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 60' ' ' THR . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.535 HD12 ' CB ' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 64' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 7.0 m-30 . . . . . 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' CG2' ' A' ' 64' ' ' ILE . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.538 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.494 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.519 HG22 ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.517 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 44' ' ' PHE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.649 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.517 ' HA ' ' CB ' ' A' ' 84' ' ' GLN . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.535 ' CB ' HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.48 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.57 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.649 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.271 0.557 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.454 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HG2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.64 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 . . . . . 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 85' ' ' LEU . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.542 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 44' ' ' PHE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 111' ' ' THR . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.676 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 93' ' ' LEU . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.563 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.676 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG2' HD13 ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.537 ' CD1' ' HG3' ' A' ' 77' ' ' GLN . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.45 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.633 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' CE ' ' CD1' ' A' ' 105' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.615 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.548 ' HG ' ' NH1' ' A' ' 95' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.648 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.6 m-80 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.648 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.449 ' O ' HD22 ' A' ' 35' ' ' LEU . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.536 ' CD ' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.536 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.546 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.687 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.687 HG23 ' HB2' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.543 ' CE ' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.413 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.543 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' CG ' HD12 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.548 ' NH1' ' HG ' ' A' ' 59' ' ' LEU . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 59' ' ' LEU . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.568 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.663 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' CD1' ' CE ' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.536 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.481 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 16.5 tttt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.608 ' CE1' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 ' CE2' ' A' ' 44' ' ' PHE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mm-40 . . . . . 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 6.4 mp . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.613 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.5 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.613 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.321 0.582 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.474 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 60' ' ' THR . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.507 ' CD1' HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.64 ' HB3' HD12 ' A' ' 102' ' ' ILE . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.604 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' CB ' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.477 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.589 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' LEU . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 35' ' ' LEU . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.618 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 . . . . . 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.615 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.615 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HB ' HD12 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.535 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.551 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.63 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.638 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.565 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.541 HD12 HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HG2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 59' ' ' LEU . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 HD12 HD12 ' A' ' 93' ' ' LEU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.638 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.534 ' HD2' ' CD2' ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.618 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.535 ' CD1' ' HG3' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.428 ' CZ ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 112' ' ' ILE . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.625 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' CG ' ' HB ' ' A' ' 110' ' ' VAL . 7.5 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.625 HD13 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.545 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.634 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.634 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' CG ' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.565 ' CB ' ' CG ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.557 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.544 ' O ' ' CE ' ' A' ' 90' ' ' MET . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.422 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.582 ' CB ' ' HB2' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.538 ' C ' ' CD ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.495 ' O ' ' CD1' ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.576 ' CZ3' HG23 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.553 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 114' ' ' ILE . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 114' ' ' ILE . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' HG21 ' A' ' 61' ' ' ILE . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.658 ' HB3' ' O ' ' A' ' 82' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.59 0.233 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.571 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.571 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.319 0.58 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.533 ' CG2' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HA ' HG21 ' A' ' 60' ' ' THR . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.599 ' CD2' ' CG2' ' A' ' 110' ' ' VAL . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 111' ' ' THR . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.658 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.601 ' CB ' ' CD2' ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.516 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.583 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.482 ' HA ' HD11 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.658 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.476 HD13 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.512 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.0 -61.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.65 2.233 . . . . 0.0 109.919 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -117.7 -168.93 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.022 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -176.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.3 153.24 25.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.596 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 p -164.7 -158.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m 47.87 47.19 18.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 9' ' ' ASP . 5.3 t -175.68 -165.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 8' ' ' THR . 0.3 OUTLIER -49.86 121.77 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -55.12 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -145.72 71.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.13 121.4 32.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.98 136.06 29.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 15' ' ' SER . . . -118.04 -71.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.348 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 54.49 169.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.02 -178.93 4.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 0.0 109.227 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' C ' ' OG ' ' A' ' 18' ' ' SER . . . -168.82 179.71 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.431 ' OG ' ' C ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER 69.9 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 143.35 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.54 141.92 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.77 -175.5 3.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLU . 2.2 t 64.24 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' VAL . 5.2 pm0 -43.65 156.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -172.51 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.49 161.74 28.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.69 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 44.53 30.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.808 . . . . 0.0 109.821 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 52.89 92.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -121.29 132.29 54.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.36 142.55 35.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.687 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.444 ' N ' HG11 ' A' ' 30' ' ' VAL . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 112' ' ' ILE . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.47 97.98 6.62 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.0 ptm -151.05 -32.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' HB1' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -85.19 19.73 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.972 -1.08 . . . . 0.0 110.275 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . 65.03 54.2 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.146 -0.971 . . . . 0.0 110.089 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 134.53 29.1 0.44 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.699 ' CE1' ' CZ3' ' A' ' 99' ' ' TRP . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.646 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HB2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -128.2 149.33 50.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -177.93 -119.9 0.62 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 57' ' ' LYS . . . 176.63 102.56 0.16 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 118.619 -1.753 . . . . 0.0 110.793 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -51.59 169.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -1.183 . . . . 0.0 108.519 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.81 -108.18 1.03 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.3 44.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -1.215 . . . . 0.0 109.247 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt 56.45 24.32 8.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.112 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -142.12 5.92 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -142.82 -102.94 0.45 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 165.26 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.665 -1.491 . . . . 0.0 110.019 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CB ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -112.72 85.26 7.34 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.548 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 59' ' ' LEU . 37.6 Cg_endo -78.96 75.46 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.154 1.903 . . . . 0.0 109.573 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 98' ' ' ALA . 2.1 mp -43.25 152.78 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.504 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.622 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 -108.06 170.81 7.77 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.39 111.47 23.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.75 38.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -177.85 -164.94 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -1.077 . . . . 0.0 109.317 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . 48.89 41.6 18.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.68 15.81 14.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' C ' ' HG2' ' A' ' 72' ' ' GLN . 3.3 mp0 -109.48 6.1 23.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.686 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 71' ' ' GLU . 1.8 pt20 -178.96 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 t 55.96 -170.71 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 -76.4 110.8 11.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 69' ' ' ALA . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.494 ' O ' HG23 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.633 HG23 ' HB2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.586 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD3' ' OE1' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 94' ' ' THR . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.699 ' CZ3' ' CE1' ' A' ' 44' ' ' PHE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.633 ' CG2' ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 99' ' ' TRP . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -88.49 117.66 27.59 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -120.61 164.21 16.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.041 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.8 t 80.91 175.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 120' ' ' GLN . 3.6 mm? -55.25 -176.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.919 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.479 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 4.0 tp60 74.7 46.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.52 120.19 10.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.056 -1.028 . . . . 0.0 109.535 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 81.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.1 38.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 125' ' ' THR . 16.8 m -81.01 52.2 1.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 124' ' ' THR . 0.1 OUTLIER 45.34 87.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.396 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.78 16.07 17.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 49.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.4 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.18 75.6 0.1 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.06 134.9 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.54 59.1 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.616 2.21 . . . . 0.0 110.591 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 58.0 t0 -65.93 -72.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 109.31 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 63.42 44.84 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.779 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 11.0 p-10 -77.41 -33.01 55.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.271 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.12 82.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.751 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 63.9 p -75.61 -165.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 61.18 139.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -120.03 137.56 54.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.53 130.44 38.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.347 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.26 142.42 33.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.37 89.61 2.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -131.0 140.22 50.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.73 87.48 2.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.35 62.26 7.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.26 -178.6 6.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.61 106.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.49 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -73.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.267 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 2.3 p30 -67.83 75.63 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 m -90.08 139.34 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.865 . . . . 0.0 109.647 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.92 81.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.629 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 60.5 t -54.24 98.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.445 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 3.1 mt-10 64.0 155.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.652 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.02 55.94 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.134 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 26' ' ' ALA . 90.6 m -104.61 149.21 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 46.74 -173.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 4.3 mt-10 65.94 97.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' GLU . . . 80.55 145.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.779 -0.576 . . . . 0.0 109.76 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p -138.29 152.03 48.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.554 ' CA ' HG11 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 7.4 tptt -86.43 76.04 9.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.432 ' HE1' ' HB3' ' A' ' 107' ' ' ASP . 5.0 ttm -151.06 32.26 0.6 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.54 -78.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.049 -1.032 . . . . 0.0 110.059 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.72 28.43 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 69.34 71.88 0.92 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.599 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.599 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 -142.37 155.65 45.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 173.96 -102.12 0.17 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 169.54 104.98 0.18 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.952 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.52 ' CB ' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -47.62 172.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.972 -1.311 . . . . 0.0 108.91 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.87 128.35 4.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.43 -172.4 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.875 -1.367 . . . . 0.0 109.829 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 52' ' ' SER . 0.3 OUTLIER 80.86 -40.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.613 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -134.69 31.44 3.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.836 -1.165 . . . . 0.0 110.782 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.67 -24.93 0.21 Allowed Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.051 -1.547 . . . . 0.0 110.381 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 0.4 OUTLIER 57.38 176.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.281 . . . . 0.0 108.963 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -113.14 84.7 7.43 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.2 Cg_endo -80.09 58.45 6.99 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.088 1.859 . . . . 0.0 109.161 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -41.69 128.83 3.32 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.586 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.6 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.6 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 -113.01 -25.52 8.92 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.62 75.82 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.828 . . . . 0.0 109.537 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.6 5.09 5.86 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.54 137.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -1.087 . . . . 0.0 109.113 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB3' HD22 ' A' ' 35' ' ' LEU . . . -176.16 144.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 109.572 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -102.62 10.82 38.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -103.11 -174.4 2.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -69.11 58.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.088 . . . . 0.0 109.615 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' GLN . 3.4 m 42.5 27.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 -144.83 57.93 1.29 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.141 -0.974 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 77' ' ' GLN . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CD1' HD13 ' A' ' 61' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 81' ' ' GLU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.497 ' NE2' HG23 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 44' ' ' PHE . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 105' ' ' LEU . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.618 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.49 ' OE1' ' HG ' ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.635 ' N ' ' OE1' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.571 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.618 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG11 ' CA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG23 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 80' ' ' ASP . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.503 ' CG ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 137.61 32.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -154.7 173.59 16.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.04 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 71.52 106.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.201 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.15 91.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.536 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -118.51 -16.42 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.0 109.294 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.63 110.57 9.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.419 -0.801 . . . . 0.0 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -19.83 24.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.735 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.3 98.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -166.88 153.45 8.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.316 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.15 -163.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 109.294 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' GLY . . . -148.89 69.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.072 -1.017 . . . . 0.0 109.626 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 126' ' ' ALA . . . 61.82 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.551 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 126' ' ' ALA . . . 142.35 38.78 0.08 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.1 38.55 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -1.13 . . . . 0.0 109.403 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.58 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.644 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.0 177.2 10.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.52 -82.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -150.92 157.61 43.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.342 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -145.35 19.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -105.05 3.9 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -41.92 60.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ALA . 1.8 t70 68.43 119.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.88 . . . . 0.0 109.284 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 5.1 t 67.35 -63.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 75.17 44.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -69.7 -45.2 68.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 42.9 t 63.11 -72.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.729 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . 62.94 56.18 1.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' ALA . 1.3 p 55.3 22.43 4.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 66.55 -78.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -89.91 86.69 6.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -60.52 -93.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -142.72 166.81 23.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.391 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 21' ' ' SER . 33.7 m -76.68 140.57 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 4.3 m 70.53 139.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 22' ' ' VAL . 28.5 m -125.01 109.77 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' O ' ' OG ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -142.14 -178.58 5.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.723 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 p 54.57 88.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -65.15 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.318 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 179.9 114.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 108.992 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 21.5 mt-10 63.71 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -0.959 . . . . 0.0 109.24 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . . . -77.78 179.31 6.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.35 128.44 18.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 112' ' ' ILE . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.639 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' CG ' ' HB ' ' A' ' 110' ' ' VAL . 5.8 mttt -77.37 93.91 4.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.518 ' HG3' ' N ' ' A' ' 39' ' ' SER . 6.2 ptm -145.41 -154.7 0.56 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.518 ' N ' ' HG3' ' A' ' 38' ' ' MET . 97.0 p 50.14 -109.01 0.36 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.805 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -130.36 -11.36 4.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.823 -1.173 . . . . 0.0 110.354 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 165.37 73.58 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 ' CD1' ' CD2' ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.504 HD23 ' CD1' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 -130.58 155.81 45.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 149.58 -118.1 0.91 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 118.0 133.57 4.9 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 118.74 -1.695 . . . . 0.0 110.565 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -56.94 148.61 20.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.033 -1.275 . . . . 0.0 109.532 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.01 -85.97 0.81 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.75 -144.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -1.129 . . . . 0.0 109.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 32.46 4.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.445 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -123.04 -1.95 8.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.062 -1.024 . . . . 0.0 109.872 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -154.09 -100.53 0.19 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.8 m-20 160.08 -179.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.083 -1.245 . . . . 0.0 109.722 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.89 84.31 25.53 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 59' ' ' LEU . 38.1 Cg_endo -82.38 72.18 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.943 1.762 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -43.83 113.03 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.631 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.631 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 -104.35 -34.41 8.31 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -127.08 131.39 50.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.53 39.64 2.73 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -173.36 119.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -1.097 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB1' HG22 ' A' ' 75' ' ' THR . . . -66.83 115.58 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' ALA . 68.5 m 44.02 -100.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.25 18.39 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.978 -1.076 . . . . 0.0 109.45 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 73' ' ' SER . 16.5 pt20 -105.22 -177.29 3.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -43.16 153.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.769 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 -67.11 116.09 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 109.094 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.533 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' C ' ' CD ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.522 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 111' ' ' THR . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.622 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.622 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 86' ' ' GLY . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.542 HG23 ' CD1' ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.499 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.14 142.41 27.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -105.11 68.97 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.054 -1.029 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.2 t 45.8 46.88 12.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.379 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -165.44 174.82 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 16.3 mm100 66.81 46.87 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.384 -0.822 . . . . 0.0 109.578 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 171.8 121.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.815 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 173.99 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.385 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -101.89 140.12 36.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.38 -44.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -46.1 -71.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -47.83 148.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -167.83 73.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' SER . . . 168.79 70.81 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.95 -86.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 128' ' ' GLY . 5.9 p . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.53 84.83 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.187 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.0 110.64 16.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.74 -170.7 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.949 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -178.68 -152.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.275 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -155.22 -43.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 109.744 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 m -79.55 -85.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.482 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.17 -67.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.34 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -123.73 136.31 54.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -145.65 127.7 15.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.41 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.2 -152.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.452 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.62 169.72 14.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -157.68 122.5 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.52 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.29 109.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.32 74.92 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.65 162.08 29.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.32 71.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.639 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.4 m -144.38 20.59 1.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.92 164.31 17.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.712 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 4.6 m -113.24 127.67 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -156.14 65.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 109.577 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 21' ' ' SER . 1.5 t 61.26 118.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.7 pt-20 179.6 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m 61.46 -179.44 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.9 m -152.46 -79.97 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.63 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 163.04 34.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.601 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.52 26.55 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.1 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.463 ' HB1' ' CD ' ' A' ' 117' ' ' LYS . . . -163.42 125.29 2.48 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -143.05 140.38 30.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.948 -1.095 . . . . 0.0 110.246 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.492 ' SG ' ' CD1' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.636 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HG2' ' CD2' ' A' ' 42' ' ' LEU . 21.3 mtmt -76.81 122.59 25.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.37 -41.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.113 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -164.58 155.05 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.03 9.2 6.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 51.61 86.41 0.02 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.546 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 -130.16 156.5 44.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 152.53 -116.39 0.74 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.56 137.06 5.92 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.91 -1.614 . . . . 0.0 110.673 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -44.36 162.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.94 -1.329 . . . . 0.0 109.296 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.46 74.54 0.32 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 m -98.16 -53.86 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.146 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.8 tp -149.84 -53.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -17.74 14.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.17 67.57 0.11 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -170.52 152.62 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -1.136 . . . . 0.0 109.293 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -114.96 85.73 12.42 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 59' ' ' LEU . 37.6 Cg_endo -80.83 65.4 8.92 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.104 1.87 . . . . 0.0 109.544 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -41.91 127.5 3.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.605 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.642 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.533 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.642 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 -120.26 -37.76 3.01 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.09 94.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.14 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.9 4.61 5.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -178.86 131.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -1.089 . . . . 0.0 109.101 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB3' ' CG2' ' A' ' 75' ' ' THR . . . -144.59 -175.39 4.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.82 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.67 -140.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.39 -0.818 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 47.84 1.0 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 0.0 109.969 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -162.68 137.63 6.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -85.05 78.57 9.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 73' ' ' SER . 1.0 OUTLIER 169.35 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.471 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 61' ' ' ILE . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.605 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.623 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.576 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.524 ' HA ' ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.558 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.541 ' CB ' ' SD ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.623 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.636 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.579 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.477 ' HG3' HG21 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 -91.51 68.53 5.73 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.568 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -89.46 62.3 5.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 108.799 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.4 t 154.64 117.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 136.16 57.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.981 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -122.02 -30.9 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' GLN . 1.0 OUTLIER 55.35 109.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.769 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -75.55 137.62 40.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.093 -1.004 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -123.21 -150.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.88 129.3 36.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.632 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 3.4 t -170.97 143.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 125' ' ' THR . . . 80.34 -8.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.764 . . . . 0.0 109.839 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' ALA . . . 45.0 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.88 -72.37 1.03 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.01 37.45 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -1.145 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 167.54 23.42 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.534 2.156 . . . . 0.0 110.436 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.72 79.04 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.205 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -92.81 93.7 8.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.711 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER 73.16 112.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.609 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.3 m -108.34 4.72 24.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 44.67 53.97 6.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.89 . . . . 0.0 109.573 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' ASP . 9.5 t -176.92 -152.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 8' ' ' THR . 7.3 m-20 -43.67 144.37 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -43.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 57.4 -162.36 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.498 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 47.1 -93.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 11' ' ' ALA . 37.6 m -60.19 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -114.52 19.54 16.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t 45.2 48.38 10.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.94 . . . . 0.0 109.519 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.92 -164.6 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' SER . . . -168.99 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER 58.33 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.8 56.69 0.98 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.92 140.19 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 p -147.34 163.13 37.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 22' ' ' VAL . 7.6 p -121.46 59.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.89 36.09 0.85 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' ALA . 53.5 m 43.74 35.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 24' ' ' SER . 24.6 p 47.57 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' SER . . . -159.31 134.69 8.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -164.72 95.3 0.71 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.774 0.797 . . . . 0.0 109.573 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.42 160.87 43.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.668 -0.645 . . . . 0.0 109.472 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p -125.36 153.01 44.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 7.4 mttm -77.68 83.67 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -131.75 -34.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.797 . . . . 0.0 109.225 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.9 m -66.29 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.46 34.89 0.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 130.85 61.78 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.446 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 -140.24 134.17 30.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -157.09 -110.0 0.3 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 57' ' ' LYS . . . 155.86 113.97 0.46 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 118.671 -1.728 . . . . 0.0 111.442 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -45.06 138.53 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.258 . . . . 0.0 108.781 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 56' ' ' ASP . . . -179.12 86.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.5 -1.333 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -107.96 42.13 1.41 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 109.228 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 mp -118.37 -33.6 4.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.744 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.95 15.28 3.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.178 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 56' ' ' ASP . . . 168.83 -93.18 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.953 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 14.7 p-10 172.64 -177.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.353 . . . . 0.0 109.586 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.55 87.29 11.52 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.39 -0.819 . . . . 0.0 109.161 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 36.3 Cg_endo -78.76 74.64 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.242 1.961 . . . . 0.0 110.498 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.532 ' HB2' ' CG ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -45.66 123.57 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.643 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.643 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 -108.54 -28.72 9.16 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 76.15 119.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.06 -57.92 0.18 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.61 113.54 20.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.159 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.01 174.36 4.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.836 . . . . 0.0 109.159 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.5 t -131.28 -147.07 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.14 -16.58 59.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.96 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 161.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.799 . . . . 0.0 109.471 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -78.19 74.18 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.23 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 109.296 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.484 ' O ' HD22 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.521 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.572 ' CD1' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.679 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.465 ' C ' ' CD ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 94' ' ' THR . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.529 ' HA ' HD11 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.679 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.624 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 105.51 17.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 118' ' ' SER . 7.1 mtpm? -69.41 164.36 23.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.19 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.1 p 67.89 119.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.41 111.89 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLN . 4.0 tt0 -153.41 31.68 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.84 23.13 5.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.523 ' HE3' ' CB ' ' A' ' 126' ' ' ALA . 13.4 mtmt -92.94 162.46 14.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.64 2.15 38.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -108.03 26.15 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.472 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' ALA . 86.3 m 60.39 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' CB ' ' HE3' ' A' ' 122' ' ' LYS . . . 61.85 141.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.525 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.65 174.8 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.29 -68.47 0.89 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -112.07 98.72 7.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.526 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.567 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 36.1 Cg_endo -76.64 162.24 33.1 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.273 1.982 . . . . 0.0 110.734 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.1 p-10 -177.57 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp 58.56 18.35 5.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.91 . . . . 0.0 108.85 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -79.66 105.44 10.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.643 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.5 p -154.37 -53.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.247 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m -91.06 47.22 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.7 -13.53 15.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 10' ' ' SER . 4.0 p30 -100.09 139.07 36.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.477 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 74.34 -74.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.384 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' SER . . . 44.1 86.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' SER . . . -138.56 137.73 37.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER 72.16 90.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.658 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -39.98 66.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.6 -6.11 10.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.8 -171.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.87 166.58 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.611 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 p -83.66 146.94 27.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 0.0 109.351 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.55 44.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.6 p -169.94 161.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -68.41 148.63 50.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.53 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 13.3 p -145.71 46.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 109.606 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 80.12 148.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.85 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 25' ' ' THR . 3.3 t -179.67 -42.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 109.104 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 24' ' ' SER . 1.6 p 52.32 176.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.528 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . . . -174.67 55.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 12.9 mt-10 65.63 96.83 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB3' ' HG2' ' A' ' 117' ' ' LYS . . . 173.87 -178.35 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p -136.17 140.93 43.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.947 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.544 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm -88.2 107.41 18.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 39' ' ' SER . 3.8 ptm -104.23 -13.23 16.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.6 OUTLIER 163.98 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . 174.37 -69.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.544 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . 137.16 63.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.524 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.2 mm-40 -132.89 155.88 48.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.502 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 129.58 -110.57 1.08 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 62.46 -103.29 0.59 Allowed Glycine 0 N--CA 1.504 3.178 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.2 mttt -51.6 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.395 -1.062 . . . . 0.0 111.604 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 52.09 118.61 0.01 OUTLIER Glycine 0 N--CA 1.497 2.722 0 O-C-N 121.468 -0.77 . . . . 0.0 111.375 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.482 ' OG ' ' HA2' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -152.43 37.39 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.756 -1.438 . . . . 0.0 109.497 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.6 -86.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 54' ' ' HIS . 16.0 t60 -138.48 -3.61 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.06 55.88 0.01 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -171.63 177.34 3.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.193 . . . . 0.0 109.477 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CE ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -114.46 83.82 9.04 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.255 -0.903 . . . . 0.0 110.414 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 59' ' ' LEU . 38.6 Cg_endo -82.69 70.35 6.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.038 1.825 . . . . 0.0 110.164 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' CB ' ' CG ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -43.93 112.88 0.44 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.652 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.652 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.78 168.34 9.25 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.08 60.15 0.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.099 -1.001 . . . . 0.0 109.396 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -117.24 95.27 0.65 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.6 172.13 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.379 -1.071 . . . . 0.0 109.541 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . 178.58 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.446 ' OG ' ' HG2' ' A' ' 36' ' ' GLU . 51.1 m 61.15 -163.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -103.77 39.59 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.532 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.7 OUTLIER -112.25 152.62 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.473 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 74' ' ' GLU . 24.6 m -67.63 93.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 109.549 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.2 OUTLIER 52.71 98.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.492 ' CD ' ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.513 HD12 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 90' ' ' MET . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.469 ' O ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.662 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.604 ' CG ' ' CB ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.531 HD21 ' CG ' ' A' ' 97' ' ' GLU . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.424 HG23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.548 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.558 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.569 ' CB ' HD23 ' A' ' 59' ' ' LEU . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.52 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 68.2 m-20 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.662 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.629 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.538 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.524 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -101.1 131.51 47.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 26' ' ' ALA . 3.8 mttt -82.85 82.35 8.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.9 OUTLIER 53.0 -157.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 109.745 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER 74.74 72.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.182 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 121' ' ' SER . 4.0 pt20 -63.59 -18.31 63.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.426 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER 71.97 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.59 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.39 146.02 30.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 109.541 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -73.41 -67.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 t -173.22 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.557 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.28 -151.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.3 150.1 20.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.76 -78.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 59.95 -152.46 36.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -87.25 121.07 29.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.239 . . . . 0.0 109.312 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.532 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.6 128.71 9.63 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.479 2.12 . . . . 0.0 110.516 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.7 p-10 -75.27 -167.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.68 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 tp -149.76 111.97 4.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.68 -19.5 7.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -23.55 23.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 109.317 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.81 -172.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.512 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -60.49 140.68 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.91 . . . . 0.0 109.41 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.12 -161.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -156.96 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.08 112.74 25.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.13 102.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.657 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' ALA . 44.1 t -78.45 -69.3 0.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 42.73 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.81 109.7 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.211 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . . . 48.67 -157.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.49 -74.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.3 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -91.33 33.81 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 66.6 t0 -109.24 62.21 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.44 30.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.45 137.36 30.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.51 145.4 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.244 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.2 37.39 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 109.83 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' OG1' ' A' ' 25' ' ' THR . 9.6 t -131.63 -16.5 2.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.37 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.408 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER 48.92 42.59 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.953 -1.092 . . . . 0.0 109.143 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 49.87 72.54 0.31 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.893 . . . . 0.0 109.251 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 15.0 mt-10 -142.32 83.31 1.82 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.936 0.874 . . . . 0.0 109.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.533 ' CB ' ' HD3' ' A' ' 115' ' ' ARG . . . 70.23 161.23 0.22 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -138.1 140.72 40.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.552 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.501 HG21 ' CG ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.611 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt -95.2 92.64 6.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.492 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 3.0 ptm -126.37 8.29 7.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 172.4 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 179.96 -69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.114 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 116.85 62.4 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.617 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.594 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 8.1 mp0 -133.52 153.24 51.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 141.39 -121.48 1.88 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.565 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -159.39 -144.95 4.11 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.52 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 3.4 ptpt -77.63 53.45 1.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.438 . . . . 0.0 110.359 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' CA ' ' O ' ' A' ' 57' ' ' LYS . . . 57.14 -87.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.9 m -165.35 142.2 5.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.48 -38.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' HIS . 36.1 t-80 -152.19 27.86 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.38 -97.46 0.11 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.2 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.747 -1.443 . . . . 0.0 110.402 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -128.74 85.77 59.33 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.632 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' CB ' ' OE1' ' A' ' 81' ' ' GLU . 38.4 Cg_endo -82.01 93.75 0.93 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.02 1.813 . . . . 0.0 110.562 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.595 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -50.97 110.01 0.38 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.942 -1.099 . . . . 0.0 108.617 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.617 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.617 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 -112.12 169.97 8.48 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -108.2 101.87 11.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.07 -1.019 . . . . 0.0 109.139 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 68' ' ' ALA . . . 173.03 136.79 2.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . 69.53 116.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.47 -179.47 1.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.78 -160.71 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.11 46.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.856 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.474 ' HB3' HG21 ' A' ' 75' ' ' THR . 2.3 tt0 -118.63 132.64 56.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 72' ' ' GLN . 54.9 p -38.98 -43.12 0.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 0.0 110.149 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' C ' ' A' ' 73' ' ' SER . 89.6 mt-10 -146.72 101.17 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.564 ' HB2' ' CB ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HA ' HG21 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.606 ' HB2' HG23 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.531 ' HA3' ' CG ' ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.694 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.595 ' HG2' ' CB ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HA ' HD11 ' A' ' 102' ' ' ILE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.694 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.611 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' OE1' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.533 ' HD3' ' CB ' ' A' ' 28' ' ' ALA . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.02 145.92 25.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.58 113.43 21.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 118' ' ' SER . 0.0 OUTLIER 64.28 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.126 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 177.51 106.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.464 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.509 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -58.55 -172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.204 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER 162.99 -63.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 109.375 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 126.78 30.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -172.72 82.62 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.2 p -73.2 131.09 41.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.75 -170.18 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.093 -1.005 . . . . 0.0 109.572 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.01 -54.71 31.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.712 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 65.48 172.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 0.0 109.328 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.31 -75.44 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -113.61 174.37 5.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -1.114 . . . . 0.0 109.548 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.45 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.541 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 1' ' ' MET . 34.9 Cg_endo -77.39 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.435 2.09 . . . . 0.0 110.803 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -154.02 163.84 39.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 109.653 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.72 -76.56 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.86 . . . . 0.0 109.486 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 6' ' ' SER . 0.7 OUTLIER -61.93 -41.13 97.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 7' ' ' SER . 4.5 m 68.01 126.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 6' ' ' SER . 29.7 t 62.3 176.55 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 p -78.95 -33.5 45.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.92 163.81 23.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -49.97 72.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 173.66 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.43 -51.59 2.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -92.76 -49.47 6.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.84 70.68 3.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -44.13 20.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.63 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.72 52.11 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 m -113.47 126.9 55.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.325 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.67 103.71 8.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' VAL . 25.7 m -50.14 141.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.366 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 22' ' ' VAL . 24.1 t -46.13 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.413 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' VAL . 5.8 m -60.42 -156.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 46.62 70.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.498 ' O ' ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -145.02 75.85 1.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.428 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 24' ' ' SER . 1.7 t 39.43 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 109.773 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.31 134.55 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.98 . . . . 0.0 109.851 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 52.37 23.48 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -177.14 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 109.165 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p -126.88 133.62 50.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.538 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm -79.93 119.5 22.87 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.8 mtm -131.73 -36.93 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.754 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.39 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 109.838 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . -156.91 29.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.357 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 43.32 62.59 2.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.608 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.611 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.51 ' CD2' HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 11.7 mp0 -131.33 156.24 45.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 154.03 -115.84 0.7 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 129.51 145.4 5.86 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 118.485 -1.817 . . . . 0.0 110.935 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' CG ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 mtpm? -44.78 128.81 6.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.981 -1.305 . . . . 0.0 109.704 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 52' ' ' SER . . . -105.37 -134.94 8.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 2.7 m 179.18 -70.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.71 -1.465 . . . . 0.0 109.337 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 36.88 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.059 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -134.93 -30.34 1.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.007 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 58' ' ' PRO . . . 156.6 45.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 57' ' ' LYS . 2.3 p-10 43.06 -149.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -1.188 . . . . 0.0 109.871 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -109.98 86.3 4.83 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 0.0 110.275 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 36.7 Cg_endo -78.01 62.68 8.03 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.976 1.784 . . . . 0.0 109.466 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.487 ' CD2' ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER -42.95 121.65 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.625 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -122.0 -66.12 1.06 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER 160.32 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -104.53 37.94 3.53 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . . . 46.87 -171.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.364 -1.08 . . . . 0.0 108.985 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.59 175.28 9.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.221 -0.924 . . . . 0.0 109.273 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 5.0 m -101.32 -22.03 14.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 70' ' ' SER . 2.1 pp20? 171.84 40.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 131.59 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.048 -1.032 . . . . 0.0 109.987 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.79 152.42 22.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.382 -0.824 . . . . 0.0 108.846 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.66 46.74 3.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.489 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.517 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.453 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 92' ' ' GLY . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.558 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.481 ' HA ' HD11 ' A' ' 93' ' ' LEU . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.612 ' CD1' HG22 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.504 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.537 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.456 ' HB2' HG21 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.443 ' CG ' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 -89.32 162.61 15.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -126.81 130.03 49.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.717 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.24 151.26 23.6 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.29 -0.881 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 78.13 5.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.39 37.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.12 134.93 34.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -90.92 63.79 5.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.77 -30.33 2.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 125' ' ' THR . 12.6 t -47.78 136.15 11.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.875 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 124' ' ' THR . 42.1 p 46.28 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.43 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.13 -60.45 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.225 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -145.58 -170.2 14.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.78 -65.02 1.04 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.92 125.98 6.93 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.693 2.262 . . . . 0.0 110.148 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -176.07 -70.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.126 -0.984 . . . . 0.0 110.001 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.23 -39.99 16.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.961 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -72.94 -159.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.9 -174.52 3.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.124 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.459 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -158.19 -56.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.938 . . . . 0.0 109.405 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 7' ' ' SER . 18.0 p 53.03 57.87 5.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.408 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.9 p-10 -154.49 130.8 10.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.269 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.02 -52.61 2.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.81 31.8 18.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.411 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.76 44.25 17.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -131.48 2.36 4.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.81 -62.64 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.88 -163.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 17' ' ' ALA . . . -81.27 -76.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.671 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 16' ' ' ALA . . . 78.74 -50.35 0.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.869 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 m -118.69 171.02 8.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.967 . . . . 0.0 109.744 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.06 158.0 17.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG21 ' N ' ' A' ' 21' ' ' SER . 2.4 p -153.49 140.72 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.66 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' N ' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER 74.41 114.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.613 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 21' ' ' SER . 3.6 t 70.69 132.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.902 . . . . 0.0 109.67 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.16 172.45 11.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.0 m -77.42 85.82 3.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 57.01 87.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.565 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -160.53 148.35 16.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 65.74 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 27' ' ' GLU . . . 65.51 157.33 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.54 129.12 21.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.088 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.617 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' HD13 ' A' ' 105' ' ' LEU . 2.8 tptp -80.02 131.84 35.88 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.455 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -119.81 -56.62 2.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.042 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.4 OUTLIER 167.8 57.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.786 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.29 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.059 . . . . 0.0 110.265 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 78.99 47.89 7.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.649 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.649 ' CE2' ' CD1' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.568 ' HB3' ' NH1' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 -145.34 150.83 37.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . 124.56 -113.39 1.98 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.606 ' HA2' ' HB2' ' A' ' 57' ' ' LYS . . . 71.77 -139.38 28.59 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.526 -1.321 . . . . 0.0 109.894 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 8.9 pttt -45.78 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.252 . . . . 0.0 109.845 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.29 -98.74 2.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -147.54 -156.69 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 109.488 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 53' ' ' LEU . 1.7 mm? -108.51 36.6 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.18 8.46 13.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 56' ' ' ASP . . . -178.73 -81.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER 169.12 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.284 . . . . 0.0 109.696 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HB2' ' HA2' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -115.31 84.24 11.35 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.0 109.898 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 40.2 Cg_endo -86.79 74.45 2.89 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.599 2.2 . . . . 0.0 111.265 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.571 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 6.5 mp -46.83 121.6 3.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.595 -1.315 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 -109.79 -59.26 1.94 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -136.04 123.05 21.46 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.079 -1.013 . . . . 0.0 109.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -95.49 -143.99 15.75 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' GLY . . . 55.58 104.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -1.128 . . . . 0.0 109.066 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 70' ' ' SER . . . -63.32 -165.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.98 . . . . 0.0 108.552 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -41.49 -55.96 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.204 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' GLN . 28.2 tt0 -131.08 -18.05 3.0 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.605 -0.684 . . . . 0.0 110.221 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -49.47 176.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 84.7 p -92.77 -74.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' OE1' ' HB2' ' A' ' 73' ' ' SER . 2.4 mp0 -122.71 103.86 8.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.526 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 90' ' ' MET . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.641 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.571 ' CE ' ' HB2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 91' ' ' GLN . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.568 ' NH1' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.596 ' CB ' ' CD2' ' A' ' 93' ' ' LEU . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.476 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.505 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.641 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.636 HD11 ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG22 ' OE1' ' A' ' 84' ' ' GLN . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.505 HG23 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 89.73 8.11 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.84 159.09 27.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.71 56.72 3.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 45.21 84.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -168.83 -156.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -163.26 -70.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 72.59 -59.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.32 -168.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.56 74.78 1.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -104.09 -179.29 3.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.396 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.76 -158.78 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 173.35 109.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.65 114.09 3.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.29 68.35 0.54 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -1.119 . . . . 0.0 109.258 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.434 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 36.6 Cg_endo -78.64 116.98 3.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.398 2.065 . . . . 0.0 110.154 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.31 -5.86 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -163.16 -161.37 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -47.1 -27.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 p -174.16 -173.63 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.576 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -175.4 34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.09 137.3 47.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -162.99 -151.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -76.28 -169.51 1.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -62.6 1.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.04 21.29 0.44 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.61 80.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -165.95 61.32 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.07 54.02 2.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -177.76 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 16' ' ' ALA . . . 68.38 -59.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 179.74 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.47 162.24 15.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.913 . . . . 0.0 109.578 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 19' ' ' ASP . 9.3 t 65.76 30.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -78.75 121.17 24.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.814 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 21' ' ' SER . 2.6 p 40.07 76.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -90.41 94.3 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.464 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER 75.97 175.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.481 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -152.77 150.67 29.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.308 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 27' ' ' GLU . . . -123.64 165.48 17.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 7.6 mt-10 150.99 102.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' CB ' ' HG2' ' A' ' 117' ' ' LYS . . . -177.32 145.65 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 109.685 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p -114.54 146.36 40.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.01 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.624 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -90.49 132.31 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.508 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 1.1 mtp -137.03 76.6 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.208 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.5 t 59.45 53.0 5.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.96 . . . . 0.0 109.339 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.25 -63.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.388 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 132.53 51.12 0.09 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.498 ' O ' HG21 ' A' ' 61' ' ' ILE . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE1' ' ND2' ' A' ' 62' ' ' ASN . 17.8 mt-10 -122.85 155.92 35.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 59' ' ' LEU . . . -153.21 123.38 1.42 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.235 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -87.59 57.38 4.44 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.387 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.0 tmtt? -44.53 116.44 1.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.001 -1.293 . . . . 0.0 109.145 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . 44.04 62.03 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -96.07 18.25 13.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mp 44.99 48.82 9.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.366 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -132.64 -25.41 1.9 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.879 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . 139.39 66.97 0.04 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.4 m-20 77.47 169.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.077 . . . . 0.0 109.367 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.29 86.32 27.11 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' CB ' ' HG3' ' A' ' 81' ' ' GLU . 37.1 Cg_endo -79.65 76.16 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.355 2.037 . . . . 0.0 110.51 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 1.6 mp -45.84 127.74 8.31 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.599 ' CG2' HG12 ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 47' ' ' GLU . 1.9 m120 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.599 HG12 ' CG2' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 -112.28 161.41 16.64 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.9 136.45 55.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.93 -170.09 12.24 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -110.51 18.97 19.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.032 -1.275 . . . . 0.0 109.491 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . 42.45 -168.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.734 -0.604 . . . . 0.0 109.646 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -132.39 -76.33 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.044 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.99 7.34 3.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.538 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -129.68 128.65 42.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -50.93 143.57 9.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.358 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' CG ' ' C ' ' A' ' 73' ' ' SER . 1.8 pt-20 38.54 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.508 -0.745 . . . . 0.0 109.76 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.532 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.545 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.691 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.555 ' HE2' ' CD2' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.564 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.467 ' HA ' HD11 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.691 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.624 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.501 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.532 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.507 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.04 177.04 6.56 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.9 mttt -151.35 175.09 12.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.7 t 78.09 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 109.71 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.6 OUTLIER 79.89 141.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.499 -0.751 . . . . 0.0 109.534 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -110.06 14.81 22.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.835 . . . . 0.0 109.707 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.7 m -47.57 -25.82 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.27 121.28 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -71.01 -58.41 3.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.63 176.89 8.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -158.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.36 -166.81 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 50.35 22.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.59 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.79 -129.47 2.35 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.36 164.79 15.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.151 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.491 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.674 2.25 . . . . 0.0 110.34 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.07 169.44 0.42 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.565 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.88 153.49 28.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' SER . 1.7 m-80 -95.59 -88.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.298 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ASN . 3.2 m 51.41 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -11.36 60.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 109.307 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.4 m -80.26 125.35 29.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -175.22 -45.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -65.87 -67.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.21 100.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.41 113.75 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 39.16 4.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 101.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -155.45 -61.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.344 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.52 147.36 39.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -154.47 108.59 2.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER 63.47 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.1 t0 72.44 129.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 3.5 t 72.2 155.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.913 . . . . 0.0 109.643 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 22' ' ' VAL . 38.6 t -165.73 -163.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.131 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 25' ' ' THR . 12.2 p -44.87 135.02 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 0.0 109.231 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 24' ' ' SER . 16.0 tp10 -124.88 119.98 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 52.85 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.936 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.542 ' CG2' HG23 ' A' ' 22' ' ' VAL . 68.7 p -110.51 58.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 0.0 109.166 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -179.41 -166.37 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.307 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 5.2 mt-10 66.5 96.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.935 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.89 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.733 -0.604 . . . . 0.0 110.129 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.9 134.79 37.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.31 118.97 21.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.0 mmm -137.0 -35.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.978 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.7 p -162.55 165.58 25.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 110.052 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.08 -72.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.42 -0.8 . . . . 0.0 109.847 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 148.62 77.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 -153.15 155.32 36.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.72 -117.57 0.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.631 ' HA3' ' CB ' ' A' ' 57' ' ' LYS . . . -145.7 158.26 27.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' CB ' ' HA ' ' A' ' 94' ' ' THR . 1.5 ptmt -86.98 -12.02 48.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.656 -1.497 . . . . 0.0 111.3 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.562 ' CA ' ' HG3' ' A' ' 57' ' ' LYS . . . 122.77 14.79 4.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 70.5 m -150.52 74.24 1.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -1.111 . . . . 0.0 109.032 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.57 -73.59 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.214 -0.929 . . . . 0.0 109.684 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -139.85 -20.62 0.9 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.201 -0.937 . . . . 0.0 110.679 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' N ' ' HE3' ' A' ' 57' ' ' LYS . . . 157.01 -22.06 0.45 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.007 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' C ' ' HD3' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -141.18 92.38 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.447 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.631 ' CB ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.69 81.28 40.64 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -93.34 112.22 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.631 2.221 . . . . 0.0 111.469 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.546 ' HB2' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -68.11 118.13 10.85 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.591 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.555 HG12 ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 -107.01 161.11 15.03 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.47 112.2 19.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.651 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.72 -44.19 0.52 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.93 114.93 28.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -1.174 . . . . 0.0 109.43 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -177.64 -173.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.156 -0.965 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -112.31 -156.46 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -117.4 35.76 4.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.455 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' O ' ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -91.57 39.93 1.02 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.592 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 72' ' ' GLN . 51.7 p 47.94 84.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.806 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 73' ' ' SER . 41.2 mt-10 63.09 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.531 ' OD2' ' CB ' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.561 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.499 ' NE2' HG22 ' A' ' 113' ' ' VAL . 1.3 pm0 -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.689 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.561 ' CE ' ' O ' ' A' ' 82' ' ' ILE . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.3 mm100 -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.556 ' CD1' HD12 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.555 ' HA ' ' CB ' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.497 ' N ' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.539 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 93' ' ' LEU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.689 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' OD1' ' CD ' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' NE2' ' A' ' 84' ' ' GLN . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 114' ' ' ILE . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 -95.68 103.78 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 61.28 6.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.006 -1.059 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.53 106.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.0 109.712 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 119' ' ' LEU . 3.1 tt -145.96 33.07 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.162 -0.962 . . . . 0.0 109.347 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 7.1 tt0 176.74 -30.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 48.79 -157.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' SER . 14.9 mttp 62.12 94.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 51.28 -157.71 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 125' ' ' THR . 38.2 p -136.76 -170.97 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.57 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 127' ' ' ALA . 27.0 p 47.59 40.7 12.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 63.09 -74.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 125' ' ' THR . . . -90.99 -149.1 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -158.91 -95.84 0.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -134.43 50.36 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -1.106 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.603 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 1' ' ' MET . 35.6 Cg_endo -78.49 82.82 2.37 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER 169.48 51.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.268 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' ASN . 1.3 mt -174.77 -73.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 11.0 p30 40.91 37.99 0.6 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.525 -0.734 . . . . 0.0 110.046 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.23 -159.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.531 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.27 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.73 91.24 2.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 0.0 109.705 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 57.61 -173.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.708 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -97.34 -8.93 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.52 -72.48 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.569 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.76 -71.3 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -167.46 145.9 4.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.53 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.92 175.88 5.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.97 116.13 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.75 34.24 5.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.24 41.75 1.92 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.343 -0.848 . . . . 0.0 109.083 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -101.05 105.96 17.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -0.826 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' O ' HG21 ' A' ' 20' ' ' VAL . 32.7 t70 -64.92 113.32 3.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER 58.24 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -166.75 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.376 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.27 148.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -95.37 96.67 9.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -144.66 107.45 4.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.3 m -101.81 46.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.12 86.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.326 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -96.04 27.69 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 109.322 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . . . -44.56 121.12 2.5 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.636 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER -150.74 148.65 28.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.567 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.473 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.632 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.72 117.31 19.74 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttp -147.08 -39.01 0.2 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.864 . . . . 0.0 109.178 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 40' ' ' ALA . 95.3 p -69.24 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.444 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -174.01 39.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 148.26 40.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.605 ' CD1' HG12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 -147.22 155.7 42.31 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -151.09 -93.09 0.1 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 167.26 104.13 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.782 -1.675 . . . . 0.0 111.477 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG3' ' CG2' ' A' ' 94' ' ' THR . 4.9 tttt -28.96 131.7 0.05 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 122.016 -0.696 . . . . 0.0 109.866 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' N ' ' HD3' ' A' ' 57' ' ' LYS . . . -40.35 100.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -126.2 139.01 53.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.09 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.2 -151.98 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.167 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' HIS . 18.2 p-80 -89.78 29.74 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -120.9 98.25 0.66 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.1 m-20 -49.28 -179.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.253 . . . . 0.0 109.26 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HG3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -110.1 82.77 2.68 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 110.736 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.3 Cg_endo -79.44 68.99 8.12 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.25 1.967 . . . . 0.0 110.206 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.578 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 2.2 mp -41.61 132.57 2.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 44' ' ' PHE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.532 ' N ' HG21 ' A' ' 61' ' ' ILE . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.589 ' CG1' ' HB2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -123.55 101.34 7.27 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 108.803 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 65' ' ' PHE . . . 166.27 72.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 67' ' ' GLY . . . 168.47 -169.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.354 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' OG1' ' A' ' 75' ' ' THR . . . 64.94 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p -162.77 42.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.52 -25.29 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 109.795 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -173.77 28.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' GLN . 24.6 p 47.92 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 110.03 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.4 mt-10 39.5 42.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.76 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 69' ' ' ALA . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.547 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.553 HG12 ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.667 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.583 ' CE ' ' CB ' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 90' ' ' MET . 12.9 mm-40 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' CB ' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.407 ' CE2' ' HE3' ' A' ' 103' ' ' LYS . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.667 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.628 ' N ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.551 ' N ' HD23 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.494 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.553 ' CG2' HG12 ' A' ' 82' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 85.36 6.2 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -72.03 90.48 1.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 109.236 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 119' ' ' LEU . 1.4 t 59.37 -163.42 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 118' ' ' SER . 2.3 mp 60.91 113.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -106.32 4.82 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.628 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.92 178.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.684 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 92.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.53 -167.6 0.11 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -141.55 -47.19 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.493 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 124' ' ' THR . 81.2 m 65.2 87.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.386 -0.822 . . . . 0.0 109.714 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.03 165.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.937 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.18 118.71 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.269 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.62 152.88 47.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.97 114.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 109.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.378 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.546 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 36.5 Cg_endo -78.83 -48.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.313 2.009 . . . . 0.0 109.883 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 72.5 m-20 62.69 -83.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.568 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -173.24 145.27 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 177.6 165.26 0.63 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -51.19 173.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.305 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.75 91.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p -105.99 -33.45 7.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.181 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -72.3 99.75 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.86 118.23 9.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.52 163.42 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.01 -44.12 6.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -169.5 161.19 9.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.632 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.28 -64.29 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.877 . . . . 0.0 109.487 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 t -157.6 59.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.23 -27.46 13.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . -77.15 -167.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 69.45 -148.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.415 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.65 82.55 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 t -87.79 154.63 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.394 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 141.63 49.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.85 175.47 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 24' ' ' SER . 66.7 mt-10 60.6 169.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 24' ' ' SER . 38.7 p 52.33 77.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 p -127.76 -76.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.89 40.92 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.524 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 49.49 23.39 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 109.578 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.91 170.34 1.21 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p -120.26 138.05 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' N ' ' A' ' 31' ' ' CYS . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.516 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp -81.96 128.37 34.0 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.539 ' HG3' ' N ' ' A' ' 39' ' ' SER . 12.2 ptp -135.71 -37.05 0.76 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.539 ' N ' ' HG3' ' A' ' 38' ' ' MET . 0.2 OUTLIER 177.33 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 178.05 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 102.26 68.77 0.81 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.514 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 -116.19 157.55 24.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' CA ' ' HG ' ' A' ' 59' ' ' LEU . . . -146.8 118.12 1.0 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -71.93 56.96 1.4 Allowed Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.62 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.8 ptmt -36.47 104.15 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.573 -0.957 . . . . 0.0 109.708 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' O ' ' OG ' ' A' ' 52' ' ' SER . . . -113.18 -109.73 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 14.3 m -167.05 -148.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.683 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.97 -17.56 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.859 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -125.7 32.84 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.932 . . . . 0.0 109.579 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -130.18 -42.42 0.21 Allowed Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.98 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 1.5 m-20 61.45 126.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -1.219 . . . . 0.0 108.761 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.81 89.37 45.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.077 . . . . 0.0 110.833 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 37.4 Cg_endo -79.82 85.38 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.337 2.025 . . . . 0.0 108.511 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 1.9 mp -44.61 151.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.083 -1.01 . . . . 0.0 110.111 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.623 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.623 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' N ' HG21 ' A' ' 64' ' ' ILE . 1.2 m-85 -109.74 -61.22 1.67 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' ALA . 23.0 tttt -133.04 109.46 9.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 76' ' ' VAL . . . -66.61 74.12 0.15 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -70.76 164.42 25.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -1.167 . . . . 0.0 109.616 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -160.52 130.18 5.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.439 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.2 m -78.98 -12.62 60.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.47 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.73 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.9 OUTLIER -142.71 161.39 38.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 109.636 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -92.73 103.5 15.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 73' ' ' SER . 0.3 OUTLIER 64.71 84.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.573 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' NE2' HG23 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HB2' HG23 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.551 ' HA2' ' CG2' ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 105' ' ' LEU . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.688 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.557 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.559 ' CD2' ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' CB ' ' CD2' ' A' ' 59' ' ' LEU . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.568 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.688 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.551 ' CG2' ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.479 HG23 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' CD1' ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.455 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -89.09 128.98 35.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.79 169.49 13.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.266 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.63 173.42 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 109.152 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' O ' ' CG ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER -168.9 67.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 109.598 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -109.11 29.82 7.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.378 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -132.07 150.78 52.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.358 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' N ' ' CD ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -95.92 145.4 25.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 178.66 95.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.643 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.91 124.6 37.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 126' ' ' ALA . 55.2 m -156.75 131.33 8.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 125' ' ' THR . . . 44.24 58.72 3.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 109.543 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.36 39.32 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.897 . . . . 0.0 109.267 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.71 -33.95 5.37 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 -151.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.494 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.494 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.26 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.818 2.346 . . . . 0.0 110.601 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ASN . 2.8 m-20 -127.67 125.31 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.925 . . . . 0.0 109.658 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -65.17 79.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' ASP . 2.2 m-20 -146.5 -71.69 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.958 . . . . 0.0 109.606 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.23 -176.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -61.01 -42.51 98.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.22 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 47.22 80.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 56.13 -118.03 1.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.07 157.05 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.753 -1.217 . . . . 0.0 109.397 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.75 3.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.97 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.61 -176.91 6.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.548 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.35 -164.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 -173.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 161.22 5.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 56.94 168.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.373 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 130.06 55.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 109.312 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 18' ' ' SER . 29.2 t0 67.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 21' ' ' SER . 29.4 m -69.41 142.19 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 4.4 t 75.25 134.93 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.581 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.7 m -153.65 120.08 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 74.64 138.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.263 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.05 106.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 118' ' ' SER . 29.7 m -79.55 -63.96 1.29 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 173.1 76.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 28' ' ' ALA . 8.3 mt-10 67.03 103.36 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.688 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . -44.48 172.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p -124.45 135.67 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.428 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.526 ' CG ' HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.32 133.39 36.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 39' ' ' SER . 34.4 mtt -132.74 -35.8 1.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 38' ' ' MET . 30.1 t 176.4 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.08 -66.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.761 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . 138.53 64.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 60' ' ' THR . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 -118.69 156.59 29.02 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 59' ' ' LEU . . . -151.13 118.51 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . -73.41 55.66 1.98 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 119.224 -1.465 . . . . 0.0 109.495 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 50' ' ' LYS . 8.0 pttp -54.31 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -1.197 . . . . 0.0 109.825 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 144.87 100.07 0.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 56' ' ' ASP . 7.5 m -136.48 -132.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 108.777 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -46.59 8.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.778 -1.201 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 8.95 1.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 109.914 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.32 67.64 0.09 OUTLIER Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 8.2 m-20 -130.32 78.05 1.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -1.176 . . . . 0.0 109.446 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -125.67 90.59 50.24 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.252 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.456 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -78.16 86.05 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.977 . . . . 0.0 109.715 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.547 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -45.35 133.37 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.986 . . . . 0.0 109.052 -179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.564 HG22 HG12 ' A' ' 64' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.45 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 7.0 m-30 -105.71 171.24 7.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.92 76.12 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 68' ' ' ALA . . . -109.92 -14.85 12.78 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' GLY . . . 71.08 116.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -1.032 . . . . 0.0 109.531 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB1' ' CB ' ' A' ' 75' ' ' THR . . . -95.48 121.28 37.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 1.8 p 48.54 -100.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER 168.31 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.085 -1.01 . . . . 0.0 109.724 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' GLU . 2.4 pt20 -101.96 65.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.283 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 56.7 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mm-40 -109.75 160.36 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 108.979 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.514 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' CG2' ' A' ' 64' ' ' ILE . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.538 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.538 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.494 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.519 HG22 ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.517 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 44' ' ' PHE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.649 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.517 ' HA ' ' CB ' ' A' ' 84' ' ' GLN . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.535 ' CB ' HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' HB2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.57 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.649 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -102.17 138.4 39.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' CG ' ' HB1' ' A' ' 28' ' ' ALA . 2.9 mttm -108.11 176.48 5.12 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 12.0 p -46.36 118.45 1.95 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mt -118.58 154.12 33.13 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -143.88 -52.25 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.676 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -130.85 39.18 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.847 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 121' ' ' SER . 6.9 pttm 41.66 -162.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.347 -0.846 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 114.62 21.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 t -85.94 154.78 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -127.93 -34.42 2.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.68 -91.65 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 176.31 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.528 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.63 78.43 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 170.6 14.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.412 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.39 -65.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.516 2.144 . . . . 0.0 110.563 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -124.64 -93.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.577 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.38 88.59 2.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 54.52 86.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.1 OUTLIER 71.34 177.92 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.51 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.04 -38.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 48.6 p-10 -92.69 69.88 4.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.229 -0.92 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -48.42 11.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.226 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.12 -171.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.55 135.72 48.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t 54.33 177.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.13 37.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.79 -42.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.544 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.02 18.3 4.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.71 27.6 13.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.27 168.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.548 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 16.7 t0 -59.15 165.61 2.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.601 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 21' ' ' SER . 46.7 t -95.3 147.74 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.65 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER 76.85 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 109.574 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 m -84.66 126.45 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.503 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' OE1' ' HB3' ' A' ' 19' ' ' ASP . 27.9 tp10 -90.28 61.46 5.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.516 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -102.35 41.81 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.7 t -72.52 169.94 15.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -103.34 -172.5 2.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 23.8 mt-10 64.44 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.11 -0.994 . . . . 0.0 109.433 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 62.02 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -150.47 144.6 25.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.454 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HG2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.82 81.65 5.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' MET . 3.6 ttm -135.5 5.19 3.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 1.3 m -105.07 -63.73 1.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 109.284 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . 165.1 45.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.977 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 120.44 53.49 0.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 -140.46 139.95 35.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -159.84 -103.3 0.19 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 57' ' ' LYS . . . 174.03 104.69 0.18 Allowed Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.787 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.6 OUTLIER -47.37 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -1.12 . . . . 0.0 109.782 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . 158.9 103.04 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 m -50.12 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -1.15 . . . . 0.0 109.704 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.53 -0.78 4.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.653 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -105.53 26.3 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.257 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . 166.98 74.74 0.03 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.2 p30 -38.99 141.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.439 -1.036 . . . . 0.0 109.598 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -112.54 84.5 6.39 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.409 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.8 Cg_endo -81.43 72.63 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.427 2.085 . . . . 0.0 109.889 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 0.3 OUTLIER -44.38 130.09 6.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 108.962 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.64 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 -108.55 -45.97 3.76 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.4 tttt 73.96 126.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.66 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.74 -62.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.59 149.34 39.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -1.136 . . . . 0.0 109.184 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.23 175.93 9.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -96.3 -100.07 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -124.08 33.01 5.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.251 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.51 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 3.7 tt0 -130.93 132.34 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.446 -0.784 . . . . 0.0 109.097 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 72' ' ' GLN . 11.3 m -44.36 -47.75 9.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 -133.55 106.77 7.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.118 -0.989 . . . . 0.0 109.693 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 123' ' ' GLU . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 85' ' ' LEU . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.542 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 44' ' ' PHE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 111' ' ' THR . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.676 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 93' ' ' LEU . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.563 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 102' ' ' ILE . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.676 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG2' HD13 ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.537 ' CD1' ' HG3' ' A' ' 77' ' ' GLN . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.45 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -123.46 105.9 10.18 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -66.68 85.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 117' ' ' LYS . 0.9 OUTLIER 59.67 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.666 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.5 tp -122.04 134.02 54.79 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -69.49 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.95 . . . . 0.0 109.345 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 122' ' ' LYS . 29.7 t -82.73 -173.32 4.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.275 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 121' ' ' SER . 3.9 ptmm? -138.87 170.13 16.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 78' ' ' PRO . 2.7 tt0 -56.17 117.07 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.79 145.37 31.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 -174.35 4.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.633 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 108.69 20.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -158.46 95.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.12 134.79 12.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -55.1 -18.39 5.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.571 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HD2' ' HG3' ' A' ' 1' ' ' MET . 35.9 Cg_endo -78.35 -13.92 14.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.796 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 25.9 t70 -102.62 -94.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.889 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 6.3 tp 76.45 73.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.194 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 4' ' ' LEU . 15.3 p30 40.56 57.91 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 7' ' ' SER . 3.7 m -75.48 -141.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.882 . . . . 0.0 109.37 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.9 OUTLIER 74.86 132.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 7' ' ' SER . 33.2 p 45.42 54.82 7.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.24 74.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -128.42 14.07 6.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.1 124.92 25.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.59 -77.46 0.57 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -99.14 110.91 23.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.29 173.63 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.2 -157.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.16 84.98 0.58 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . 177.99 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -55.08 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' C ' ' CG2' ' A' ' 20' ' ' VAL . 9.6 m-20 -119.19 49.36 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 37.96 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 p -117.88 30.27 7.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.153 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.63 38.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.512 -0.742 . . . . 0.0 109.384 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 24' ' ' SER . 3.5 pt-20 174.6 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.61 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER 66.65 94.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.463 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 74.5 p -110.81 17.47 20.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 25' ' ' THR . . . 65.06 127.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 62.69 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 0.0 109.763 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' CG ' ' A' ' 117' ' ' LYS . . . 174.47 139.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p -127.56 144.14 51.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.07 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.633 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' CE ' ' CD1' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -78.45 99.68 6.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtt -150.77 31.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.612 -0.68 . . . . 0.0 109.236 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 m -141.54 -143.39 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.13 -5.82 59.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 110.041 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 156.72 76.1 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.615 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 -152.87 156.46 39.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.642 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 179.17 -100.73 0.14 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 176.39 103.71 0.17 Allowed Glycine 0 N--CA 1.495 2.62 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.185 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -47.31 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.237 . . . . 0.0 108.592 178.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -44.12 97.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.59 -65.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.9 -131.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -127.45 33.64 4.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.979 -1.075 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 56' ' ' ASP . . . -119.67 -70.29 0.32 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 170.62 176.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 0.0 109.65 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -113.34 84.45 7.58 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.3 Cg_endo -80.27 79.48 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.29 1.994 . . . . 0.0 110.516 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.548 ' HG ' ' NH1' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -46.35 135.22 8.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 108.122 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.648 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.6 m-80 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.648 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 2.8 m-30 -107.82 160.24 15.89 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 106.34 16.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.37 125.98 0.84 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 46.23 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.418 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . 46.49 42.7 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 48.12 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -111.33 -9.36 14.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 109.95 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 73' ' ' SER . 61.0 mt-30 -103.27 39.41 1.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 72' ' ' GLN . 8.0 t 67.41 56.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 76' ' ' VAL . 0.8 OUTLIER 70.18 96.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.499 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 69' ' ' ALA . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' OD2' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.546 HD13 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.687 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 101' ' ' ILE . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.687 HG23 ' HB2' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.543 ' CE ' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' O ' ' CD2' ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' CG ' HD12 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.464 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HD2' ' N ' ' A' ' 48' ' ' GLY . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 59' ' ' LEU . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.578 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.568 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.663 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' CD1' ' CE ' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.536 ' CD1' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -89.86 149.23 22.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -135.79 120.56 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 75.48 178.02 0.2 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.46 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 174.19 7.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.7 8.65 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 53.42 36.38 22.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 70.16 -77.84 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.03 159.45 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.509 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.2 p -137.27 51.8 1.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 39.4 p -65.3 -155.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 125' ' ' THR . . . 66.68 -179.47 0.21 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.94 31.57 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . -109.49 99.69 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.5 m-20 65.19 -150.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.56 85.3 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.455 2.103 . . . . 0.0 110.287 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 64.81 93.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mt 57.15 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 6' ' ' SER . 44.8 m-80 -79.39 -73.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.534 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER 167.97 -68.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER 68.47 49.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.48 ' CB ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 74.45 133.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 10' ' ' SER . 2.9 t0 -134.41 170.19 16.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 168.77 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.3 54.3 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.24 91.58 2.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.895 . . . . 0.0 109.365 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -107.84 146.97 31.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.63 -168.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.17 -0.957 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 p -103.04 -59.48 1.7 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.216 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.33 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.2 49.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.85 58.66 4.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.436 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 0.6 OUTLIER 51.57 40.9 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.531 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 19' ' ' ASP . 4.8 m 39.51 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.581 -0.7 . . . . 0.0 109.739 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.19 111.24 15.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.408 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.99 103.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -66.81 138.15 57.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.21 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' A' ' 25' ' ' THR . 68.8 m -68.87 -74.33 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.748 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.403 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.1 OUTLIER 60.2 59.94 2.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.187 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' O ' ' CB ' ' A' ' 27' ' ' GLU . . . -133.52 84.55 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 19.2 mt-10 147.62 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 27' ' ' GLU . . . 152.56 -179.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p -126.8 127.06 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.481 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 16.5 tttt -83.76 116.99 22.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.9 mtm -114.17 -50.12 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.89 45.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.76 23.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 46.15 50.98 11.93 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.608 ' CE1' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 ' CE2' ' A' ' 44' ' ' PHE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mm-40 -137.43 155.59 49.17 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.46 -121.85 2.64 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -168.57 -156.58 10.53 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -88.18 108.54 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.602 -1.528 . . . . 0.0 110.19 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . 28.54 -112.75 0.03 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.9 m -154.18 58.08 0.71 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 108.789 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD21 ' CE ' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -54.65 -49.08 71.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.287 -179.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.61 13.63 3.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.007 . . . . 0.0 110.082 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 56' ' ' ASP . . . -157.95 -110.91 0.3 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' CG ' ' O ' ' A' ' 55' ' ' GLY . 4.9 m-20 -162.1 84.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.348 . . . . 0.0 109.032 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.652 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -123.16 85.4 51.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.093 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -83.86 159.83 13.96 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.391 2.061 . . . . 0.0 109.689 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 90' ' ' MET . 6.4 mp -90.06 135.41 33.67 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 108.619 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.613 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.5 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.613 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.72 -58.07 1.98 Allowed 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -146.25 127.8 15.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' HA3' ' CG2' ' A' ' 76' ' ' VAL . . . -94.71 -113.18 2.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.36 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -1.122 . . . . 0.0 109.588 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -76.71 -172.86 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 50.3 m -63.66 -27.99 69.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 70' ' ' SER . 2.0 mt-10 179.3 45.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -136.64 50.42 2.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 74' ' ' GLU . 1.2 p 45.93 -156.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' N ' ' OG ' ' A' ' 73' ' ' SER . 4.0 pm0 -61.38 135.22 57.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.09 -1.006 . . . . 0.0 109.672 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.474 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.548 ' HB3' ' CG ' ' A' ' 77' ' ' GLN . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 60' ' ' THR . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.507 ' CD1' HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.64 ' HB3' HD12 ' A' ' 102' ' ' ILE . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.604 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' CB ' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.477 ' CE3' ' HA ' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.589 ' HB ' ' OG1' ' A' ' 88' ' ' THR . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 85' ' ' LEU . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 35' ' ' LEU . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -94.68 -179.41 4.86 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.05 83.76 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.031 -1.043 . . . . 0.0 109.412 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 p -169.17 146.44 3.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 67.33 3.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' SER . 4.4 tt0 -106.62 20.52 18.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLN . 1.5 p -44.83 140.19 2.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.259 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -119.29 -92.32 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' N ' ' CG ' ' A' ' 122' ' ' LYS . 1.4 pt-20 -156.03 29.03 0.36 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.02 67.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.7 p -135.12 149.57 50.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.07 -20.8 61.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.404 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 49.37 69.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.52 140.75 5.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.29 28.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -1.108 . . . . 0.0 109.239 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.499 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -8.35 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.24 . . . . 0.0 110.438 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.432 ' O ' HD23 ' A' ' 4' ' ' LEU . 5.4 m-20 -69.24 -24.48 64.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -131.38 -41.83 1.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.475 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' LEU . 14.2 p30 41.87 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.428 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.5 OUTLIER 62.33 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.423 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -55.35 176.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.364 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 -162.44 0.82 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.127 -0.983 . . . . 0.0 109.443 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -68.82 74.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.4 120.61 33.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.01 123.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.398 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.64 -65.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 14' ' ' ALA . 1.4 t -138.41 -91.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . 57.02 49.51 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.166 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -91.31 87.32 6.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' ALA . . . -138.78 -77.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.219 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . 64.72 16.73 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER 65.43 -73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.406 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 43.64 70.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.4 135.76 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.39 103.51 10.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.474 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.81 146.52 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 2.0 pt-20 -80.13 129.33 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.717 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.95 116.48 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.151 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -137.98 -176.52 4.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -0.954 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -175.02 120.01 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -165.86 95.09 0.6 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.581 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' HG21 ' A' ' 29' ' ' THR . . . -71.97 127.28 32.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.609 -0.682 . . . . 0.0 109.167 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 28' ' ' ALA . 21.1 p -149.33 142.84 25.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.988 . . . . 0.0 110.128 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.618 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -77.61 137.08 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 39' ' ' SER . 5.6 mtt -144.29 40.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.51 -0.743 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 74.55 77.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.275 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.85 -49.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 117.54 51.29 0.35 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD1' ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 -132.97 154.45 50.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 145.43 -123.4 1.89 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 95' ' ' ARG . . . -161.06 -152.0 6.45 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.853 -1.381 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.0 OUTLIER -95.95 93.84 7.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.32 . . . . 0.0 109.413 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.63 113.22 1.95 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.81 -74.39 0.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.271 . . . . 0.0 109.733 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -80.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -92.46 24.97 3.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -97.77 -47.37 2.12 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER 78.36 57.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.996 . . . . 0.0 110.265 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HB2' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -127.49 86.8 57.67 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.999 -1.063 . . . . 0.0 110.052 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -87.67 114.06 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.547 2.165 . . . . 0.0 110.47 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 90' ' ' MET . 0.2 OUTLIER -61.88 118.69 7.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 108.217 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.615 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.615 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 -109.74 170.65 7.93 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -118.59 90.52 3.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.69 58.02 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -154.48 -177.94 6.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -1.109 . . . . 0.0 109.401 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 72' ' ' GLN . . . 55.33 167.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.503 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 1.1 p -72.73 -96.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 109.187 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' O ' ' OG ' ' A' ' 73' ' ' SER . 15.2 pm0 -82.02 50.54 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 108.853 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' HG2' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -38.42 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.54 -0.725 . . . . 0.0 110.339 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -123.22 -33.33 3.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 73' ' ' SER . 3.6 mt-10 -167.07 33.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HB ' HD12 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.535 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.551 HD12 ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.63 ' HB2' HG23 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.638 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.565 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.541 HD12 HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 59' ' ' LEU . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 HD12 HD12 ' A' ' 93' ' ' LEU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.638 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.534 ' HD2' ' CD2' ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.618 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.535 ' CD1' ' HG3' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.428 ' CZ ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 63.67 7.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.414 ' CB ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -110.47 168.98 9.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.736 . . . . 0.0 109.386 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.8 p -168.04 154.14 7.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 0.0 109.899 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' GLN . 1.7 mm? 65.65 88.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.793 . . . . 0.0 109.594 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 19.6 tp60 175.11 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 109.095 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 64.07 73.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.806 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 169.87 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.469 ' HG2' ' HA3' ' A' ' 128' ' ' GLY . 7.9 mt-10 -78.17 114.39 17.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.0 -66.71 0.51 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.4 m -124.11 171.58 9.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.65 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.55 -154.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.664 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.22 83.69 2.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.469 ' HA3' ' HG2' ' A' ' 123' ' ' GLU . . . -63.08 137.68 43.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.78 -70.07 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.472 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -27.1 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.703 2.269 . . . . 0.0 110.323 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -147.52 -149.87 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.62 42.88 1.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -100.04 146.03 27.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -147.24 -43.21 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.641 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -66.64 88.63 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.413 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.29 -55.76 2.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 t70 63.58 37.38 10.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.656 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 44.4 p -152.0 179.89 8.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' SER . . . 59.58 155.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.46 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.25 -75.49 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p 55.22 -175.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.5 37.44 1.36 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t -79.8 60.18 3.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.88 28.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.37 -62.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m 55.91 86.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.26 43.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 20' ' ' VAL . 17.7 t -95.28 30.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -85.54 143.91 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.403 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 23' ' ' GLU . 59.0 t -88.4 145.39 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.39 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' N ' HG11 ' A' ' 22' ' ' VAL . 9.8 tt0 -77.08 79.61 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.576 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 25' ' ' THR . 1.1 m 169.07 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 24' ' ' SER . 76.3 p -156.84 144.81 19.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.83 149.8 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.332 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 1.9 mt-10 46.27 26.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 108.931 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 27' ' ' GLU . . . 70.44 164.96 0.27 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.687 -0.633 . . . . 0.0 109.339 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p -125.65 130.53 51.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.456 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 112' ' ' ILE . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.625 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' CG ' ' HB ' ' A' ' 110' ' ' VAL . 7.5 mttt -78.98 127.2 31.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.1 mtp -150.74 -75.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 109.233 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 79.2 p -141.54 159.34 42.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.877 . . . . 0.0 109.373 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . 76.75 -3.12 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.693 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 67.84 86.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.625 HD13 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.545 ' CD2' ' HE2' ' A' ' 90' ' ' MET . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 -130.3 131.51 45.45 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . 158.95 -127.74 1.91 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . 64.1 -61.54 0.06 OUTLIER Glycine 0 N--CA 1.513 3.783 0 O-C-N 121.086 -1.243 . . . . 0.0 110.207 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 48' ' ' GLY . 1.6 ptmm? -93.05 57.03 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 109.281 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -41.47 -82.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.1 m -151.33 -91.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.153 . . . . 0.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.77 10.72 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -104.05 -18.62 14.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.581 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 57' ' ' LYS . . . 103.85 -19.62 43.6 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.086 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -68.23 111.32 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.025 -1.28 . . . . 0.0 109.704 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -130.5 90.17 41.79 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 37.9 Cg_endo -81.9 78.58 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.25 1.967 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 90' ' ' MET . 0.7 OUTLIER -43.17 123.25 2.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.634 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.634 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -110.27 170.26 8.2 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -103.16 135.58 44.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.118 -0.989 . . . . 0.0 109.607 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.94 -29.9 4.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . -77.54 89.73 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -1.218 . . . . 0.0 109.611 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.9 1.23 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.154 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -169.65 28.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.61 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -141.88 -41.68 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -160.15 176.21 12.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.475 -0.765 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.51 39.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 -160.76 45.68 0.2 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.185 -0.947 . . . . 0.0 109.246 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' CG ' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.565 ' CB ' ' CG ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.557 ' HA ' ' CG2' ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.544 ' O ' ' CE ' ' A' ' 90' ' ' MET . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.422 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.582 ' CB ' ' HB2' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.538 ' C ' ' CD ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.495 ' O ' ' CD1' ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.576 ' CZ3' HG23 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.553 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' O ' HD13 ' A' ' 114' ' ' ILE . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.427 ' C ' ' HG2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -95.74 -167.68 1.64 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' A' ' 116' ' ' ARG . 5.0 pttt 177.82 157.39 0.4 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.69 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -80.11 131.82 35.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.955 -1.091 . . . . 0.0 109.367 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.37 -164.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -81.04 -87.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.599 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.3 OUTLIER 75.44 130.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.523 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -63.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 t -164.38 43.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -56.14 177.03 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 109.205 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -110.48 106.59 15.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.793 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.95 170.51 8.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.29 65.55 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 130' ' ' SER . 1.3 p30 -134.07 129.91 36.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 109.466 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 129' ' ' ASP . 49.6 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.371 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 34.7 Cg_endo -78.3 -60.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 110.674 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 60.1 m-20 60.12 -174.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.311 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mt -101.59 121.85 42.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.459 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -148.54 -43.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.46 154.71 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -82.51 166.46 19.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 9' ' ' ASP . 12.3 p -84.25 -169.93 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.441 ' OD1' ' OG1' ' A' ' 8' ' ' THR . 8.7 m-20 62.65 165.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.85 22.55 12.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.48 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.41 -57.41 1.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.517 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.69 22.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.724 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.2 156.27 41.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.28 40.03 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.77 132.21 46.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.304 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.61 -63.11 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.644 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.41 66.21 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 109.303 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.9 m -60.47 160.81 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.63 94.76 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.363 -0.836 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 t -80.73 135.53 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.05 157.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.288 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.94 103.19 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.153 -0.967 . . . . 0.0 109.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.19 99.52 9.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.293 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.82 158.39 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.594 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -161.7 58.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -122.6 30.8 6.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 4.8 mt-10 -150.4 88.29 1.49 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.081 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.58 158.49 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.75 135.19 48.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 114' ' ' ILE . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.631 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt -75.38 92.47 2.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 39' ' ' SER . 41.6 mtp -131.75 -179.5 5.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 38' ' ' MET . 8.8 t 67.41 -128.83 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.98 -1.075 . . . . 0.0 109.443 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.96 5.26 9.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.729 -1.232 . . . . 0.0 110.191 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 170.34 65.88 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' HG21 ' A' ' 61' ' ' ILE . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 -134.52 139.03 45.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 95' ' ' ARG . . . 108.6 -170.32 14.75 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 57' ' ' LYS . . . 135.98 -77.36 0.36 Allowed Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.877 -1.367 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.581 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.47 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.272 -1.134 . . . . 0.0 110.614 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.32 107.12 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 m -126.41 -72.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.242 . . . . 0.0 109.693 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.91 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.753 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -77.35 -7.41 56.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.65 63.49 0.61 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.72 114.33 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.738 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.581 ' HG3' ' N ' ' A' ' 50' ' ' LYS . 10.1 ptpt -129.44 90.35 44.56 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.515 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 37.6 Cg_endo -83.55 152.6 13.5 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.511 2.141 . . . . 0.0 109.917 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.658 ' HB3' ' O ' ' A' ' 82' ' ' ILE . 2.9 mp -58.29 123.9 17.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.132 -0.98 . . . . 0.0 110.446 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.571 ' CG2' ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.571 ' CG1' ' CG2' ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -107.21 169.85 8.32 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -100.55 98.91 9.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.263 -0.898 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 68' ' ' ALA . . . 140.96 -160.84 26.75 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 67' ' ' GLY . . . 44.18 52.26 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 75' ' ' THR . . . -152.52 155.1 36.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.425 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 t -68.16 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.2 24.85 11.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 74' ' ' GLU . 4.0 mt-30 -83.48 141.69 31.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 109.415 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -46.01 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.703 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 72' ' ' GLN . 10.1 mp0 49.94 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.533 ' CG2' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HA ' HG21 ' A' ' 60' ' ' THR . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.599 ' CD2' ' CG2' ' A' ' 110' ' ' VAL . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 111' ' ' THR . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.658 ' CG2' ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.601 ' CB ' ' CD2' ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.583 ' O ' ' CD1' ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.531 ' CB ' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.482 ' HA ' HD11 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CD1' ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.658 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.631 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 HD13 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.512 ' HB2' ' CG2' ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.8 136.36 41.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 93.12 4.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.049 -1.032 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.8 p -74.84 -164.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.456 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.9 mp -47.97 140.04 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.513 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -162.52 -59.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.43 88.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.466 -0.771 . . . . 0.0 109.244 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -83.42 53.55 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.651 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 124' ' ' THR . 27.3 mt-10 -85.0 -34.94 22.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.2 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER 77.0 42.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.392 -0.817 . . . . 0.0 109.97 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 m -45.46 -64.02 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.168 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.95 12.6 8.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.65 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' GLY . . . -103.29 160.12 14.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.528 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ALA . . . 51.56 95.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.11 142.3 31.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.387 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.387 0.613 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.912 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.809 HD11 ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.1 mp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.882 HG21 HD11 ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.433 ' ND2' ' HG2' ' A' ' 47' ' ' GLU . 3.6 p-10 -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.882 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 . . . . . 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.406 ' O ' HD21 ' A' ' 35' ' ' LEU . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HA ' HG22 ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HB2' HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.613 ' O ' HG21 ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.685 ' OG1' HD13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.589 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.793 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 101' ' ' ILE . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.589 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 1.066 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.066 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 102' ' ' ILE . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 32' ' ' THR . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.749 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.277 0.561 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.877 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.752 HD12 HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 105' ' ' LEU . 7.4 tptt . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.885 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.746 HG21 ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.464 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.746 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.368 0.604 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.414 ' OG1' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.671 ' O ' HG22 ' A' ' 60' ' ' THR . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.844 ' HA ' HG22 ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 114' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.65 ' NE2' HG21 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.731 HD13 ' HE3' ' A' ' 90' ' ' MET . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.821 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.731 ' HE3' HD13 ' A' ' 85' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.525 ' OE1' HD12 ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 1.04 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.635 ' N ' ' OE1' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.942 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.885 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.752 HD13 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.877 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 111' ' ' THR . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.754 HD11 HG13 ' A' ' 76' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' HD22 ' A' ' 42' ' ' LEU . 5.8 mttt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.871 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.878 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.787 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.766 HG21 HD11 ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.631 ' OG1' HD21 ' A' ' 35' ' ' LEU . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.787 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.988 HD13 HG22 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.878 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.913 HG21 HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.854 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' LEU . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.913 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.827 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.827 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 34' ' ' THR . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.988 HG22 HD13 ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.453 0.644 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 1.041 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.827 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HG2' HD21 ' A' ' 42' ' ' LEU . 21.3 mtmt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.544 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.791 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.924 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.881 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.49 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.897 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.435 0.636 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.55 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' THR . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.881 ' HA ' HG22 ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.814 HG12 HG22 ' A' ' 114' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.498 ' HA3' HG23 ' A' ' 110' ' ' VAL . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.095 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.082 ' CE ' ' HB1' ' A' ' 98' ' ' ALA . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.924 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.967 ' O ' HD12 ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.082 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.624 HD13 ' HD3' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.624 ' HD3' HD13 ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HE3' ' A' ' 37' ' ' LYS . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.041 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.48 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 . . . . . 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.639 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.475 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.988 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 42' ' ' LEU . 7.4 mttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.845 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.876 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.93 HD23 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.775 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.947 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.989 HG21 HD11 ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.989 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' HD21 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 35' ' ' LEU . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.947 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 2.3 pm0 -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.999 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.791 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.105 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.93 ' SD ' HD23 ' A' ' 46' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 1.055 ' O ' HD22 ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.055 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.775 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.843 ' O ' HD12 ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.508 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.105 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 ' HA3' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.679 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.844 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.944 HG22 ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.838 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.717 HG23 HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.839 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.825 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.547 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' HD21 ' A' ' 35' ' ' LEU . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.032 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HA ' HG22 ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.567 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.669 HD11 ' NH2' ' A' ' 115' ' ' ARG . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.14 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.838 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.898 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 89' ' ' ALA . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.14 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.717 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.032 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.944 ' HB2' HG22 ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.303 0.573 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HB2' HD11 ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.903 HG23 HG13 ' A' ' 113' ' ' VAL . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' OG1' ' A' ' 75' ' ' THR . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.848 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 8.1 mp0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.798 HG22 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.744 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.793 HG23 HG22 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.458 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 101' ' ' ILE . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.813 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.793 HG22 HG23 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm . . . . . 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.866 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.865 HD22 HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mp0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 7.4 m-20 -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.775 HD11 HG21 ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.953 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.916 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.974 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.725 ' HG3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.453 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 101' ' ' ILE . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.782 ' HA ' HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.956 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.547 ' HB1' ' HE3' ' A' ' 90' ' ' MET . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.974 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.858 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.426 ' H ' ' HA2' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.953 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG3' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' CD ' HD11 ' A' ' 105' ' ' LEU . 2.8 tptp . . . . . 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.566 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.856 HD21 ' CG2' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.513 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 . . . . . 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 95' ' ' ARG . 6.5 mp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 1.045 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.652 HG21 HD11 ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 . . . . . 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.295 0.569 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' HD21 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.629 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.045 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.573 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.901 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.929 ' HG2' HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' MET . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 1.013 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 101' ' ' ILE . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.518 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.694 ' O ' HD22 ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.921 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.683 ' HB2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.046 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 1.046 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.93 HD21 ' CE ' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 95' ' ' ARG . 17.8 mt-10 . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 90' ' ' MET . 1.6 mp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 81' ' ' GLU . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 1.2 m-80 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.278 0.561 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.753 ' CG ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.946 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.988 ' HA ' HG22 ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.81 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.742 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.133 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.703 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.93 ' CE ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.98 ' O ' HD12 ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.98 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.133 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.845 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.742 ' O ' HD22 ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.946 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.904 ' HB2' HG22 ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 HD13 ' A' ' 112' ' ' ILE . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.538 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.878 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.878 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 1.01 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 m-20 -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.714 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 . . . . . 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.249 0.547 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.585 ' OG1' HD21 ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.858 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 114' ' ' ILE . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.852 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.464 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.777 ' HE3' ' HB2' ' A' ' 59' ' ' LEU . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.797 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.9 ' O ' HD12 ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.612 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.741 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.704 HD13 HD12 ' A' ' 35' ' ' LEU . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.858 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.789 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.888 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.535 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.74 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.588 ' CD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.998 ' CE2' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.2 mp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.321 0.582 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.886 HG22 ' HA ' ' A' ' 81' ' ' GLU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.807 HG21 HG13 ' A' ' 64' ' ' ILE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.493 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.807 HG13 HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.183 0.516 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.685 ' O ' HD21 ' A' ' 35' ' ' LEU . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' A' ' 82' ' ' ILE . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.886 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.998 HD21 ' CE2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.947 HG21 HD11 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.051 ' CE ' ' HB2' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 90' ' ' MET . 12.9 mm-40 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 1.017 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.827 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.493 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.04 ' O ' HD12 ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.051 ' HB2' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.626 ' HZ3' HD11 ' A' ' 42' ' ' LEU . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.04 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.982 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.982 HD12 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.57 ' N ' HD22 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.674 HG11 HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.74 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.888 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 115' ' ' ARG . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.998 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 HG23 HG13 ' A' ' 113' ' ' VAL . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.97 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.97 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.829 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 95' ' ' ARG . 1.9 mp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.727 HG22 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.84 HG21 HD11 ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 60' ' ' THR . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.602 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.771 ' NE2' HG21 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.931 ' HA2' HG22 ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 101' ' ' ILE . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.578 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 1.03 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.015 ' O ' HD12 ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 101' ' ' ILE . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.931 HG22 ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.998 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.688 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.335 0.588 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.82 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HG ' HD23 ' A' ' 59' ' ' LEU . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.721 HD13 ' CB ' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.789 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' CD1' HD11 ' A' ' 82' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 7.0 m-30 . . . . . 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.782 ' HA ' HG11 ' A' ' 33' ' ' VAL . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.88 ' OD2' HG21 ' A' ' 114' ' ' ILE . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.789 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' ILE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.888 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.894 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.751 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 1.058 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.058 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.943 ' CG ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.888 ' CD1' HG21 ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.765 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.474 ' HB2' HG22 ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.271 0.557 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 113' ' ' VAL . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD11 HG13 ' A' ' 76' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.903 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.903 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.844 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.911 HG21 HD11 ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.911 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 . . . . . 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.857 ' OG1' HD21 ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.861 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.68 ' HG3' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.69 ' CG ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.951 ' HA ' HG22 ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.772 ' CD1' HG22 ' A' ' 112' ' ' ILE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.115 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.861 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.023 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.115 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.026 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.772 HG22 ' CD1' ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.69 HD12 ' CG ' ' A' ' 80' ' ' ASP . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.445 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.714 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.894 ' CE1' HD13 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.894 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HG ' ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 HD11 ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 4.0 m120 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HB ' HD13 ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.611 ' NE2' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.922 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.861 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 114' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.911 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.038 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.939 ' HE2' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.957 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.572 ' HD3' ' HG ' ' A' ' 59' ' ' LEU . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.788 ' O ' HD12 ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.669 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.038 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.828 HD22 ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.637 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.672 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' GLY . 16.5 tttt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.967 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.905 ' HE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 82' ' ' ILE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 11.7 mm-40 . . . . . 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 90' ' ' MET . 6.4 mp . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.836 HG13 HD11 ' A' ' 82' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.821 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.321 0.582 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.484 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.819 ' OD2' HG21 ' A' ' 114' ' ' ILE . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.836 HD11 HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.967 HD21 ' CD1' ' A' ' 42' ' ' LEU . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.928 HG21 HD11 ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.872 ' HG3' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.843 HD23 ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.699 ' NH2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.022 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.49 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.022 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.928 HD11 HG21 ' A' ' 88' ' ' THR . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.676 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.449 ' OD1' ' HE3' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.819 HG21 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 115' ' ' ARG . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.4 HG23 HG13 ' A' ' 113' ' ' VAL . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.086 HD23 HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.787 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.945 ' CE1' HD13 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.945 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 . . . . . 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.833 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.842 HG21 HD11 ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.842 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.656 ' HA ' HG11 ' A' ' 33' ' ' VAL . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.833 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.735 HG23 HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.706 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.641 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' OG1' ' A' ' 88' ' ' THR . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.845 ' O ' HD12 ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.641 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.941 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.941 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.858 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 1.086 HD11 HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 32' ' ' THR . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.901 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 HG13 ' A' ' 113' ' ' VAL . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.765 HD11 HG13 ' A' ' 76' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HE2' HG23 ' A' ' 102' ' ' ILE . 7.5 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.823 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.774 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.844 HG21 HD11 ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.0 m-20 -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.844 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 33' ' ' VAL . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.765 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 1.125 ' NE2' HG21 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 61' ' ' ILE . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.588 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.992 ' HB2' HG22 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.02 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE3' ' HB3' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.444 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.699 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.818 ' O ' HD12 ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.02 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 ' HD3' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD3' HD13 ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.125 HG21 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.821 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.564 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 76' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.06 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 1.06 ' CE2' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.999 HD21 ' CB ' ' A' ' 90' ' ' MET . 2.9 mp . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.59 0.233 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.756 HG21 ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.756 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.319 0.58 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.65 HG23 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.858 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 60' ' ' THR . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.807 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.784 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.052 ' HB3' HG22 ' A' ' 88' ' ' THR . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 85' ' ' LEU . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.999 ' CB ' HD21 ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.78 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.715 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.715 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.9 HG23 ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 82' ' ' ILE . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.856 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.0 -61.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.65 2.233 . . . . 0.0 109.919 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -117.7 -168.93 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.022 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -176.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.3 153.24 25.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.596 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 8' ' ' THR . 9.2 p -164.7 -158.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m 47.87 47.19 18.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 6' ' ' SER . 5.3 t -175.68 -165.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 8' ' ' THR . 0.3 OUTLIER -49.86 121.77 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -55.12 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -145.72 71.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.13 121.4 32.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.98 136.06 29.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 15' ' ' SER . . . -118.04 -71.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.348 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 54.49 169.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.02 -178.93 4.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 0.0 109.227 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' C ' ' OG ' ' A' ' 18' ' ' SER . . . -168.82 179.71 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.431 ' OG ' ' C ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER 69.9 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 143.35 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.54 141.92 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.488 ' C ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -126.77 -175.5 3.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 21' ' ' SER . 2.2 t 64.24 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' VAL . 5.2 pm0 -43.65 156.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -172.51 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.49 161.74 28.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.69 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 44.53 30.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.808 . . . . 0.0 109.821 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 52.89 92.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -121.29 132.29 54.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.36 142.55 35.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.687 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.47 97.98 6.62 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.0 ptm -151.05 -32.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -85.19 19.73 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.972 -1.08 . . . . 0.0 110.275 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 65.03 54.2 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.146 -0.971 . . . . 0.0 110.089 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 134.53 29.1 0.44 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.912 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.809 HD11 ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -128.2 149.33 50.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -177.93 -119.9 0.62 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . 176.63 102.56 0.16 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 118.619 -1.753 . . . . 0.0 110.793 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.707 ' CB ' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -51.59 169.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -1.183 . . . . 0.0 108.519 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.81 -108.18 1.03 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.3 44.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -1.215 . . . . 0.0 109.247 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt 56.45 24.32 8.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.112 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -142.12 5.92 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -142.82 -102.94 0.45 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 165.26 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.665 -1.491 . . . . 0.0 110.019 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -112.72 85.26 7.34 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.548 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.6 Cg_endo -78.96 75.46 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.154 1.903 . . . . 0.0 109.573 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.1 mp -43.25 152.78 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.882 HG21 HD11 ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.433 ' ND2' ' HG2' ' A' ' 47' ' ' GLU . 3.6 p-10 -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.882 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 -108.06 170.81 7.77 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.39 111.47 23.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.75 38.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -177.85 -164.94 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -1.077 . . . . 0.0 109.317 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HB1' ' H ' ' A' ' 75' ' ' THR . . . 48.89 41.6 18.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.68 15.81 14.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' C ' ' HG2' ' A' ' 72' ' ' GLN . 3.3 mp0 -109.48 6.1 23.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.686 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 71' ' ' GLU . 1.8 pt20 -178.96 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 t 55.96 -170.71 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 -76.4 110.8 11.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.493 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HA ' HG22 ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HB2' HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.613 ' O ' HG21 ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.685 ' OG1' HD13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.589 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.707 HG22 ' CB ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.793 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 101' ' ' ILE . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.589 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 1.066 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.066 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 102' ' ' ILE . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 32' ' ' THR . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.749 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -88.49 117.66 27.59 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -120.61 164.21 16.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.041 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.8 t 80.91 175.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 120' ' ' GLN . 3.6 mm? -55.25 -176.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.919 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 119' ' ' LEU . 4.0 tp60 74.7 46.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.52 120.19 10.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.056 -1.028 . . . . 0.0 109.535 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 81.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.1 38.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 125' ' ' THR . 16.8 m -81.01 52.2 1.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 124' ' ' THR . 0.1 OUTLIER 45.34 87.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.396 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.78 16.07 17.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 49.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.4 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.18 75.6 0.1 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.06 134.9 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.2 mtp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 36.3 Cg_endo -79.54 59.1 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.616 2.21 . . . . 0.0 110.591 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 58.0 t0 -65.93 -72.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 109.31 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 63.42 44.84 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.779 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 11.0 p-10 -77.41 -33.01 55.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.271 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.12 82.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.751 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 63.9 p -75.61 -165.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 61.18 139.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -120.03 137.56 54.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.53 130.44 38.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.347 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.26 142.42 33.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.37 89.61 2.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -131.0 140.22 50.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.73 87.48 2.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.35 62.26 7.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.26 -178.6 6.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.61 106.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.49 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -73.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.267 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 2.3 p30 -67.83 75.63 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 20' ' ' VAL . 14.8 m -90.08 139.34 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.865 . . . . 0.0 109.647 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.92 81.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.629 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 60.5 t -54.24 98.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.445 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 3.1 mt-10 64.0 155.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.652 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.02 55.94 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.134 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 26' ' ' ALA . 90.6 m -104.61 149.21 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 46.74 -173.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.3 mt-10 65.94 97.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 80.55 145.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.779 -0.576 . . . . 0.0 109.76 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p -138.29 152.03 48.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.877 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.752 HD12 HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' OE2' ' HB1' ' A' ' 68' ' ' ALA . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 105' ' ' LEU . 7.4 tptt -86.43 76.04 9.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.06 32.26 0.6 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.54 -78.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.049 -1.032 . . . . 0.0 110.059 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.72 28.43 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 69.34 71.88 0.92 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.885 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 -142.37 155.65 45.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 173.96 -102.12 0.17 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 169.54 104.98 0.18 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.952 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.9 ' CB ' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -47.62 172.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.972 -1.311 . . . . 0.0 108.91 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.87 128.35 4.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.43 -172.4 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.875 -1.367 . . . . 0.0 109.829 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 52' ' ' SER . 0.3 OUTLIER 80.86 -40.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.613 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -134.69 31.44 3.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.836 -1.165 . . . . 0.0 110.782 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.67 -24.93 0.21 Allowed Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.051 -1.547 . . . . 0.0 110.381 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 57.38 176.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.281 . . . . 0.0 108.963 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.14 84.7 7.43 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 60' ' ' THR . 37.2 Cg_endo -80.09 58.45 6.99 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.088 1.859 . . . . 0.0 109.161 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -41.69 128.83 3.32 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.746 HG21 ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.746 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -113.01 -25.52 8.92 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.62 75.82 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.828 . . . . 0.0 109.537 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.6 5.09 5.86 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HB1' ' OE2' ' A' ' 36' ' ' GLU . . . -171.54 137.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -1.087 . . . . 0.0 109.113 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 75' ' ' THR . . . -176.16 144.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 109.572 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -102.62 10.82 38.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -103.11 -174.4 2.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -69.11 58.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.088 . . . . 0.0 109.615 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 71' ' ' GLU . 3.4 m 42.5 27.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 -144.83 57.93 1.29 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.141 -0.974 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 HG21 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.671 ' O ' HG22 ' A' ' 60' ' ' THR . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.844 ' HA ' HG22 ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 114' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.65 ' NE2' HG21 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.731 HD13 ' HE3' ' A' ' 90' ' ' MET . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.821 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.731 ' HE3' HD13 ' A' ' 85' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.525 ' OE1' HD12 ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 1.04 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.9 HG22 ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.504 ' NH1' ' HG2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.942 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.885 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.752 HD13 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.877 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 137.61 32.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -154.7 173.59 16.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.04 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 71.52 106.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.201 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.15 91.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.536 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -118.51 -16.42 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.0 109.294 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.63 110.57 9.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.419 -0.801 . . . . 0.0 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -19.83 24.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.735 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.3 98.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -166.88 153.45 8.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.316 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.15 -163.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 109.294 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' GLY . . . -148.89 69.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.072 -1.017 . . . . 0.0 109.626 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 126' ' ' ALA . . . 61.82 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.551 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 126' ' ' ALA . . . 142.35 38.78 0.08 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.1 38.55 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -1.13 . . . . 0.0 109.403 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.58 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.644 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.0 177.2 10.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.52 -82.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -150.92 157.61 43.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.342 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -145.35 19.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -105.05 3.9 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -41.92 60.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ALA . 1.8 t70 68.43 119.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.88 . . . . 0.0 109.284 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 t 67.35 -63.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 75.17 44.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -69.7 -45.2 68.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 42.9 t 63.11 -72.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.729 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . 62.94 56.18 1.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 p 55.3 22.43 4.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . 66.55 -78.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -89.91 86.69 6.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -60.52 -93.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -142.72 166.81 23.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.391 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' SER . 33.7 m -76.68 140.57 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 4.3 m 70.53 139.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 22' ' ' VAL . 28.5 m -125.01 109.77 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -142.14 -178.58 5.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.723 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 26.1 p 54.57 88.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -65.15 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.318 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 179.9 114.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 108.992 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 21.5 mt-10 63.71 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -0.959 . . . . 0.0 109.24 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . . . -77.78 179.31 6.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.35 128.44 18.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 111' ' ' THR . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.754 HD11 HG13 ' A' ' 76' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' HD22 ' A' ' 42' ' ' LEU . 5.8 mttt -77.37 93.91 4.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 39' ' ' SER . 6.2 ptm -145.41 -154.7 0.56 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 38' ' ' MET . 97.0 p 50.14 -109.01 0.36 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.805 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -130.36 -11.36 4.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.823 -1.173 . . . . 0.0 110.354 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 165.37 73.58 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.871 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.878 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 -130.58 155.81 45.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.538 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 149.58 -118.1 0.91 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 118.0 133.57 4.9 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 118.74 -1.695 . . . . 0.0 110.565 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -56.94 148.61 20.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.033 -1.275 . . . . 0.0 109.532 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.01 -85.97 0.81 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.75 -144.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -1.129 . . . . 0.0 109.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 32.46 4.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.445 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -123.04 -1.95 8.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.062 -1.024 . . . . 0.0 109.872 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -154.09 -100.53 0.19 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.8 m-20 160.08 -179.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.083 -1.245 . . . . 0.0 109.722 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.89 84.31 25.53 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 60' ' ' THR . 38.1 Cg_endo -82.38 72.18 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.943 1.762 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -43.83 113.03 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.787 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.766 HG21 HD11 ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 -104.35 -34.41 8.31 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -127.08 131.39 50.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.53 39.64 2.73 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -173.36 119.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -1.097 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB2' ' OG1' ' A' ' 75' ' ' THR . . . -66.83 115.58 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' ALA . 68.5 m 44.02 -100.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.25 18.39 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.978 -1.076 . . . . 0.0 109.45 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 73' ' ' SER . 16.5 pt20 -105.22 -177.29 3.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -43.16 153.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.769 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 -67.11 116.09 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 109.094 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.787 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.988 HD13 HG22 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.878 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.913 HG21 HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.854 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' LEU . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.913 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.827 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.827 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 34' ' ' THR . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.988 HG22 HD13 ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.14 142.41 27.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG3' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -105.11 68.97 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.054 -1.029 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 119' ' ' LEU . 4.2 t 45.8 46.88 12.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -165.44 174.82 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 16.3 mm100 66.81 46.87 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.384 -0.822 . . . . 0.0 109.578 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 171.8 121.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.815 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 173.99 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.385 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -101.89 140.12 36.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.38 -44.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -46.1 -71.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -47.83 148.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -167.83 73.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' SER . . . 168.79 70.81 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.95 -86.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 128' ' ' GLY . 5.9 p . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.53 84.83 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.187 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.0 110.64 16.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 4' ' ' LEU . 8.5 mp -101.74 -170.7 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.949 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -178.68 -152.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.275 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -155.22 -43.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 109.744 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 m -79.55 -85.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.482 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.17 -67.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.34 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -123.73 136.31 54.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -145.65 127.7 15.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.41 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.2 -152.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.452 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.62 169.72 14.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -157.68 122.5 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.52 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.29 109.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.32 74.92 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.65 162.08 29.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.32 71.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.639 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.4 m -144.38 20.59 1.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.92 164.31 17.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.712 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.6 m -113.24 127.67 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.528 ' C ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -156.14 65.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 109.577 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 21' ' ' SER . 1.5 t 61.26 118.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.7 pt-20 179.6 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m 61.46 -179.44 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.9 m -152.46 -79.97 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.63 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 163.04 34.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.601 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.52 26.55 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.1 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.691 ' HB2' ' CD ' ' A' ' 117' ' ' LYS . . . -163.42 125.29 2.48 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -143.05 140.38 30.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.948 -1.095 . . . . 0.0 110.246 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 1.041 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.827 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HG2' HD21 ' A' ' 42' ' ' LEU . 21.3 mtmt -76.81 122.59 25.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.37 -41.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.113 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 t -164.58 155.05 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 67.03 9.2 6.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 51.61 86.41 0.02 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.544 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.791 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 -130.16 156.5 44.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 152.53 -116.39 0.74 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.56 137.06 5.92 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.91 -1.614 . . . . 0.0 110.673 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -44.36 162.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.94 -1.329 . . . . 0.0 109.296 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.46 74.54 0.32 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 m -98.16 -53.86 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.146 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.8 tp -149.84 -53.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -17.74 14.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.17 67.57 0.11 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -170.52 152.62 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -1.136 . . . . 0.0 109.293 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -114.96 85.73 12.42 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 60' ' ' THR . 37.6 Cg_endo -80.83 65.4 8.92 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.104 1.87 . . . . 0.0 109.544 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.924 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -41.91 127.5 3.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.881 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.49 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.897 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 -120.26 -37.76 3.01 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.09 94.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.14 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.9 4.61 5.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -178.86 131.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -1.089 . . . . 0.0 109.101 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 75' ' ' THR . . . -144.59 -175.39 4.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.82 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.67 -140.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.39 -0.818 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 47.84 1.0 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 0.0 109.969 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -162.68 137.63 6.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.436 ' C ' ' HG2' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -85.05 78.57 9.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER 169.35 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.57 HG21 ' HB1' ' A' ' 69' ' ' ALA . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' THR . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.881 ' HA ' HG22 ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.814 HG12 HG22 ' A' ' 114' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.498 ' HA3' HG23 ' A' ' 110' ' ' VAL . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.095 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.082 ' CE ' ' HB1' ' A' ' 98' ' ' ALA . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.924 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.967 ' O ' HD12 ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.082 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.624 HD13 ' HD3' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.624 ' HD3' HD13 ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HE3' ' A' ' 37' ' ' LYS . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.041 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.48 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 -91.51 68.53 5.73 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.691 ' CD ' ' HB2' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -89.46 62.3 5.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 108.799 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.4 t 154.64 117.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -62.55 136.16 57.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.981 . . . . 0.0 109.188 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -122.02 -30.9 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' GLN . 1.0 OUTLIER 55.35 109.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.769 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -75.55 137.62 40.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.093 -1.004 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -123.21 -150.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.88 129.3 36.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.632 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 3.4 t -170.97 143.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 80.34 -8.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.764 . . . . 0.0 109.839 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' ALA . . . 45.0 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.88 -72.37 1.03 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.01 37.45 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -1.145 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 167.54 23.42 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.534 2.156 . . . . 0.0 110.436 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.72 79.04 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.205 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -92.81 93.7 8.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.711 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER 73.16 112.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.609 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.3 m -108.34 4.72 24.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 44.67 53.97 6.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.89 . . . . 0.0 109.573 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' ASP . 9.5 t -176.92 -152.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 8' ' ' THR . 7.3 m-20 -43.67 144.37 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -43.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 57.4 -162.36 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.498 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 47.1 -93.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 11' ' ' ALA . 37.6 m -60.19 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -114.52 19.54 16.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t 45.2 48.38 10.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.94 . . . . 0.0 109.519 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.92 -164.6 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' SER . . . -168.99 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER 58.33 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.8 56.69 0.98 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.92 140.19 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 p -147.34 163.13 37.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 22' ' ' VAL . 7.6 p -121.46 59.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.89 36.09 0.85 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' ALA . 53.5 m 43.74 35.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 24' ' ' SER . 24.6 p 47.57 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' SER . . . -159.31 134.69 8.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -164.72 95.3 0.71 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.774 0.797 . . . . 0.0 109.573 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . . . -149.42 160.87 43.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.668 -0.645 . . . . 0.0 109.472 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p -125.36 153.01 44.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.639 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.475 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.988 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 42' ' ' LEU . 7.4 mttm -77.68 83.67 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -131.75 -34.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.797 . . . . 0.0 109.225 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.9 m -66.29 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.46 34.89 0.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 130.85 61.78 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.845 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.876 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.93 HD23 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 -140.24 134.17 30.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -157.09 -110.0 0.3 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . 155.86 113.97 0.46 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 118.671 -1.728 . . . . 0.0 111.442 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -45.06 138.53 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.258 . . . . 0.0 108.781 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ASP . . . -179.12 86.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.5 -1.333 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -107.96 42.13 1.41 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 109.228 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 mp -118.37 -33.6 4.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.744 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.95 15.28 3.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.178 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' ' ' ASP . . . 168.83 -93.18 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.953 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 14.7 p-10 172.64 -177.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.353 . . . . 0.0 109.586 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.55 87.29 11.52 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.39 -0.819 . . . . 0.0 109.161 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 60' ' ' THR . 36.3 Cg_endo -78.76 74.64 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.242 1.961 . . . . 0.0 110.498 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.775 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -45.66 123.57 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.947 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.989 HG21 HD11 ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.989 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 -108.54 -28.72 9.16 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 76.15 119.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.06 -57.92 0.18 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.61 113.54 20.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.159 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.01 174.36 4.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.836 . . . . 0.0 109.159 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.5 t -131.28 -147.07 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.14 -16.58 59.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.96 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 161.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.799 . . . . 0.0 109.471 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -78.19 74.18 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.23 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 109.296 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' HD21 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 35' ' ' LEU . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.947 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 2.3 pm0 -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.999 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.791 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.105 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.93 ' SD ' HD23 ' A' ' 46' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 1.055 ' O ' HD22 ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.055 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.775 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.843 ' O ' HD12 ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.508 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.105 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 ' HA3' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.679 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.844 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 105.51 17.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.567 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 7.1 mtpm? -69.41 164.36 23.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.19 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.1 p 67.89 119.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.41 111.89 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLN . 4.0 tt0 -153.41 31.68 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.84 23.13 5.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HE3' ' CB ' ' A' ' 126' ' ' ALA . 13.4 mtmt -92.94 162.46 14.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.64 2.15 38.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -108.03 26.15 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.472 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 86.3 m 60.39 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.532 ' CB ' ' HE3' ' A' ' 122' ' ' LYS . . . 61.85 141.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.525 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.65 174.8 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.29 -68.47 0.89 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -112.07 98.72 7.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.526 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.567 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 36.1 Cg_endo -76.64 162.24 33.1 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.273 1.982 . . . . 0.0 110.734 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.1 p-10 -177.57 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 4' ' ' LEU . 6.6 mp 58.56 18.35 5.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.91 . . . . 0.0 108.85 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -79.66 105.44 10.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.643 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.5 p -154.37 -53.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.247 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m -91.06 47.22 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.7 -13.53 15.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 10' ' ' SER . 4.0 p30 -100.09 139.07 36.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.477 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 74.34 -74.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.384 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' SER . . . 44.1 86.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' SER . . . -138.56 137.73 37.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER 72.16 90.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.658 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -39.98 66.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.6 -6.11 10.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.8 -171.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.87 166.58 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.611 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 p -83.66 146.94 27.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 0.0 109.351 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.55 44.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.6 p -169.94 161.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -68.41 148.63 50.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.3 p -145.71 46.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 109.606 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 80.12 148.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.85 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 25' ' ' THR . 3.3 t -179.67 -42.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 109.104 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 24' ' ' SER . 1.6 p 52.32 176.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.528 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . . . -174.67 55.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 12.9 mt-10 65.63 96.83 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 173.87 -178.35 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p -136.17 140.93 43.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.947 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.944 HG22 ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.838 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.717 HG23 HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm -88.2 107.41 18.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 39' ' ' SER . 3.8 ptm -104.23 -13.23 16.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER 163.98 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 174.37 -69.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . 137.16 63.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.839 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.825 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 4.2 mm-40 -132.89 155.88 48.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 129.58 -110.57 1.08 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 62.46 -103.29 0.59 Allowed Glycine 0 N--CA 1.504 3.178 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.2 mttt -51.6 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.395 -1.062 . . . . 0.0 111.604 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 52.09 118.61 0.01 OUTLIER Glycine 0 N--CA 1.497 2.722 0 O-C-N 121.468 -0.77 . . . . 0.0 111.375 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' OG ' ' HA2' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -152.43 37.39 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.756 -1.438 . . . . 0.0 109.497 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.6 -86.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -138.48 -3.61 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.06 55.88 0.01 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -171.63 177.34 3.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.193 . . . . 0.0 109.477 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CE ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -114.46 83.82 9.04 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.255 -0.903 . . . . 0.0 110.414 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' O ' HG23 ' A' ' 60' ' ' THR . 38.6 Cg_endo -82.69 70.35 6.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.038 1.825 . . . . 0.0 110.164 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -43.93 112.88 0.44 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 58' ' ' PRO . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.547 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.78 168.34 9.25 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.08 60.15 0.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.099 -1.001 . . . . 0.0 109.396 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . -117.24 95.27 0.65 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 64.6 172.13 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.379 -1.071 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ALA . . . 178.58 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' HG2' ' A' ' 36' ' ' GLU . 51.1 m 61.15 -163.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -103.77 39.59 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.559 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.7 OUTLIER -112.25 152.62 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.473 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 74' ' ' GLU . 24.6 m -67.63 93.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 109.549 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.2 OUTLIER 52.71 98.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.032 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HA ' HG22 ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.567 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.669 HD11 ' NH2' ' A' ' 115' ' ' ARG . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.14 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.838 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.898 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 89' ' ' ALA . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.14 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.717 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.032 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.944 ' HB2' HG22 ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -101.1 131.51 47.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 26' ' ' ALA . 3.8 mttt -82.85 82.35 8.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.9 OUTLIER 53.0 -157.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 109.745 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER 74.74 72.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.182 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 121' ' ' SER . 11.8 pt20 -63.59 -18.31 63.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.426 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER 71.97 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.59 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.39 146.02 30.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 109.541 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -73.41 -67.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.498 HG23 ' N ' ' A' ' 125' ' ' THR . 3.4 t -173.22 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.557 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 124' ' ' THR . 0.2 OUTLIER 46.28 -151.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 125' ' ' THR . . . -93.3 150.1 20.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.76 -78.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 59.95 -152.46 36.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -87.25 121.07 29.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.239 . . . . 0.0 109.312 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.532 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.6 128.71 9.63 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.479 2.12 . . . . 0.0 110.516 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.7 p-10 -75.27 -167.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.68 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 7' ' ' SER . 2.8 tp -149.76 111.97 4.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.68 -19.5 7.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -23.55 23.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 109.317 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.614 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 61.81 -172.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.512 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -60.49 140.68 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.91 . . . . 0.0 109.41 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.12 -161.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -156.96 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.08 112.74 25.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.13 102.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.657 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' ALA . 44.1 t -78.45 -69.3 0.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 42.73 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.81 109.7 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.211 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . . . 48.67 -157.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.49 -74.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.3 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -91.33 33.81 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 66.6 t0 -109.24 62.21 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.7 t -115.44 30.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.45 137.36 30.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 24' ' ' SER . 94.1 t -152.51 145.4 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.244 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.2 37.39 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 109.83 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 22' ' ' VAL . 9.6 t -131.63 -16.5 2.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.37 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.408 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER 48.92 42.59 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.953 -1.092 . . . . 0.0 109.143 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 49.87 72.54 0.31 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.893 . . . . 0.0 109.251 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 15.0 mt-10 -142.32 83.31 1.82 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.936 0.874 . . . . 0.0 109.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.828 ' HB1' ' HD3' ' A' ' 115' ' ' ARG . . . 70.23 161.23 0.22 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -138.1 140.72 40.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.552 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HB2' HD11 ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.903 HG23 HG13 ' A' ' 113' ' ' VAL . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' OG1' ' A' ' 75' ' ' THR . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt -95.2 92.64 6.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 3.0 ptm -126.37 8.29 7.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 172.4 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.96 -69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 116.85 62.4 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.848 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 8.1 mp0 -133.52 153.24 51.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 141.39 -121.48 1.88 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -159.39 -144.95 4.11 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 3.4 ptpt -77.63 53.45 1.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.438 . . . . 0.0 110.359 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' CA ' ' O ' ' A' ' 57' ' ' LYS . . . 57.14 -87.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.9 m -165.35 142.2 5.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.48 -38.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' HIS . 36.1 t-80 -152.19 27.86 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.38 -97.46 0.11 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER 177.2 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.747 -1.443 . . . . 0.0 110.402 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -128.74 85.77 59.33 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.632 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' O ' HG23 ' A' ' 60' ' ' THR . 38.4 Cg_endo -82.01 93.75 0.93 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.02 1.813 . . . . 0.0 110.562 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -50.97 110.01 0.38 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.942 -1.099 . . . . 0.0 108.617 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.798 HG22 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -112.12 169.97 8.48 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -108.2 101.87 11.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.07 -1.019 . . . . 0.0 109.139 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . 173.03 136.79 2.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 69.53 116.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.47 -179.47 1.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.686 ' H ' HG21 ' A' ' 75' ' ' THR . 0.8 OUTLIER -112.78 -160.71 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.11 46.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.856 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.863 ' HB3' HG22 ' A' ' 75' ' ' THR . 2.3 tt0 -118.63 132.64 56.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 72' ' ' GLN . 54.9 p -38.98 -43.12 0.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 0.0 110.149 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HG3' ' C ' ' A' ' 73' ' ' SER . 89.6 mt-10 -146.72 101.17 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 72' ' ' GLN . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.793 HG23 HG22 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.458 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 101' ' ' ILE . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.813 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.793 HG22 HG23 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.828 ' HD3' ' HB1' ' A' ' 28' ' ' ALA . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.681 ' HD2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.02 145.92 25.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.58 113.43 21.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 118' ' ' SER . 0.0 OUTLIER 64.28 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.126 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 116' ' ' ARG . 0.5 OUTLIER 177.51 106.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.464 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.509 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -58.55 -172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.204 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER 162.99 -63.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 109.375 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 126.78 30.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -172.72 82.62 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.2 p -73.2 131.09 41.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.75 -170.18 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.093 -1.005 . . . . 0.0 109.572 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -53.01 -54.71 31.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.712 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 126' ' ' ALA . . . 65.48 172.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 0.0 109.328 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.31 -75.44 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -113.61 174.37 5.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -1.114 . . . . 0.0 109.548 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.45 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 1' ' ' MET . 34.9 Cg_endo -77.39 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.435 2.09 . . . . 0.0 110.803 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -154.02 163.84 39.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 109.653 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.72 -76.56 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.86 . . . . 0.0 109.486 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.93 -41.13 97.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 7' ' ' SER . 4.5 m 68.01 126.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 6' ' ' SER . 29.7 t 62.3 176.55 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 p -78.95 -33.5 45.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.92 163.81 23.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -63.14 -49.97 72.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 173.66 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.43 -51.59 2.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -92.76 -49.47 6.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.84 70.68 3.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -44.13 20.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.63 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.72 52.11 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 m -113.47 126.9 55.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.325 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.67 103.71 8.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' VAL . 25.7 m -50.14 141.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.366 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 22' ' ' VAL . 24.1 t -46.13 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.413 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 23' ' ' GLU . 5.8 m -60.42 -156.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 22' ' ' VAL . 6.2 mt-10 46.62 70.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.498 ' O ' ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -145.02 75.85 1.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.428 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 24' ' ' SER . 1.7 t 39.43 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 109.773 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.31 134.55 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.98 . . . . 0.0 109.851 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 121' ' ' SER . 3.3 mt-10 52.37 23.48 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.001 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -177.14 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 109.165 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p -126.88 133.62 50.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm -79.93 119.5 22.87 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.8 mtm -131.73 -36.93 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.754 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.39 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 109.838 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . -156.91 29.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.357 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 43.32 62.59 2.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.866 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.865 HD22 HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mp0 -131.33 156.24 45.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 154.03 -115.84 0.7 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 129.51 145.4 5.86 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 118.485 -1.817 . . . . 0.0 110.935 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.652 ' HD2' HG23 ' A' ' 94' ' ' THR . 8.3 mtpm? -44.78 128.81 6.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.981 -1.305 . . . . 0.0 109.704 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.37 -134.94 8.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m 179.18 -70.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.71 -1.465 . . . . 0.0 109.337 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -120.85 36.88 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.059 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -134.93 -30.34 1.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.007 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 56' ' ' ASP . . . 156.6 45.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.3 p-10 43.06 -149.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -1.188 . . . . 0.0 109.871 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HE3' ' CG ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -109.98 86.3 4.83 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 0.0 110.275 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.79 ' O ' HG23 ' A' ' 60' ' ' THR . 36.7 Cg_endo -78.01 62.68 8.03 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.976 1.784 . . . . 0.0 109.466 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER -42.95 121.65 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 7.4 m-20 -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.775 HD11 HG21 ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -122.0 -66.12 1.06 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER 160.32 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -104.53 37.94 3.53 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . . . 46.87 -171.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.364 -1.08 . . . . 0.0 108.985 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.59 175.28 9.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.221 -0.924 . . . . 0.0 109.273 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 5.0 m -101.32 -22.03 14.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 70' ' ' SER . 2.1 pp20? 171.84 40.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 131.59 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.048 -1.032 . . . . 0.0 109.987 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.79 152.42 22.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.382 -0.824 . . . . 0.0 108.846 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.66 46.74 3.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.953 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.916 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.974 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.725 ' HG3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.453 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 101' ' ' ILE . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.652 HG23 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.782 ' HA ' HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.956 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.547 ' HB1' ' HE3' ' A' ' 90' ' ' MET . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.974 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.858 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.426 ' H ' ' HA2' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.953 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG3' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 -89.32 162.61 15.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -126.81 130.03 49.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.717 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.24 151.26 23.6 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.29 -0.881 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 78.13 5.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.39 37.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.405 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -83.12 134.93 34.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -90.92 63.79 5.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.77 -30.33 2.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 125' ' ' THR . 12.6 t -47.78 136.15 11.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.875 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 124' ' ' THR . 42.1 p 46.28 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.43 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.13 -60.45 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.225 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -145.58 -170.2 14.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.78 -65.02 1.04 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.92 125.98 6.93 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.693 2.262 . . . . 0.0 110.148 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -176.07 -70.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.126 -0.984 . . . . 0.0 110.001 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.23 -39.99 16.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.961 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -72.94 -159.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.9 -174.52 3.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.124 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.459 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -158.19 -56.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.938 . . . . 0.0 109.405 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 7' ' ' SER . 18.0 p 53.03 57.87 5.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.408 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 23.9 p-10 -154.49 130.8 10.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.269 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.02 -52.61 2.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.81 31.8 18.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.411 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.76 44.25 17.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -131.48 2.36 4.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.81 -62.64 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.88 -163.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -81.27 -76.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.671 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 78.74 -50.35 0.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.869 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 m -118.69 171.02 8.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.967 . . . . 0.0 109.744 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.06 158.0 17.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 21' ' ' SER . 2.4 p -153.49 140.72 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.66 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 74.41 114.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.613 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 21' ' ' SER . 3.6 t 70.69 132.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.902 . . . . 0.0 109.67 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.16 172.45 11.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.0 m -77.42 85.82 3.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 57.01 87.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.565 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -160.53 148.35 16.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER 65.74 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 65.51 157.33 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.54 129.12 21.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.088 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' CD ' HD11 ' A' ' 105' ' ' LEU . 2.8 tptp -80.02 131.84 35.88 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.455 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -119.81 -56.62 2.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.042 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.4 OUTLIER 167.8 57.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.786 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.29 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.059 . . . . 0.0 110.265 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.566 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 78.99 47.89 7.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.856 HD21 ' CG2' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.513 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 -145.34 150.83 37.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . 124.56 -113.39 1.98 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 57' ' ' LYS . . . 71.77 -139.38 28.59 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.526 -1.321 . . . . 0.0 109.894 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.9 pttt -45.78 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.252 . . . . 0.0 109.845 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.29 -98.74 2.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -147.54 -156.69 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 109.488 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.7 mm? -108.51 36.6 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.18 8.46 13.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . . . -178.73 -81.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER 169.12 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.284 . . . . 0.0 109.696 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HB2' ' HA2' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -115.31 84.24 11.35 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.0 109.898 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 60' ' ' THR . 40.2 Cg_endo -86.79 74.45 2.89 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.599 2.2 . . . . 0.0 111.265 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 95' ' ' ARG . 6.5 mp -46.83 121.6 3.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.595 -1.315 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 1.045 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.652 HG21 HD11 ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 -109.79 -59.26 1.94 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -136.04 123.05 21.46 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.079 -1.013 . . . . 0.0 109.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -95.49 -143.99 15.75 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' SER . . . 55.58 104.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -1.128 . . . . 0.0 109.066 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB3' ' HB2' ' A' ' 72' ' ' GLN . . . -63.32 -165.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.98 . . . . 0.0 108.552 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -41.49 -55.96 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.204 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' GLN . 28.2 tt0 -131.08 -18.05 3.0 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.605 -0.684 . . . . 0.0 110.221 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -49.47 176.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 84.7 p -92.77 -74.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 73' ' ' SER . 2.4 mp0 -122.71 103.86 8.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' HD21 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.629 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.045 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.573 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.901 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.929 ' HG2' HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' MET . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 1.013 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 101' ' ' ILE . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.518 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.694 ' O ' HD22 ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.658 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.921 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 89.73 8.11 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.84 159.09 27.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.71 56.72 3.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 45.21 84.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -168.83 -156.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -163.26 -70.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 72.59 -59.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.32 -168.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.56 74.78 1.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -104.09 -179.29 3.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.396 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -94.76 -158.78 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . 173.35 109.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.65 114.09 3.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.29 68.35 0.54 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -1.119 . . . . 0.0 109.258 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.434 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 36.6 Cg_endo -78.64 116.98 3.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.398 2.065 . . . . 0.0 110.154 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.31 -5.86 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -163.16 -161.37 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -47.1 -27.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 p -174.16 -173.63 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.576 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -175.4 34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.09 137.3 47.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -162.99 -151.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -76.28 -169.51 1.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -62.6 1.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.04 21.29 0.44 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.61 80.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -165.95 61.32 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.07 54.02 2.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -177.76 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 68.38 -59.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 179.74 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.47 162.24 15.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.913 . . . . 0.0 109.578 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 20' ' ' VAL . 9.3 t 65.76 30.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -78.75 121.17 24.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.814 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 22' ' ' VAL . 2.6 p 40.07 76.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -90.41 94.3 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.464 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER 75.97 175.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.481 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -152.77 150.67 29.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.308 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 27' ' ' GLU . . . -123.64 165.48 17.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 7.6 mt-10 150.99 102.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . . . -177.32 145.65 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 109.685 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p -114.54 146.36 40.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.01 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.683 ' HB2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -90.49 132.31 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 1.1 mtp -137.03 76.6 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.208 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.5 t 59.45 53.0 5.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.96 . . . . 0.0 109.339 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.25 -63.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.388 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 132.53 51.12 0.09 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.046 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 1.046 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.93 HD21 ' CE ' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 95' ' ' ARG . 17.8 mt-10 -122.85 155.92 35.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.585 ' HA3' ' HG ' ' A' ' 59' ' ' LEU . . . -153.21 123.38 1.42 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.235 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -87.59 57.38 4.44 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.387 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.0 tmtt? -44.53 116.44 1.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.001 -1.293 . . . . 0.0 109.145 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . 44.04 62.03 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -96.07 18.25 13.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mp 44.99 48.82 9.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.366 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -132.64 -25.41 1.9 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.879 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . 139.39 66.97 0.04 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.4 m-20 77.47 169.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.077 . . . . 0.0 109.367 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.29 86.32 27.11 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.993 ' O ' HG23 ' A' ' 60' ' ' THR . 37.1 Cg_endo -79.65 76.16 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.355 2.037 . . . . 0.0 110.51 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 90' ' ' MET . 1.6 mp -45.84 127.74 8.31 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 58' ' ' PRO . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 1.2 m-80 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 -112.28 161.41 16.64 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.9 136.45 55.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.93 -170.09 12.24 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -110.51 18.97 19.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.032 -1.275 . . . . 0.0 109.491 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . 42.45 -168.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.734 -0.604 . . . . 0.0 109.646 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -132.39 -76.33 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.044 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.99 7.34 3.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.538 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.668 ' O ' HG23 ' A' ' 75' ' ' THR . 10.5 tt0 -129.68 128.65 42.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -50.93 143.57 9.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.358 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' CG ' ' C ' ' A' ' 73' ' ' SER . 1.8 pt-20 38.54 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.508 -0.745 . . . . 0.0 109.76 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.753 ' CG ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.946 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.988 ' HA ' HG22 ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.81 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.742 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.133 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.703 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.93 ' CE ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.98 ' O ' HD12 ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.98 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.133 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.845 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.742 ' O ' HD22 ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.946 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.904 ' HB2' HG22 ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.04 177.04 6.56 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 mttt -151.35 175.09 12.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.7 t 78.09 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 109.71 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.6 OUTLIER 79.89 141.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.499 -0.751 . . . . 0.0 109.534 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -110.06 14.81 22.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.835 . . . . 0.0 109.707 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.7 m -47.57 -25.82 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.27 121.28 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -71.01 -58.41 3.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.63 176.89 8.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -158.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.36 -166.81 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 50.35 22.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.59 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.79 -129.47 2.35 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.36 164.79 15.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.151 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.491 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.674 2.25 . . . . 0.0 110.34 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.07 169.44 0.42 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.565 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -61.88 153.49 28.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' SER . 1.7 m-80 -95.59 -88.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.298 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ASN . 3.2 m 51.41 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -11.36 60.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 109.307 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.4 m -80.26 125.35 29.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -175.22 -45.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -65.87 -67.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.21 100.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.41 113.75 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 39.16 4.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 101.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -155.45 -61.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.344 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.52 147.36 39.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -154.47 108.59 2.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER 63.47 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' C ' HG23 ' A' ' 20' ' ' VAL . 1.1 t0 72.44 129.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 19' ' ' ASP . 3.5 t 72.2 155.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.913 . . . . 0.0 109.643 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 22' ' ' VAL . 38.6 t -165.73 -163.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.131 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' N ' ' OG ' ' A' ' 21' ' ' SER . 12.2 p -44.87 135.02 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 0.0 109.231 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 24' ' ' SER . 16.0 tp10 -124.88 119.98 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 52.85 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.936 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 68.7 p -110.51 58.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 0.0 109.166 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -179.41 -166.37 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.307 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 5.2 mt-10 66.5 96.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.935 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.89 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.733 -0.604 . . . . 0.0 110.129 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.9 134.79 37.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 HD13 ' A' ' 112' ' ' ILE . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.31 118.97 21.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.0 mmm -137.0 -35.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.978 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 30.7 p -162.55 165.58 25.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 110.052 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 67.08 -72.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.42 -0.8 . . . . 0.0 109.847 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.538 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 148.62 77.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.878 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.878 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 -153.15 155.32 36.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.72 -117.57 0.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.674 ' O ' HD12 ' A' ' 59' ' ' LEU . . . -145.7 158.26 27.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.706 ' HD2' HG23 ' A' ' 94' ' ' THR . 1.5 ptmt -86.98 -12.02 48.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.656 -1.497 . . . . 0.0 111.3 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.6 ' CA ' ' HG3' ' A' ' 57' ' ' LYS . . . 122.77 14.79 4.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 70.5 m -150.52 74.24 1.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -1.111 . . . . 0.0 109.032 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.57 -73.59 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.214 -0.929 . . . . 0.0 109.684 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -139.85 -20.62 0.9 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.201 -0.937 . . . . 0.0 110.679 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' N ' ' HE3' ' A' ' 57' ' ' LYS . . . 157.01 -22.06 0.45 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.007 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' C ' ' HD3' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -141.18 92.38 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.447 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.639 ' CB ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.69 81.28 40.64 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -93.34 112.22 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.631 2.221 . . . . 0.0 111.469 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -68.11 118.13 10.85 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 1.01 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 m-20 -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.714 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 -107.01 161.11 15.03 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.47 112.2 19.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.651 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.72 -44.19 0.52 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.93 114.93 28.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -1.174 . . . . 0.0 109.43 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -177.64 -173.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.156 -0.965 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -112.31 -156.46 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -117.4 35.76 4.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.455 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.8 OUTLIER -91.57 39.93 1.02 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.592 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 72' ' ' GLN . 51.7 p 47.94 84.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.806 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' SER . 41.2 mt-10 63.09 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.585 ' OG1' HD21 ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.858 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 114' ' ' ILE . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.852 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.464 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.777 ' HE3' ' HB2' ' A' ' 59' ' ' LEU . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.706 HG23 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.797 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.9 ' O ' HD12 ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.612 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.741 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.704 HD13 HD12 ' A' ' 35' ' ' LEU . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.858 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.789 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 -95.68 103.78 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 61.28 6.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.006 -1.059 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.53 106.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.0 109.712 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 119' ' ' LEU . 3.1 tt -145.96 33.07 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.162 -0.962 . . . . 0.0 109.347 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 7.1 tt0 176.74 -30.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 48.79 -157.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' SER . 14.9 mttp 62.12 94.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 51.28 -157.71 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 125' ' ' THR . 38.2 p -136.76 -170.97 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.57 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 127' ' ' ALA . 27.0 p 47.59 40.7 12.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 63.09 -74.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 125' ' ' THR . . . -90.99 -149.1 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -158.91 -95.84 0.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -134.43 50.36 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -1.106 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.603 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 1' ' ' MET . 35.6 Cg_endo -78.49 82.82 2.37 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER 169.48 51.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.268 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' ASN . 1.3 mt -174.77 -73.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 5' ' ' ASN . 2.4 p-10 40.91 37.99 0.6 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.525 -0.734 . . . . 0.0 110.046 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.23 -159.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.531 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.27 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.73 91.24 2.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 0.0 109.705 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 57.61 -173.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.708 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -97.34 -8.93 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.52 -72.48 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.569 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.76 -71.3 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -167.46 145.9 4.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.53 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.92 175.88 5.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.97 116.13 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.75 34.24 5.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.24 41.75 1.92 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.343 -0.848 . . . . 0.0 109.083 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -101.05 105.96 17.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -0.826 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 20' ' ' VAL . 32.7 t70 -64.92 113.32 3.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER 58.24 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -86.11 -166.75 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.376 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.27 148.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -95.37 96.67 9.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -144.66 107.45 4.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.3 m -101.81 46.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.12 86.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.326 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -96.04 27.69 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 109.322 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . . . -44.56 121.12 2.5 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.636 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER -150.74 148.65 28.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.567 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.888 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.535 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.74 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' CD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -78.72 117.31 19.74 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttp -147.08 -39.01 0.2 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.864 . . . . 0.0 109.178 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 40' ' ' ALA . 95.3 p -69.24 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.444 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -174.01 39.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 148.26 40.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.998 ' CE2' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 -147.22 155.7 42.31 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -151.09 -93.09 0.1 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 167.26 104.13 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.782 -1.675 . . . . 0.0 111.477 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 49' ' ' GLY . 4.9 tttt -28.96 131.7 0.05 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 122.016 -0.696 . . . . 0.0 109.866 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 57' ' ' LYS . . . -40.35 100.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -126.2 139.01 53.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.09 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER 59.2 -151.98 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.167 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.551 ' H ' HD23 ' A' ' 53' ' ' LEU . 18.2 p-80 -89.78 29.74 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -120.9 98.25 0.66 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.1 m-20 -49.28 -179.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.253 . . . . 0.0 109.26 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -110.1 82.77 2.68 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 110.736 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 60' ' ' THR . 37.3 Cg_endo -79.44 68.99 8.12 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.25 1.967 . . . . 0.0 110.206 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.2 mp -41.61 132.57 2.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.886 HG22 ' HA ' ' A' ' 81' ' ' GLU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.807 HG21 HG13 ' A' ' 64' ' ' ILE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.493 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.807 HG13 HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -123.55 101.34 7.27 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 108.803 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 68' ' ' ALA . . . 166.27 72.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . 168.47 -169.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.354 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 75' ' ' THR . . . 64.94 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p -162.77 42.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.52 -25.29 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 109.795 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -173.77 28.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' GLN . 24.6 p 47.92 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 110.03 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.4 mt-10 39.5 42.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.76 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.685 ' O ' HD21 ' A' ' 35' ' ' LEU . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' A' ' 82' ' ' ILE . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.886 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.998 HD21 ' CE2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.947 HG21 HD11 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.051 ' CE ' ' HB2' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 90' ' ' MET . 8.9 mm100 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 1.017 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.827 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.493 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.04 ' O ' HD12 ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.051 ' HB2' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.626 ' HZ3' HD11 ' A' ' 42' ' ' LEU . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.04 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.982 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.982 HD12 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.57 ' N ' HD22 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.674 HG11 HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.74 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.888 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 85.36 6.2 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -72.03 90.48 1.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 109.236 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 119' ' ' LEU . 1.4 t 59.37 -163.42 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 118' ' ' SER . 2.3 mp 60.91 113.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -106.32 4.82 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.628 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.92 178.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.684 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 92.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.53 -167.6 0.11 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -141.55 -47.19 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.493 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 124' ' ' THR . 81.2 m 65.2 87.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.386 -0.822 . . . . 0.0 109.714 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.03 165.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.937 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.18 118.71 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.269 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.62 152.88 47.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.97 114.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 109.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.378 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.586 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 36.5 Cg_endo -78.83 -48.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.313 2.009 . . . . 0.0 109.883 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 72.5 m-20 62.69 -83.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.568 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -173.24 145.27 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 177.6 165.26 0.63 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -51.19 173.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.305 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.75 91.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p -105.99 -33.45 7.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.181 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -72.3 99.75 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.86 118.23 9.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.52 163.42 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.01 -44.12 6.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -169.5 161.19 9.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.632 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.28 -64.29 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.877 . . . . 0.0 109.487 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 t -157.6 59.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.23 -27.46 13.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . -77.15 -167.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 69.45 -148.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.415 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.65 82.55 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 t -87.79 154.63 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.394 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 141.63 49.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.85 175.47 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 66.7 mt-10 60.6 169.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 24' ' ' SER . 38.7 p 52.33 77.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 p -127.76 -76.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.89 40.92 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.524 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 49.49 23.39 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 109.578 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.91 170.34 1.21 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p -120.26 138.05 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 115' ' ' ARG . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.998 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 HG23 HG13 ' A' ' 113' ' ' VAL . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp -81.96 128.37 34.0 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.564 ' HG3' ' N ' ' A' ' 39' ' ' SER . 12.2 ptp -135.71 -37.05 0.76 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' A' ' 38' ' ' MET . 0.2 OUTLIER 177.33 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 178.05 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 110.223 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 102.26 68.77 0.81 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.97 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.97 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.829 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 -116.19 157.55 24.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' CA ' ' HG ' ' A' ' 59' ' ' LEU . . . -146.8 118.12 1.0 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -71.93 56.96 1.4 Allowed Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.62 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HB3' HG22 ' A' ' 94' ' ' THR . 2.8 ptmt -36.47 104.15 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.573 -0.957 . . . . 0.0 109.708 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 52' ' ' SER . . . -113.18 -109.73 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 14.3 m -167.05 -148.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.683 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.97 -17.56 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.859 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -125.7 32.84 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.932 . . . . 0.0 109.579 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -130.18 -42.42 0.21 Allowed Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.98 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 1.5 m-20 61.45 126.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -1.219 . . . . 0.0 108.761 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.81 89.37 45.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.077 . . . . 0.0 110.833 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 37.4 Cg_endo -79.82 85.38 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.337 2.025 . . . . 0.0 108.511 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 95' ' ' ARG . 1.9 mp -44.61 151.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.083 -1.01 . . . . 0.0 110.111 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.727 HG22 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.84 HG21 HD11 ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -109.74 -61.22 1.67 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 68' ' ' ALA . 23.0 tttt -133.04 109.46 9.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.831 ' HA2' HG21 ' A' ' 76' ' ' VAL . . . -66.61 74.12 0.15 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -70.76 164.42 25.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -1.167 . . . . 0.0 109.616 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.52 130.18 5.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.439 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.2 m -78.98 -12.62 60.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.47 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.73 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.547 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.9 OUTLIER -142.71 161.39 38.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 109.636 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -92.73 103.5 15.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 73' ' ' SER . 0.3 OUTLIER 64.71 84.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' HA2' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 60' ' ' THR . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.602 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.771 ' NE2' HG21 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.931 ' HA2' HG22 ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 101' ' ' ILE . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.578 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 1.03 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.8 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.015 ' O ' HD12 ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 101' ' ' ILE . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.931 HG22 ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.998 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.688 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -89.09 128.98 35.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.79 169.49 13.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.266 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.63 173.42 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 109.152 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' O ' ' CG ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER -168.9 67.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 109.598 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -109.11 29.82 7.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.378 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -132.07 150.78 52.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.358 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -95.92 145.4 25.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 178.66 95.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.643 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.91 124.6 37.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 126' ' ' ALA . 55.2 m -156.75 131.33 8.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 125' ' ' THR . . . 44.24 58.72 3.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 109.543 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.36 39.32 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.897 . . . . 0.0 109.267 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.71 -33.95 5.37 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 -151.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.494 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.494 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.26 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.818 2.346 . . . . 0.0 110.601 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ASN . 2.8 m-20 -127.67 125.31 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.925 . . . . 0.0 109.658 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -65.17 79.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' ASP . 2.2 m-20 -146.5 -71.69 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.958 . . . . 0.0 109.606 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.23 -176.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -61.01 -42.51 98.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.22 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 47.22 80.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 56.13 -118.03 1.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.07 157.05 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.753 -1.217 . . . . 0.0 109.397 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.75 3.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.97 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.61 -176.91 6.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.548 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.35 -164.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 -173.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 161.22 5.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 56.94 168.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.373 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 130.06 55.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 109.312 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' SER . 29.2 t0 67.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 21' ' ' SER . 29.4 m -69.41 142.19 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 4.4 t 75.25 134.93 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.581 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.7 m -153.65 120.08 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 74.64 138.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.263 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.05 106.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 29.7 m -79.55 -63.96 1.29 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 25' ' ' THR . . . 173.1 76.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 8.3 mt-10 67.03 103.36 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.688 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 117' ' ' LYS . . . -44.48 172.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p -124.45 135.67 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.428 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.82 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.32 133.39 36.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 39' ' ' SER . 34.4 mtt -132.74 -35.8 1.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 38' ' ' MET . 30.1 t 176.4 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.08 -66.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.761 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . 138.53 64.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HG ' HD23 ' A' ' 59' ' ' LEU . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 -118.69 156.59 29.02 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' LEU . . . -151.13 118.51 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . -73.41 55.66 1.98 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 119.224 -1.465 . . . . 0.0 109.495 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 50' ' ' LYS . 8.0 pttp -54.31 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -1.197 . . . . 0.0 109.825 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 144.87 100.07 0.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 56' ' ' ASP . 7.5 m -136.48 -132.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 108.777 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -46.59 8.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.778 -1.201 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 8.95 1.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 109.914 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.32 67.64 0.09 OUTLIER Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 8.2 m-20 -130.32 78.05 1.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -1.176 . . . . 0.0 109.446 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -125.67 90.59 50.24 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.252 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 36.6 Cg_endo -78.16 86.05 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.977 . . . . 0.0 109.715 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.721 HD13 ' CB ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -45.35 133.37 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.986 . . . . 0.0 109.052 -179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.789 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' CD1' HD11 ' A' ' 82' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 7.0 m-30 -105.71 171.24 7.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.92 76.12 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.92 -14.85 12.78 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 71.08 116.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -1.032 . . . . 0.0 109.531 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.754 ' HB3' ' CG2' ' A' ' 75' ' ' THR . . . -95.48 121.28 37.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' GLU . 1.8 p 48.54 -100.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER 168.31 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.085 -1.01 . . . . 0.0 109.724 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' GLU . 3.8 pt20 -101.96 65.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.283 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 56.7 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mm-40 -109.75 160.36 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 108.979 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.782 ' HA ' HG11 ' A' ' 33' ' ' VAL . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.88 ' OD2' HG21 ' A' ' 114' ' ' ILE . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.789 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' ILE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.888 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.894 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.751 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 1.058 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.058 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.943 ' CG ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.888 ' CD1' HG21 ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.765 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.474 ' HB2' HG22 ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -102.17 138.4 39.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.631 ' CG ' ' HB2' ' A' ' 28' ' ' ALA . 2.9 mttm -108.11 176.48 5.12 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.474 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 12.0 p -46.36 118.45 1.95 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mt -118.58 154.12 33.13 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -143.88 -52.25 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.676 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -130.85 39.18 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.847 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 121' ' ' SER . 6.9 pttm 41.66 -162.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.347 -0.846 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 114.62 21.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 t -85.94 154.78 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -127.93 -34.42 2.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -134.68 -91.65 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . 176.31 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.528 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.63 78.43 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 170.6 14.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.412 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.39 -65.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.516 2.144 . . . . 0.0 110.563 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -124.64 -93.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.577 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.38 88.59 2.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 54.52 86.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.1 OUTLIER 71.34 177.92 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.51 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.04 -38.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 48.6 p-10 -92.69 69.88 4.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.229 -0.92 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -48.42 11.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.226 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.12 -171.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.55 135.72 48.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t 54.33 177.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.13 37.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.79 -42.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.544 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -88.02 18.3 4.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 64.71 27.6 13.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.27 168.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.548 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 16.7 t0 -59.15 165.61 2.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.601 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 21' ' ' SER . 46.7 t -95.3 147.74 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.65 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER 76.85 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 109.574 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 22' ' ' VAL . 12.7 m -84.66 126.45 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.503 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' A' ' 19' ' ' ASP . 27.9 tp10 -90.28 61.46 5.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.516 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -102.35 41.81 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.7 t -72.52 169.94 15.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -103.34 -172.5 2.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 23.8 mt-10 64.44 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.11 -0.994 . . . . 0.0 109.433 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 62.02 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -150.47 144.6 25.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 113' ' ' VAL . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD11 HG13 ' A' ' 76' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.82 81.65 5.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' MET . 3.6 ttm -135.5 5.19 3.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m -105.07 -63.73 1.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 109.284 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 165.1 45.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.977 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 120.44 53.49 0.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.903 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.903 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.844 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 -140.46 139.95 35.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -159.84 -103.3 0.19 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 57' ' ' LYS . . . 174.03 104.69 0.18 Allowed Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.787 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 1.051 ' HB3' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -47.37 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -1.12 . . . . 0.0 109.782 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . 158.9 103.04 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.722 ' HB3' HD23 ' A' ' 53' ' ' LEU . 40.0 m -50.12 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -1.15 . . . . 0.0 109.704 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD23 ' HB3' ' A' ' 52' ' ' SER . 0.1 OUTLIER -129.53 -0.78 4.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.653 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -105.53 26.3 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.257 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . 166.98 74.74 0.03 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.2 p30 -38.99 141.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.439 -1.036 . . . . 0.0 109.598 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -112.54 84.5 6.39 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.409 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' O ' HG23 ' A' ' 60' ' ' THR . 37.8 Cg_endo -81.43 72.63 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.427 2.085 . . . . 0.0 109.889 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -44.38 130.09 6.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 108.962 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.911 HG21 HD11 ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.911 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 -108.55 -45.97 3.76 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.4 tttt 73.96 126.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.66 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.74 -62.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.59 149.34 39.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -1.136 . . . . 0.0 109.184 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.23 175.93 9.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 71' ' ' GLU . 89.0 p -96.3 -100.07 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' N ' ' OG ' ' A' ' 70' ' ' SER . 15.6 pm0 -124.08 33.01 5.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.251 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.771 ' HB3' HG22 ' A' ' 75' ' ' THR . 3.7 tt0 -130.93 132.34 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.446 -0.784 . . . . 0.0 109.097 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 72' ' ' GLN . 11.3 m -44.36 -47.75 9.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 -133.55 106.77 7.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.118 -0.989 . . . . 0.0 109.693 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.857 ' OG1' HD21 ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.861 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.68 ' HG3' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 123' ' ' GLU . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.69 ' CG ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.951 ' HA ' HG22 ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.772 ' CD1' HG22 ' A' ' 112' ' ' ILE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.115 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 1.051 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.861 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.023 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.115 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.026 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.772 HG22 ' CD1' ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.69 HD12 ' CG ' ' A' ' 80' ' ' ASP . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.445 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -123.46 105.9 10.18 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -66.68 85.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 117' ' ' LYS . 0.9 OUTLIER 59.67 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.666 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.5 tp -122.04 134.02 54.79 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -69.49 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.95 . . . . 0.0 109.345 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 122' ' ' LYS . 29.7 t -82.73 -173.32 4.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.275 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 121' ' ' SER . 3.9 ptmm? -138.87 170.13 16.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' HB2' ' HD3' ' A' ' 78' ' ' PRO . 2.7 tt0 -56.17 117.07 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.79 145.37 31.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 -174.35 4.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.633 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 108.69 20.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -158.46 95.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.12 134.79 12.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -55.1 -18.39 5.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.571 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 1' ' ' MET . 35.9 Cg_endo -78.35 -13.92 14.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.796 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 25.9 t70 -102.62 -94.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.889 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 6.3 tp 76.45 73.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.194 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.587 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 0.8 OUTLIER 40.56 57.91 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.722 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 7' ' ' SER . 3.7 m -75.48 -141.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.882 . . . . 0.0 109.37 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.9 OUTLIER 74.86 132.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 7' ' ' SER . 33.2 p 45.42 54.82 7.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.24 74.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -128.42 14.07 6.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.1 124.92 25.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.59 -77.46 0.57 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -99.14 110.91 23.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.29 173.63 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.2 -157.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ALA . . . -162.16 84.98 0.58 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . 177.99 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -55.08 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.6 m-20 -119.19 49.36 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 37.96 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 p -117.88 30.27 7.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.153 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.63 38.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.512 -0.742 . . . . 0.0 109.384 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' SER . 3.5 pt-20 174.6 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.61 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER 66.65 94.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 74.5 p -110.81 17.47 20.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 25' ' ' THR . . . 65.06 127.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 mt-10 62.69 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 174.47 139.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p -127.56 144.14 51.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.07 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 69' ' ' ALA . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.714 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -78.45 99.68 6.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtt -150.77 31.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.612 -0.68 . . . . 0.0 109.236 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 m -141.54 -143.39 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.13 -5.82 59.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 110.041 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 156.72 76.1 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.894 ' CE1' HD13 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.894 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 -152.87 156.46 39.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 179.17 -100.73 0.14 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 176.39 103.71 0.17 Allowed Glycine 0 N--CA 1.495 2.62 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.185 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -47.31 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.237 . . . . 0.0 108.592 178.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -44.12 97.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.59 -65.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.9 -131.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -127.45 33.64 4.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.979 -1.075 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -119.67 -70.29 0.32 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 170.62 176.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 0.0 109.65 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -113.34 84.45 7.58 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 60' ' ' THR . 37.3 Cg_endo -80.27 79.48 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.29 1.994 . . . . 0.0 110.516 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HG ' ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -46.35 135.22 8.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 108.122 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 HD11 ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 4.0 m120 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 2.8 m-30 -107.82 160.24 15.89 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 106.34 16.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.37 125.98 0.84 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 46.23 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.418 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . 46.49 42.7 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 48.12 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -111.33 -9.36 14.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 109.95 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 73' ' ' SER . 61.0 mt-30 -103.27 39.41 1.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 72' ' ' GLN . 8.0 t 67.41 56.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER 70.18 96.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.499 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HB ' HD13 ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.611 ' NE2' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.922 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.861 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 114' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.911 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.038 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.939 ' HE2' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.957 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HD2' ' N ' ' A' ' 48' ' ' GLY . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.788 ' O ' HD12 ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.669 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.038 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.828 HD22 ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.637 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.672 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -89.86 149.23 22.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -135.79 120.56 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 75.48 178.02 0.2 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.46 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 174.19 7.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.7 8.65 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 53.42 36.38 22.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 70.16 -77.84 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.03 159.45 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.509 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.2 p -137.27 51.8 1.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 39.4 p -65.3 -155.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 66.68 -179.47 0.21 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.94 31.57 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . -109.49 99.69 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.5 m-20 65.19 -150.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.56 85.3 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.455 2.103 . . . . 0.0 110.287 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 64.81 93.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mt 57.15 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 6' ' ' SER . 44.8 m-80 -79.39 -73.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.534 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER 167.97 -68.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER 68.47 49.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 ' CB ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 74.45 133.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 10' ' ' SER . 2.9 t0 -134.41 170.19 16.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 168.77 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.3 54.3 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.24 91.58 2.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.895 . . . . 0.0 109.365 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -107.84 146.97 31.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.63 -168.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.17 -0.957 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 p -103.04 -59.48 1.7 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.216 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.33 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.2 49.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.85 58.66 4.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.436 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 0.6 OUTLIER 51.57 40.9 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.531 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 19' ' ' ASP . 4.8 m 39.51 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.581 -0.7 . . . . 0.0 109.739 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.19 111.24 15.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.408 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.99 103.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -66.81 138.15 57.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.21 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' A' ' 25' ' ' THR . 68.8 m -68.87 -74.33 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.748 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.403 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.1 OUTLIER 60.2 59.94 2.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.187 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' O ' ' CB ' ' A' ' 27' ' ' GLU . . . -133.52 84.55 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.2 mt-10 147.62 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 152.56 -179.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p -126.8 127.06 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' GLY . 16.5 tttt -83.76 116.99 22.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.9 mtm -114.17 -50.12 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.89 45.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.76 23.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 46.15 50.98 11.93 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.967 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.905 ' HE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 82' ' ' ILE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 11.7 mm-40 -137.43 155.59 49.17 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.46 -121.85 2.64 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -168.57 -156.58 10.53 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.619 ' CE ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.18 108.54 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.602 -1.528 . . . . 0.0 110.19 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . 28.54 -112.75 0.03 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.525 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.9 m -154.18 58.08 0.71 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 108.789 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.619 HD23 ' CE ' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -54.65 -49.08 71.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.287 -179.276 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.61 13.63 3.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.007 . . . . 0.0 110.082 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 56' ' ' ASP . . . -157.95 -110.91 0.3 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' CG ' ' O ' ' A' ' 55' ' ' GLY . 4.9 m-20 -162.1 84.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.348 . . . . 0.0 109.032 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -123.16 85.4 51.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.093 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -83.86 159.83 13.96 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.391 2.061 . . . . 0.0 109.689 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 90' ' ' MET . 6.4 mp -90.06 135.41 33.67 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 108.619 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.836 HG13 HD11 ' A' ' 82' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.821 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.72 -58.07 1.98 Allowed 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -146.25 127.8 15.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CG2' ' A' ' 76' ' ' VAL . . . -94.71 -113.18 2.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 60.36 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -1.122 . . . . 0.0 109.588 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.69 ' HB2' ' CG2' ' A' ' 75' ' ' THR . . . -76.71 -172.86 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 50.3 m -63.66 -27.99 69.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' SER . 2.0 mt-10 179.3 45.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -136.64 50.42 2.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 74' ' ' GLU . 1.2 p 45.93 -156.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' N ' ' OG ' ' A' ' 73' ' ' SER . 4.0 pm0 -61.38 135.22 57.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.09 -1.006 . . . . 0.0 109.672 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.69 ' CG2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.819 ' OD2' HG21 ' A' ' 114' ' ' ILE . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.836 HD11 HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.967 HD21 ' CD1' ' A' ' 42' ' ' LEU . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.928 HG21 HD11 ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.872 ' HG3' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.843 HD23 ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.699 ' NH2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.022 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CE3' ' HA ' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.022 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.928 HD11 HG21 ' A' ' 88' ' ' THR . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.676 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.449 ' OD1' ' HE3' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.819 HG21 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -94.68 -179.41 4.86 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.05 83.76 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.031 -1.043 . . . . 0.0 109.412 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 p -169.17 146.44 3.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 67.33 3.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' SER . 4.4 tt0 -106.62 20.52 18.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLN . 1.5 p -44.83 140.19 2.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.259 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -119.29 -92.32 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' N ' ' CG ' ' A' ' 122' ' ' LYS . 1.4 pt-20 -156.03 29.03 0.36 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.02 67.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.7 p -135.12 149.57 50.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.07 -20.8 61.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.404 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 49.37 69.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.52 140.75 5.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.29 28.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -1.108 . . . . 0.0 109.239 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.499 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -8.35 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.24 . . . . 0.0 110.438 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.652 ' O ' HD22 ' A' ' 4' ' ' LEU . 5.4 m-20 -69.24 -24.48 64.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -131.38 -41.83 1.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.475 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' LEU . 14.2 p30 41.87 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.428 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.5 OUTLIER 62.33 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.423 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -55.35 176.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.364 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 -162.44 0.82 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.127 -0.983 . . . . 0.0 109.443 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -68.82 74.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.4 120.61 33.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.01 123.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.398 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.64 -65.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 14' ' ' ALA . 1.4 t -138.41 -91.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . 57.02 49.51 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.166 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -91.31 87.32 6.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -138.78 -77.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.219 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 64.72 16.73 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER 65.43 -73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.406 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 43.64 70.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.4 135.76 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.39 103.51 10.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.474 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.81 146.52 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 2.0 pt-20 -80.13 129.33 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.717 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.95 116.48 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.151 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -137.98 -176.52 4.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -0.954 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -175.02 120.01 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -165.86 95.09 0.6 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.581 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.97 127.28 32.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.609 -0.682 . . . . 0.0 109.167 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -149.33 142.84 25.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.988 . . . . 0.0 110.128 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 115' ' ' ARG . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.4 HG23 HG13 ' A' ' 113' ' ' VAL . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.086 HD23 HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -77.61 137.08 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 39' ' ' SER . 5.6 mtt -144.29 40.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.51 -0.743 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 74.55 77.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.275 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.85 -49.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 117.54 51.29 0.35 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.787 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.945 ' CE1' HD13 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.945 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 -132.97 154.45 50.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 145.43 -123.4 1.89 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.561 ' CA ' ' HB2' ' A' ' 95' ' ' ARG . . . -161.06 -152.0 6.45 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.853 -1.381 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.857 ' HB3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -95.95 93.84 7.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.32 . . . . 0.0 109.413 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.63 113.22 1.95 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.81 -74.39 0.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.271 . . . . 0.0 109.733 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -80.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -92.46 24.97 3.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -97.77 -47.37 2.12 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER 78.36 57.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.996 . . . . 0.0 110.265 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.559 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -127.49 86.8 57.67 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.999 -1.063 . . . . 0.0 110.052 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -87.67 114.06 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.547 2.165 . . . . 0.0 110.47 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -61.88 118.69 7.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 108.217 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.833 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.842 HG21 HD11 ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.842 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 -109.74 170.65 7.93 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -118.59 90.52 3.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.69 58.02 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -154.48 -177.94 6.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -1.109 . . . . 0.0 109.401 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB2' HD13 ' A' ' 35' ' ' LEU . . . 55.33 167.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.503 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 1.1 p -72.73 -96.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 109.187 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 72' ' ' GLN . 15.2 pm0 -82.02 50.54 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 108.853 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.814 ' HG2' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -38.42 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.54 -0.725 . . . . 0.0 110.339 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -123.22 -33.33 3.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 73' ' ' SER . 3.6 mt-10 -167.07 33.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.656 ' HA ' HG11 ' A' ' 33' ' ' VAL . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.833 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.735 HG23 HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.706 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.641 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' OG1' ' A' ' 88' ' ' THR . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.845 ' O ' HD12 ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.641 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.941 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.941 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.858 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.086 HD11 HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 32' ' ' THR . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 63.67 7.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.47 168.98 9.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.736 . . . . 0.0 109.386 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.8 p -168.04 154.14 7.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 0.0 109.899 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' GLN . 1.7 mm? 65.65 88.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.793 . . . . 0.0 109.594 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 19.6 tp60 175.11 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 109.095 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 64.07 73.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.806 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 169.87 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG2' ' HA3' ' A' ' 128' ' ' GLY . 7.9 mt-10 -78.17 114.39 17.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.0 -66.71 0.51 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 126' ' ' ALA . 3.4 m -124.11 171.58 9.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.534 ' H ' HG22 ' A' ' 125' ' ' THR . . . 59.55 -154.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.664 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.22 83.69 2.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 123' ' ' GLU . . . -63.08 137.68 43.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.78 -70.07 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.472 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -27.1 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.703 2.269 . . . . 0.0 110.323 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -147.52 -149.87 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.62 42.88 1.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -100.04 146.03 27.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -147.24 -43.21 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.641 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -66.64 88.63 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.413 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.29 -55.76 2.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 t70 63.58 37.38 10.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.656 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 44.4 p -152.0 179.89 8.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' SER . . . 59.58 155.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.46 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.25 -75.49 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p 55.22 -175.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.5 37.44 1.36 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t -79.8 60.18 3.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.88 28.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.37 -62.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m 55.91 86.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.26 43.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 20' ' ' VAL . 17.7 t -95.28 30.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -85.54 143.91 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.403 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.4 145.39 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.39 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 24' ' ' SER . 9.8 tt0 -77.08 79.61 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.576 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 25' ' ' THR . 1.1 m 169.07 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 24' ' ' SER . 76.3 p -156.84 144.81 19.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.83 149.8 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.332 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.9 mt-10 46.27 26.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 108.931 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 70.44 164.96 0.27 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.687 -0.633 . . . . 0.0 109.339 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p -125.65 130.53 51.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.456 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.901 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 HG13 ' A' ' 113' ' ' VAL . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.765 HD11 HG13 ' A' ' 76' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HE2' HG23 ' A' ' 102' ' ' ILE . 7.5 mttt -78.98 127.2 31.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.1 mtp -150.74 -75.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 109.233 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.2 p -141.54 159.34 42.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.877 . . . . 0.0 109.373 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 76.75 -3.12 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.693 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 67.84 86.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.823 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.774 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 -130.3 131.51 45.45 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . 158.95 -127.74 1.91 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . 64.1 -61.54 0.06 OUTLIER Glycine 0 N--CA 1.513 3.783 0 O-C-N 121.086 -1.243 . . . . 0.0 110.207 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 48' ' ' GLY . 1.6 ptmm? -93.05 57.03 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 109.281 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -41.47 -82.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.57 ' O ' HD22 ' A' ' 53' ' ' LEU . 58.1 m -151.33 -91.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.153 . . . . 0.0 109.466 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -141.77 10.72 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -104.05 -18.62 14.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.581 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' LYS . . . 103.85 -19.62 43.6 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.086 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -68.23 111.32 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.025 -1.28 . . . . 0.0 109.704 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -130.5 90.17 41.79 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' THR . 37.9 Cg_endo -81.9 78.58 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.25 1.967 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -43.17 123.25 2.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.844 HG21 HD11 ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.0 m-20 -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.844 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -110.27 170.26 8.2 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -103.16 135.58 44.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.118 -0.989 . . . . 0.0 109.607 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.94 -29.9 4.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' O ' HD22 ' A' ' 35' ' ' LEU . . . -77.54 89.73 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -1.218 . . . . 0.0 109.611 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.9 1.23 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.154 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -169.65 28.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.61 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -141.88 -41.68 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -160.15 176.21 12.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.475 -0.765 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.51 39.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 -160.76 45.68 0.2 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.185 -0.947 . . . . 0.0 109.246 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 33' ' ' VAL . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.765 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 1.125 ' NE2' HG21 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 61' ' ' ILE . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.588 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.992 ' HB2' HG22 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.02 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE3' ' HB3' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.444 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.699 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.818 ' O ' HD12 ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.02 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 ' HD3' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD3' HD13 ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.125 HG21 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.821 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.437 ' C ' ' HG2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -95.74 -167.68 1.64 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 116' ' ' ARG . 5.0 pttt 177.82 157.39 0.4 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.69 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -80.11 131.82 35.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.955 -1.091 . . . . 0.0 109.367 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.37 -164.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -81.04 -87.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.599 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.3 OUTLIER 75.44 130.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.523 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -63.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 t -164.38 43.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -56.14 177.03 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 109.205 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -110.48 106.59 15.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.793 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.95 170.51 8.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.29 65.55 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' SER . 1.3 p30 -134.07 129.91 36.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 109.466 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 129' ' ' ASP . 49.6 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.371 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 1' ' ' MET . 34.7 Cg_endo -78.3 -60.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 110.674 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 60.1 m-20 60.12 -174.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.311 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mt -101.59 121.85 42.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.459 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -148.54 -43.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.46 154.71 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -82.51 166.46 19.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 12.3 p -84.25 -169.93 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 8' ' ' THR . 8.7 m-20 62.65 165.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.85 22.55 12.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.48 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.41 -57.41 1.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.517 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.69 22.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.724 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.2 156.27 41.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.28 40.03 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.77 132.21 46.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.304 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.61 -63.11 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.644 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.41 66.21 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 109.303 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.9 m -60.47 160.81 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.63 94.76 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.363 -0.836 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 t -80.73 135.53 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.05 157.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.288 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.94 103.19 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.153 -0.967 . . . . 0.0 109.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.19 99.52 9.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.293 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.82 158.39 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.594 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -161.7 58.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -122.6 30.8 6.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 4.8 mt-10 -150.4 88.29 1.49 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.081 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.58 158.49 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.75 135.19 48.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.564 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 76' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt -75.38 92.47 2.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 39' ' ' SER . 41.6 mtp -131.75 -179.5 5.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 38' ' ' MET . 8.8 t 67.41 -128.83 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.98 -1.075 . . . . 0.0 109.443 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.96 5.26 9.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.729 -1.232 . . . . 0.0 110.191 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 170.34 65.88 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.06 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 1.06 ' CE2' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 -134.52 139.03 45.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 58' ' ' PRO . . . 108.6 -170.32 14.75 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 57' ' ' LYS . . . 135.98 -77.36 0.36 Allowed Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.877 -1.367 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.47 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.272 -1.134 . . . . 0.0 110.614 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.32 107.12 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 m -126.41 -72.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.242 . . . . 0.0 109.693 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.91 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.753 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -77.35 -7.41 56.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.65 63.49 0.61 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.72 114.33 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.738 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 50' ' ' LYS . 10.1 ptpt -129.44 90.35 44.56 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 37.6 Cg_endo -83.55 152.6 13.5 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.511 2.141 . . . . 0.0 109.917 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.999 HD21 ' CB ' ' A' ' 90' ' ' MET . 2.9 mp -58.29 123.9 17.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.132 -0.98 . . . . 0.0 110.446 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.756 HG21 ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.756 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -107.21 169.85 8.32 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -100.55 98.91 9.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.263 -0.898 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 68' ' ' ALA . . . 140.96 -160.84 26.75 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 67' ' ' GLY . . . 44.18 52.26 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -152.52 155.1 36.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.425 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 t -68.16 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.2 24.85 11.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 74' ' ' GLU . 11.7 mt-30 -83.48 141.69 31.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 109.415 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -46.01 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.703 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 72' ' ' GLN . 10.1 mp0 49.94 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.65 HG23 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.858 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 60' ' ' THR . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.807 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.784 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.052 ' HB3' HG22 ' A' ' 88' ' ' THR . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 85' ' ' LEU . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.999 ' CB ' HD21 ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.78 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.715 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.715 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.9 HG23 ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 82' ' ' ILE . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.856 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.8 136.36 41.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 93.12 4.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.049 -1.032 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.8 p -74.84 -164.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.456 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 119' ' ' LEU . 10.9 mp -47.97 140.04 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -162.52 -59.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.43 88.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.466 -0.771 . . . . 0.0 109.244 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -83.42 53.55 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.651 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 124' ' ' THR . 27.3 mt-10 -85.0 -34.94 22.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.2 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER 77.0 42.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.392 -0.817 . . . . 0.0 109.97 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.59 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 23.3 m -45.46 -64.02 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 68.95 12.6 8.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.65 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 125' ' ' THR . . . -103.29 160.12 14.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.528 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ALA . . . 51.56 95.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.11 142.3 31.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.387 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.387 0.613 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.912 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.809 HD11 ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HB2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.1 mp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.882 HG21 HD11 ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.882 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 . . . . . 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.406 ' O ' HD21 ' A' ' 35' ' ' LEU . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HA ' HG22 ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HB2' HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.613 ' O ' HG21 ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.685 ' OG1' HD13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.589 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.793 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 101' ' ' ILE . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.589 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 1.066 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.066 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 102' ' ' ILE . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 32' ' ' THR . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.749 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.277 0.561 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.877 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.752 HD12 HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 105' ' ' LEU . 7.4 tptt . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.885 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.746 HG21 ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.464 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.746 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.368 0.604 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.414 ' OG1' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.671 ' O ' HG22 ' A' ' 60' ' ' THR . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.844 ' HA ' HG22 ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 114' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.65 ' NE2' HG21 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.731 HD13 ' HE3' ' A' ' 90' ' ' MET . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.821 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.731 ' HE3' HD13 ' A' ' 85' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.525 ' OE1' HD12 ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 1.04 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.635 ' N ' ' OE1' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.942 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.885 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.752 HD13 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.877 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 111' ' ' THR . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.754 HD11 HG13 ' A' ' 76' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' HD22 ' A' ' 42' ' ' LEU . 5.8 mttt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.871 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.878 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.787 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.766 HG21 HD11 ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.631 ' OG1' HD21 ' A' ' 35' ' ' LEU . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.787 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.988 HD13 HG22 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.878 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.913 HG21 HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.854 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' LEU . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.913 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.827 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.827 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 34' ' ' THR . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.988 HG22 HD13 ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.453 0.644 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 1.041 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.827 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HG2' HD21 ' A' ' 42' ' ' LEU . 21.3 mtmt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.544 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.791 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.924 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.881 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.49 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.897 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.435 0.636 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.55 ' O ' HD21 ' A' ' 35' ' ' LEU . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' THR . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.881 ' HA ' HG22 ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.814 HG12 HG22 ' A' ' 114' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.498 ' HA3' HG23 ' A' ' 110' ' ' VAL . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.095 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.082 ' CE ' ' HB1' ' A' ' 98' ' ' ALA . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.924 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.967 ' O ' HD12 ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.082 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.624 HD13 ' HD3' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.624 ' HD3' HD13 ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HE3' ' A' ' 37' ' ' LYS . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.041 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.48 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 . . . . . 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.639 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.475 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.988 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 42' ' ' LEU . 7.4 mttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.845 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.876 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.93 HD23 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.775 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.947 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.989 HG21 HD11 ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.989 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' HD21 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 35' ' ' LEU . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.947 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.999 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.791 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.105 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.93 ' SD ' HD23 ' A' ' 46' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 1.055 ' O ' HD22 ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.055 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.775 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.843 ' O ' HD12 ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.508 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.105 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 ' HA3' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.679 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.844 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.944 HG22 ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.838 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.717 HG23 HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.839 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.825 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.547 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' HD21 ' A' ' 35' ' ' LEU . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.032 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HA ' HG22 ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.567 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.669 HD11 ' NH2' ' A' ' 115' ' ' ARG . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.14 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.838 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.898 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 89' ' ' ALA . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 68.2 m-20 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.14 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.717 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.032 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.944 ' HB2' HG22 ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.303 0.573 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HB2' HD11 ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.903 HG23 HG13 ' A' ' 113' ' ' VAL . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' OG1' ' A' ' 75' ' ' THR . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.848 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 8.1 mp0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.798 HG22 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.744 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.793 HG23 HG22 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.458 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 101' ' ' ILE . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.813 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.793 HG22 HG23 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm . . . . . 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.866 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.865 HD22 HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mp0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.775 HD11 HG21 ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.953 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.916 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.974 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.725 ' HG3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.453 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 101' ' ' ILE . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.782 ' HA ' HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.956 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.547 ' HB1' ' HE3' ' A' ' 90' ' ' MET . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.974 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.858 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.426 ' H ' ' HA2' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.953 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG3' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' CD ' HD11 ' A' ' 105' ' ' LEU . 2.8 tptp . . . . . 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.566 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.856 HD21 ' CG2' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.513 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 . . . . . 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 95' ' ' ARG . 6.5 mp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 1.045 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.652 HG21 HD11 ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 . . . . . 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.295 0.569 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' HD21 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.045 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.573 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.901 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.929 ' HG2' HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' MET . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 1.013 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 101' ' ' ILE . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.518 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.694 ' O ' HD22 ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.776 HG21 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.921 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.683 ' HB2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.046 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 1.046 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.93 HD21 ' CE ' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE1' ' ND2' ' A' ' 62' ' ' ASN . 17.8 mt-10 . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 90' ' ' MET . 1.6 mp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 81' ' ' GLU . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 47' ' ' GLU . 1.9 m120 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.278 0.561 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.753 ' CG ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.946 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.988 ' HA ' HG22 ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.81 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.742 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.133 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.703 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.93 ' CE ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.98 ' O ' HD12 ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.98 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.133 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.845 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.742 ' O ' HD22 ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.946 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.904 ' HB2' HG22 ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 HD13 ' A' ' 112' ' ' ILE . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.538 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.878 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.878 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 1.01 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.714 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 . . . . . 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.249 0.547 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.585 ' OG1' HD21 ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.858 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 114' ' ' ILE . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 1.3 pm0 -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.852 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.464 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.777 ' HE3' ' HB2' ' A' ' 59' ' ' LEU . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 1.3 mm100 -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.797 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.9 ' O ' HD12 ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.612 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.741 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.704 HD13 HD12 ' A' ' 35' ' ' LEU . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.449 ' CG2' ' NE2' ' A' ' 84' ' ' GLN . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.858 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.789 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.888 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.535 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.74 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.588 ' CD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.998 ' CE2' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.2 mp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.321 0.582 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.886 HG22 ' HA ' ' A' ' 81' ' ' GLU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.807 HG21 HG13 ' A' ' 64' ' ' ILE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.493 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.807 HG13 HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.183 0.516 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.685 ' O ' HD21 ' A' ' 35' ' ' LEU . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' A' ' 82' ' ' ILE . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.886 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.998 HD21 ' CE2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.947 HG21 HD11 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.051 ' CE ' ' HB2' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 90' ' ' MET . 12.9 mm-40 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 1.017 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.827 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.493 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.04 ' O ' HD12 ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.051 ' HB2' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.626 ' HZ3' HD11 ' A' ' 42' ' ' LEU . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.04 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.982 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.982 HD12 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.57 ' N ' HD22 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.674 HG11 HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.74 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.888 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 115' ' ' ARG . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.998 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 HG23 HG13 ' A' ' 113' ' ' VAL . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp . . . . . 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.97 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.97 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.829 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 95' ' ' ARG . 1.9 mp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.727 HG22 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.84 HG21 HD11 ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 60' ' ' THR . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.602 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.771 ' NE2' HG21 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.931 ' HA2' HG22 ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 101' ' ' ILE . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.578 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 1.03 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.015 ' O ' HD12 ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 101' ' ' ILE . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.931 HG22 ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.998 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.688 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.335 0.588 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.82 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HG ' HD23 ' A' ' 59' ' ' LEU . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.721 HD13 ' CB ' ' A' ' 90' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.789 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' CD1' HD11 ' A' ' 82' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 7.0 m-30 . . . . . 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.782 ' HA ' HG11 ' A' ' 33' ' ' VAL . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.88 ' OD2' HG21 ' A' ' 114' ' ' ILE . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.789 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' ILE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.888 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.894 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.751 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 1.058 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.058 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HD2' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.943 ' CG ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.888 ' CD1' HG21 ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.765 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.474 ' HB2' HG22 ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.271 0.557 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 113' ' ' VAL . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD11 HG13 ' A' ' 76' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.903 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.903 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.844 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.911 HG21 HD11 ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.911 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 . . . . . 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.857 ' OG1' HD21 ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.861 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.68 ' HG3' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.69 ' CG ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.951 ' HA ' HG22 ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.772 ' CD1' HG22 ' A' ' 112' ' ' ILE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.115 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.54 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.861 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.023 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.115 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.026 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.772 HG22 ' CD1' ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.69 HD12 ' CG ' ' A' ' 80' ' ' ASP . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.445 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.714 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.894 ' CE1' HD13 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.894 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HG ' ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 HD11 ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.6 m-80 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HB ' HD13 ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.611 ' NE2' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.922 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.861 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 114' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.911 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.038 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.939 ' HE2' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.957 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.572 ' HD3' ' HG ' ' A' ' 59' ' ' LEU . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.788 ' O ' HD12 ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.669 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.038 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.828 HD22 ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.637 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.672 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' GLY . 16.5 tttt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.967 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.905 ' HE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 82' ' ' ILE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 11.7 mm-40 . . . . . 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 90' ' ' MET . 6.4 mp . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.836 HG13 HD11 ' A' ' 82' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.821 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.6 m-30 . . . . . 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.321 0.582 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.484 ' O ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.819 ' OD2' HG21 ' A' ' 114' ' ' ILE . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.836 HD11 HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.967 HD21 ' CD1' ' A' ' 42' ' ' LEU . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.928 HG21 HD11 ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.872 ' HG3' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.843 HD23 ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.699 ' NH2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.022 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.49 ' HA ' ' CE3' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.022 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.928 HD11 HG21 ' A' ' 88' ' ' THR . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.676 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.449 ' OD1' ' HE3' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.819 HG21 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 115' ' ' ARG . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.4 HG23 HG13 ' A' ' 113' ' ' VAL . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.086 HD23 HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.787 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.945 ' CE1' HD13 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.945 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 . . . . . 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.833 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.842 HG21 HD11 ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.842 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 . . . . . 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.656 ' HA ' HG11 ' A' ' 33' ' ' VAL . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.833 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.735 HG23 HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.706 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.641 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' OG1' ' A' ' 88' ' ' THR . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.845 ' O ' HD12 ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.641 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.941 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.941 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.858 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 1.086 HD11 HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 32' ' ' THR . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.901 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 HG13 ' A' ' 113' ' ' VAL . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.765 HD11 HG13 ' A' ' 76' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HE2' HG23 ' A' ' 102' ' ' ILE . 7.5 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.823 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.774 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.844 HG21 HD11 ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.844 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 33' ' ' VAL . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.765 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.975 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 61' ' ' ILE . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.588 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.992 ' HB2' HG22 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.02 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE3' ' HB3' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.444 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.699 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.818 ' O ' HD12 ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.02 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 ' HD3' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD3' HD13 ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.975 HG21 ' OE1' ' A' ' 77' ' ' GLN . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.821 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.564 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 76' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.06 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 1.06 ' CE2' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.999 HD21 ' CB ' ' A' ' 90' ' ' MET . 2.9 mp . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 120.59 0.233 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.756 HG21 ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.756 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 . . . . . 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.319 0.58 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.65 HG23 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.858 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 60' ' ' THR . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.807 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.784 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.052 ' HB3' HG22 ' A' ' 88' ' ' THR . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 85' ' ' LEU . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.999 ' CB ' HD21 ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.78 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.715 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.715 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.9 HG23 ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 82' ' ' ILE . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.856 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.0 -61.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.65 2.233 . . . . 0.0 109.919 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -117.7 -168.93 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.022 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -176.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.3 153.24 25.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.596 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 8' ' ' THR . 9.2 p -164.7 -158.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.9 m 47.87 47.19 18.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 6' ' ' SER . 5.3 t -175.68 -165.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' N ' ' OG1' ' A' ' 8' ' ' THR . 0.3 OUTLIER -49.86 121.77 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -55.12 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -145.72 71.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.13 121.4 32.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.98 136.06 29.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.699 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 15' ' ' SER . . . -118.04 -71.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.348 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 54.49 169.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.02 -178.93 4.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 0.0 109.227 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' C ' ' OG ' ' A' ' 18' ' ' SER . . . -168.82 179.71 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 109.602 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.431 ' OG ' ' C ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER 69.9 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 143.35 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.422 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.54 141.92 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.488 ' C ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -126.77 -175.5 3.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 21' ' ' SER . 2.2 t 64.24 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' VAL . 5.2 pm0 -43.65 156.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -172.51 0.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.346 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.49 161.74 28.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.69 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 44.53 30.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.808 . . . . 0.0 109.821 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 52.89 92.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -121.29 132.29 54.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.36 142.55 35.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.687 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.3 t -105.01 151.38 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.1 m -134.15 87.81 2.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.416 -0.802 . . . . 0.0 109.571 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -76.7 121.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.185 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -142.45 164.23 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.157 -0.964 . . . . 0.0 110.809 -178.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -113.84 131.69 56.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.87 -1.144 . . . . 0.0 110.812 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -100.94 178.71 4.59 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 19.6 pt-20 -114.68 115.82 27.71 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.664 -1.272 . . . . 0.0 108.762 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.47 97.98 6.62 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.916 -1.115 . . . . 0.0 109.239 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.0 ptm -151.05 -32.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -85.19 19.73 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.972 -1.08 . . . . 0.0 110.275 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 65.03 54.2 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.146 -0.971 . . . . 0.0 110.089 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 134.53 29.1 0.44 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.912 HD12 ' CE1' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 40.02 25.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -1.084 . . . . 0.0 110.229 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 61.55 9.14 16.59 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -132.01 153.26 50.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.581 -1.541 . . . . 0.0 109.457 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 t -130.61 144.22 51.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.809 HD11 ' CE2' ' A' ' 44' ' ' PHE . 7.4 mp -103.02 135.66 44.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 112.182 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HB2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -128.2 149.33 50.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -177.93 -119.9 0.62 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . 176.63 102.56 0.16 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 118.619 -1.753 . . . . 0.0 110.793 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.707 ' CB ' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -51.59 169.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.189 -1.183 . . . . 0.0 108.519 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.81 -108.18 1.03 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.3 44.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -1.215 . . . . 0.0 109.247 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt 56.45 24.32 8.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.112 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -142.12 5.92 1.72 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -142.82 -102.94 0.45 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 165.26 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.665 -1.491 . . . . 0.0 110.019 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -112.72 85.26 7.34 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.548 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 56' ' ' ASP . 37.6 Cg_endo -78.96 75.46 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.154 1.903 . . . . 0.0 109.573 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.1 mp -43.25 152.78 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -146.42 159.04 43.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.022 -1.048 . . . . 0.0 109.974 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.882 HG21 HD11 ' A' ' 64' ' ' ILE . 81.8 mt -79.13 125.76 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.115 -1.615 . . . . 0.0 109.703 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -113.07 -49.78 2.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.279 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 93.74 4.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 110.884 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.882 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -91.86 144.05 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.6 m-30 -108.06 170.81 7.77 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.709 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.39 111.47 23.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.449 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.75 38.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -177.85 -164.94 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -1.077 . . . . 0.0 109.317 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HB1' ' H ' ' A' ' 75' ' ' THR . . . 48.89 41.6 18.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.68 15.81 14.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' C ' ' HG2' ' A' ' 72' ' ' GLN . 3.3 mp0 -109.48 6.1 23.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.965 . . . . 0.0 109.686 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 71' ' ' GLU . 1.8 pt20 -178.96 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 t 55.96 -170.71 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 pm0 -76.4 110.8 11.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.546 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.493 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 44.6 p -94.92 26.66 3.49 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 1.7 m -137.45 162.45 32.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 110.087 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.29 139.64 13.02 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.54 132.84 9.16 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.307 2.005 . . . . 0.0 110.907 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.55 12.62 67.14 Favored Glycine 0 N--CA 1.507 3.402 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.025 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 60' ' ' THR . 48.0 p-10 -71.64 140.34 49.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.592 -1.534 . . . . 0.0 109.019 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.611 ' HA ' HG22 ' A' ' 60' ' ' THR . 80.1 tt0 -83.13 64.89 7.92 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.555 -1.341 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -55.24 123.14 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 120.875 -1.14 . . . . 0.0 109.442 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.1 OUTLIER -86.66 -42.23 13.58 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.484 -1.385 . . . . 0.0 110.768 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -139.55 146.86 40.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.645 -1.284 . . . . 0.0 109.062 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HB2' HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -99.57 -165.82 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -62.59 -11.04 33.39 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.613 ' O ' HG21 ' A' ' 101' ' ' ILE . . . -165.31 32.86 0.24 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 119.008 -1.568 . . . . 0.0 112.025 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.685 ' OG1' HD13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -155.23 133.86 11.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.277 -1.719 . . . . 0.0 107.895 177.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -108.61 108.5 19.41 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.108 -0.995 . . . . 0.0 109.516 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.589 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 6.8 mmt -52.52 -57.26 10.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.675 -0.641 . . . . 0.0 110.073 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -41.1 -32.12 0.24 Allowed 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.019 -1.073 . . . . 0.0 113.033 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.863 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -115.55 49.53 0.85 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -161.28 150.56 16.53 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.802 -0.822 . . . . 0.0 109.204 -177.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.707 HG22 ' CB ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -80.6 -176.83 5.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.793 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -70.68 -56.11 7.17 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.705 -1.247 . . . . 0.0 109.512 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.429 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 93.6 m-85 -65.52 -53.81 37.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 101' ' ' ILE . 75.9 mm-40 -51.29 -40.46 59.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.285 -0.885 . . . . 0.0 109.412 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.589 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -61.23 -64.18 1.04 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.174 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 1.066 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 7.9 t-105 -58.44 -9.5 1.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.322 -0.861 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.0 m-80 -82.22 -46.47 13.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.633 -1.292 . . . . 0.0 111.152 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.3 mp -56.81 -40.01 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.349 -1.469 . . . . 0.0 109.742 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.066 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.6 OUTLIER -58.25 -64.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 102' ' ' ILE . 21.2 mtpt -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.62 0.724 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.96 -1.83 53.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.507 -0.746 . . . . 0.0 111.296 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.654 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 10.4 mt -68.09 176.36 1.39 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.858 -1.151 . . . . 0.0 109.567 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -82.59 177.74 6.71 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.577 2.185 . . . . 0.0 110.635 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 6.2 m-20 -96.26 92.62 6.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -166.03 -150.82 6.46 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 104.92 1.96 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.964 2.443 . . . . 0.0 110.509 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.15 125.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' LEU . 4.6 m -88.57 127.75 35.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.717 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.3 pt -110.46 152.78 12.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 32' ' ' THR . 0.9 OUTLIER -138.81 108.22 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.2 pp -121.26 141.68 40.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.554 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.749 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttp180 -123.15 103.35 8.5 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -88.49 117.66 27.59 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -120.61 164.21 16.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.041 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.8 t 80.91 175.41 0.11 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.351 -0.843 . . . . 0.0 109.391 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 120' ' ' GLN . 3.6 mm? -55.25 -176.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.919 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 119' ' ' LEU . 4.0 tp60 74.7 46.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.52 120.19 10.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.056 -1.028 . . . . 0.0 109.535 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 81.78 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.1 38.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 125' ' ' THR . 16.8 m -81.01 52.2 1.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 124' ' ' THR . 0.1 OUTLIER 45.34 87.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.396 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.78 16.07 17.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 49.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.4 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.18 75.6 0.1 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.06 134.9 49.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.2 mtp . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 36.3 Cg_endo -79.54 59.1 7.27 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.616 2.21 . . . . 0.0 110.591 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 3' ' ' ASP . 58.0 t0 -65.93 -72.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 109.31 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 63.42 44.84 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.779 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 11.0 p-10 -77.41 -33.01 55.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.271 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.12 82.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.751 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 63.9 p -75.61 -165.81 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 61.18 139.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -120.03 137.56 54.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.519 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.53 130.44 38.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 109.347 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.26 142.42 33.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.37 89.61 2.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -131.0 140.22 50.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.73 87.48 2.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.35 62.26 7.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.26 -178.6 6.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 0.0 109.511 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.61 106.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.49 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -73.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.267 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 2.3 p30 -67.83 75.63 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 20' ' ' VAL . 14.8 m -90.08 139.34 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.865 . . . . 0.0 109.647 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.92 81.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.629 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 60.5 t -54.24 98.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.445 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 3.1 mt-10 64.0 155.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.652 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.02 55.94 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.134 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 26' ' ' ALA . 90.6 m -104.61 149.21 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 46.74 -173.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 4.3 mt-10 65.94 97.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 80.55 145.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.779 -0.576 . . . . 0.0 109.76 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 62.8 p -138.29 152.03 48.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 115' ' ' ARG . 6.3 t -135.44 150.16 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.257 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.877 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -146.8 88.72 1.77 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -72.99 129.87 39.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.861 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -146.85 157.04 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.12 . . . . 0.0 111.127 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.08 122.41 43.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.367 -0.833 . . . . 0.0 110.393 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.752 HD12 HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -93.75 -178.22 4.61 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' OE2' ' HB1' ' A' ' 68' ' ' ALA . 15.9 pt-20 -114.62 121.8 44.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.517 -1.364 . . . . 0.0 108.876 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 105' ' ' LEU . 7.4 tptt -86.43 76.04 9.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.94 -1.1 . . . . 0.0 109.552 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.06 32.26 0.6 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.54 -78.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.049 -1.032 . . . . 0.0 110.059 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.72 28.43 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 69.34 71.88 0.92 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.885 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 63.73 -2.22 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.303 -1.116 . . . . 0.0 111.303 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 53.31 15.24 3.76 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.3 p90 -135.62 148.34 48.98 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.733 -1.451 . . . . 0.0 109.545 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -116.1 143.7 45.13 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -97.45 138.79 34.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.712 -0.618 . . . . 0.0 112.128 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG3' ' CG ' ' A' ' 62' ' ' ASN . 27.0 mt-10 -142.37 155.65 45.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.296 -0.878 . . . . 0.0 109.134 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 173.96 -102.12 0.17 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 169.54 104.98 0.18 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.772 -1.68 . . . . 0.0 110.952 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.9 ' CB ' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -47.62 172.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.972 -1.311 . . . . 0.0 108.91 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.87 128.35 4.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.43 -172.4 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.875 -1.367 . . . . 0.0 109.829 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 52' ' ' SER . 0.3 OUTLIER 80.86 -40.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.613 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -134.69 31.44 3.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.836 -1.165 . . . . 0.0 110.782 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.67 -24.93 0.21 Allowed Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.051 -1.547 . . . . 0.0 110.381 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 57.38 176.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.281 . . . . 0.0 108.963 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.14 84.7 7.43 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.82 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 60' ' ' THR . 37.2 Cg_endo -80.09 58.45 6.99 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.088 1.859 . . . . 0.0 109.161 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -41.69 128.83 3.32 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.6 p -124.1 156.79 35.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.746 HG21 ' CG1' ' A' ' 64' ' ' ILE . 57.3 mt -73.73 121.08 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.069 -1.644 . . . . 0.0 109.647 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -99.56 -47.48 5.1 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.885 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -119.96 105.2 10.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.068 . . . . 0.0 110.192 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.746 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.3 mt -99.28 144.45 11.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 121.931 0.872 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -113.01 -25.52 8.92 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.62 75.82 0.15 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.828 . . . . 0.0 109.537 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.6 5.09 5.86 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HB1' ' OE2' ' A' ' 36' ' ' GLU . . . -171.54 137.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -1.087 . . . . 0.0 109.113 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 75' ' ' THR . . . -176.16 144.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 109.572 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -102.62 10.82 38.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -103.11 -174.4 2.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -69.11 58.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.088 . . . . 0.0 109.615 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 71' ' ' GLU . 3.4 m 42.5 27.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 109.623 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 1.5 tt0 -144.83 57.93 1.29 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.141 -0.974 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 HG21 ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -120.66 41.05 3.37 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -156.41 149.15 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -145.18 150.08 43.91 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.306 -0.871 . . . . 0.0 109.486 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -80.07 121.46 4.45 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.77 2.313 . . . . 0.0 111.084 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.38 8.5 83.8 Favored Glycine 0 N--CA 1.507 3.408 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.098 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.671 ' O ' HG22 ' A' ' 60' ' ' THR . 4.5 p30 -56.27 139.38 48.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.677 -1.484 . . . . 0.0 109.291 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.844 ' HA ' HG22 ' A' ' 60' ' ' THR . 27.7 tt0 -84.7 59.35 5.47 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 120.471 -1.393 . . . . 0.0 109.281 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 114' ' ' ILE . 1.4 mt -60.25 122.54 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 83' ' ' LEU . 2.1 mm? -85.92 -50.64 6.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.796 -1.19 . . . . 0.0 110.35 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.65 ' NE2' HG21 ' A' ' 113' ' ' VAL . 1.3 pm0 -127.87 150.15 49.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.902 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.731 HD13 ' HE3' ' A' ' 90' ' ' MET . 5.7 mp -112.43 178.07 4.42 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.88 60.23 0.2 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 101' ' ' ILE . . . 146.27 13.62 0.19 Allowed Glycine 0 N--CA 1.502 3.092 0 C-N-CA 119.358 -1.401 . . . . 0.0 111.092 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.821 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.86 155.15 9.93 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 120.285 -1.715 . . . . 0.0 108.974 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.56 101.87 5.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.731 ' HE3' HD13 ' A' ' 85' ' ' LEU . 3.0 mpp? -52.09 -57.81 8.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 110.571 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.525 ' OE1' HD12 ' A' ' 83' ' ' LEU . 2.9 mt-30 -36.5 -27.78 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.6 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 1.04 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -112.21 45.48 1.31 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -158.27 -166.24 1.89 Allowed 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.9 HG22 ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -119.68 -159.3 0.77 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.504 ' NH1' ' HG2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -79.56 -61.84 1.88 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.287 -1.508 . . . . 0.0 112.212 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 51.7 m-85 -65.43 -60.12 3.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.277 -1.514 . . . . 0.0 110.229 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.942 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -45.22 -29.21 0.92 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 0.0 110.259 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' N ' ' OE1' ' A' ' 97' ' ' GLU . . . -68.07 -65.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.522 -1.361 . . . . 0.0 110.025 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.652 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.4 t-105 -58.73 -12.8 4.66 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.628 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -80.99 -46.7 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.681 -1.262 . . . . 0.0 110.943 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.942 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.5 mp -55.94 -41.5 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.514 -1.366 . . . . 0.0 109.792 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -60.79 -58.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.42 -0.8 . . . . 0.0 108.906 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -41.84 -33.37 0.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.601 0.715 . . . . 0.0 109.714 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.78 52.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.505 -0.747 . . . . 0.0 111.209 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -60.0 179.57 0.2 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.653 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.3 Cg_endo -81.65 174.86 10.01 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.68 2.254 . . . . 0.0 110.681 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 28.1 m-20 -96.62 91.1 5.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.58 -143.81 4.1 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.14 106.36 2.23 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.785 2.323 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.885 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -85.9 113.06 23.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.668 HG23 HG23 ' A' ' 34' ' ' THR . 1.6 m -86.88 125.49 34.04 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.898 0.856 . . . . 0.0 110.527 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.752 HD13 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -113.77 156.0 14.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.89 96.61 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.877 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.2 pp -99.39 133.53 41.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.728 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.73 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.2 102.34 4.97 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 137.61 32.16 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.128 -0.982 . . . . 0.0 108.997 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -154.7 173.59 16.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.036 -1.04 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 71.52 106.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.201 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.15 91.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.536 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -118.51 -16.42 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.0 109.294 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.63 110.57 9.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.419 -0.801 . . . . 0.0 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -19.83 24.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.735 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.3 98.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -166.88 153.45 8.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.316 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.15 -163.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 109.294 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 128' ' ' GLY . . . -148.89 69.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.072 -1.017 . . . . 0.0 109.626 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 126' ' ' ALA . . . 61.82 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.551 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 126' ' ' ALA . . . 142.35 38.78 0.08 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -132.1 38.55 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -1.13 . . . . 0.0 109.403 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.58 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.644 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.0 177.2 10.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.52 -82.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -150.92 157.61 43.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.342 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 p -145.35 19.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -105.05 3.9 30.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -41.92 60.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' ALA . 1.8 t70 68.43 119.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.88 . . . . 0.0 109.284 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 5.1 t 67.35 -63.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 75.17 44.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.473 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -69.7 -45.2 68.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 42.9 t 63.11 -72.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -0.886 . . . . 0.0 109.729 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . 62.94 56.18 1.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 p 55.3 22.43 4.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . 66.55 -78.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -89.91 86.69 6.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -60.52 -93.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -142.72 166.81 23.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.391 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' SER . 33.7 m -76.68 140.57 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 4.3 m 70.53 139.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 22' ' ' VAL . 28.5 m -125.01 109.77 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -142.14 -178.58 5.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.723 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.469 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 26.1 p 54.57 88.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -65.15 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.318 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . 179.9 114.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 108.992 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 21.5 mt-10 63.71 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -0.959 . . . . 0.0 109.24 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . . . -77.78 179.31 6.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.35 128.44 18.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 11.6 t -99.56 148.58 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -137.72 87.01 2.22 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 111' ' ' THR . 1.7 m -67.18 127.95 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.992 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -141.19 159.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.38 -0.825 . . . . 0.0 110.093 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.04 135.91 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.701 -1.25 . . . . 0.0 109.776 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.754 HD11 HG13 ' A' ' 76' ' ' VAL . 11.3 mt -123.93 69.08 1.05 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.6 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -6.41 119.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.434 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' HD22 ' A' ' 42' ' ' LEU . 5.8 mttt -77.37 93.91 4.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.797 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 39' ' ' SER . 6.2 ptm -145.41 -154.7 0.56 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 38' ' ' MET . 97.0 p 50.14 -109.01 0.36 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.805 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -130.36 -11.36 4.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.823 -1.173 . . . . 0.0 110.354 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 165.37 73.58 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.871 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER 39.25 26.36 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.519 -0.989 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 52.9 15.92 3.7 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.878 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -150.43 143.58 24.87 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.648 -1.501 . . . . 0.0 110.248 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -122.42 144.92 48.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -92.5 144.31 25.48 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 111.399 -178.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 21.2 mp0 -130.58 155.81 45.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.566 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.538 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 149.58 -118.1 0.91 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 118.0 133.57 4.9 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 118.74 -1.695 . . . . 0.0 110.565 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -56.94 148.61 20.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.033 -1.275 . . . . 0.0 109.532 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.01 -85.97 0.81 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.75 -144.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -1.129 . . . . 0.0 109.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 32.46 4.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.445 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -123.04 -1.95 8.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.062 -1.024 . . . . 0.0 109.872 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -154.09 -100.53 0.19 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.8 m-20 160.08 -179.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.083 -1.245 . . . . 0.0 109.722 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.89 84.31 25.53 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 60' ' ' THR . 38.1 Cg_endo -82.38 72.18 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.943 1.762 . . . . 0.0 109.993 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -43.83 113.03 0.46 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.787 HG22 ' O ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -118.28 154.17 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.904 -177.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.766 HG21 HD11 ' A' ' 64' ' ' ILE . 22.7 mt -76.51 115.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.164 -1.585 . . . . 0.0 109.126 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 5.2 m120 -108.25 -45.75 3.86 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.542 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 90.28 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.816 -1.177 . . . . 0.0 110.434 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.23 143.01 12.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.243 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 3.4 m-30 -104.35 -34.41 8.31 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.137 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -127.08 131.39 50.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.53 39.64 2.73 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -173.36 119.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -1.097 . . . . 0.0 109.571 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB2' ' OG1' ' A' ' 75' ' ' THR . . . -66.83 115.58 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' ALA . 68.5 m 44.02 -100.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.25 18.39 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.978 -1.076 . . . . 0.0 109.45 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 73' ' ' SER . 16.5 pt20 -105.22 -177.29 3.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -43.16 153.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.769 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 pm0 -67.11 116.09 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 109.094 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.733 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 61.8 p -102.34 29.15 5.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 110.29 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -127.42 157.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.463 -0.773 . . . . 0.0 109.13 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -143.05 143.98 27.07 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.301 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.0 Cg_endo -81.26 111.03 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.542 2.161 . . . . 0.0 111.618 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.7 24.58 76.22 Favored Glycine 0 N--CA 1.507 3.381 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.087 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.787 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -74.11 153.72 39.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.606 -1.526 . . . . 0.0 108.464 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 60' ' ' THR . 36.3 tt0 -88.18 91.21 8.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.66 -1.275 . . . . 0.0 108.518 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.988 HD13 HG22 ' A' ' 114' ' ' ILE . 2.5 mm -78.65 118.82 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.552 -1.343 . . . . 0.0 109.51 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' MET . 1.6 mm? -83.93 -43.54 15.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.565 -1.335 . . . . 0.0 109.995 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.35 159.45 30.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.734 -1.229 . . . . 0.0 108.64 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.878 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -135.37 81.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.228 . . . . 0.0 110.798 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 23.6 44.5 0.01 OUTLIER Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 144.01 16.91 0.23 Allowed Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.142 -1.504 . . . . 0.0 110.987 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.913 HG21 HD11 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.22 155.21 9.36 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.846 -1.385 . . . . 0.0 107.373 179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.854 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -122.72 110.18 15.17 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.604 ' CE ' ' CG2' ' A' ' 88' ' ' THR . 0.0 OUTLIER -53.5 -28.23 29.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.2 mt-30 -70.7 156.63 39.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.13 -0.981 . . . . 0.0 108.452 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.62 38.01 4.0 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 89' ' ' ALA . 6.0 mt -156.54 137.32 13.35 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.356 -1.085 . . . . 0.0 108.64 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -67.55 -171.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.83 . . . . 0.0 108.875 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' LEU . 6.9 tmm_? -80.21 -67.08 0.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.913 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 6.6 p90 -56.9 -43.83 81.75 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.819 -1.152 . . . . 0.0 107.941 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 tt0 -44.21 -56.88 3.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.547 -0.72 . . . . 0.0 109.971 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -58.92 -62.28 2.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.165 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.73 -25.91 2.06 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.624 -0.672 . . . . 0.0 110.514 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 29.6 m-20 -76.3 -51.17 12.53 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.584 -1.323 . . . . 0.0 110.438 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.25 -40.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.756 -1.215 . . . . 0.0 109.36 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.913 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.22 -66.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -42.86 -29.92 0.36 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.518 0.675 . . . . 0.0 109.805 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.31 -42.23 62.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 0.0 110.463 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.827 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -52.64 177.17 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.827 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.6 Cg_endo -79.84 179.96 5.83 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.598 2.199 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 4.6 m-20 -96.82 90.91 5.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -141.56 -150.32 5.36 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.33 98.99 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.803 2.335 . . . . 0.0 110.308 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.85 110.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 34' ' ' THR . 1.3 m -88.96 121.96 31.84 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.063 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -103.05 155.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.461 0.648 . . . . 0.0 109.679 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.55 91.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.988 HG22 HD13 ' A' ' 82' ' ' ILE . 1.3 pp -90.15 132.48 34.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.53 -0.732 . . . . 0.0 109.79 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -119.89 98.27 6.02 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.14 142.41 27.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG3' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -105.11 68.97 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.054 -1.029 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 119' ' ' LEU . 4.2 t 45.8 46.88 12.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.379 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -165.44 174.82 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 16.3 mm100 66.81 46.87 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.384 -0.822 . . . . 0.0 109.578 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 171.8 121.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.815 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 173.99 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.385 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -101.89 140.12 36.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.38 -44.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -46.1 -71.54 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -47.83 148.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -167.83 73.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' SER . . . 168.79 70.81 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.95 -86.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 128' ' ' GLY . 5.9 p . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.53 84.83 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.187 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.0 110.64 16.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 4' ' ' LEU . 8.5 mp -101.74 -170.7 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.949 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -178.68 -152.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.275 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -155.22 -43.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 109.744 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 m -79.55 -85.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.94 . . . . 0.0 109.482 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.17 -67.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.34 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -123.73 136.31 54.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -145.65 127.7 15.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.41 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.2 -152.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.452 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.62 169.72 14.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -157.68 122.5 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.52 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.29 109.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.32 74.92 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.65 162.08 29.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.32 71.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.639 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.4 m -144.38 20.59 1.71 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.92 164.31 17.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.712 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 20' ' ' VAL . 4.6 m -113.24 127.67 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.528 ' C ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -156.14 65.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 109.577 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 21' ' ' SER . 1.5 t 61.26 118.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.7 pt-20 179.6 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m 61.46 -179.44 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.9 m -152.46 -79.97 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.63 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -141.36 163.04 34.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.601 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.52 26.55 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.1 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.691 ' HB2' ' CD ' ' A' ' 117' ' ' LYS . . . -163.42 125.29 2.48 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -143.05 140.38 30.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.948 -1.095 . . . . 0.0 110.246 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 115' ' ' ARG . 7.1 t -114.55 146.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.486 -0.759 . . . . 0.0 109.031 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 1.041 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -143.53 87.85 1.96 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -72.47 128.48 35.73 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.29 162.36 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.788 -1.195 . . . . 0.0 112.049 -177.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.4 128.32 55.97 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.827 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.3 mm? -106.2 60.92 0.65 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.074 -1.016 . . . . 0.0 110.864 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -13.46 109.66 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HG2' HD21 ' A' ' 42' ' ' LEU . 21.3 mtmt -76.81 122.59 25.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.531 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.37 -41.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.113 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 t -164.58 155.05 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 67.03 9.2 6.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 51.61 86.41 0.02 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.913 HD22 HG11 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 49.69 13.88 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.281 -1.129 . . . . 0.0 110.929 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 49.82 16.15 1.09 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -142.17 145.18 33.9 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.585 -1.538 . . . . 0.0 109.771 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.544 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -117.7 140.83 49.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.791 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -90.03 143.91 26.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 111.574 -178.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 8.3 mp0 -130.16 156.5 44.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 152.53 -116.39 0.74 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 107.925 -2.07 . . . . 0.0 107.925 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.56 137.06 5.92 Favored Glycine 0 N--CA 1.501 3.005 0 C-N-CA 118.91 -1.614 . . . . 0.0 110.673 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -44.36 162.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.94 -1.329 . . . . 0.0 109.296 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.46 74.54 0.32 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 m -98.16 -53.86 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.146 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.8 tp -149.84 -53.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.464 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -17.74 14.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.17 67.57 0.11 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -170.52 152.62 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -1.136 . . . . 0.0 109.293 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -114.96 85.73 12.42 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 60' ' ' THR . 37.6 Cg_endo -80.83 65.4 8.92 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.104 1.87 . . . . 0.0 109.544 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.924 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -41.91 127.5 3.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.881 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -130.49 156.63 44.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 0.0 109.679 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 64' ' ' ILE . 52.6 mt -76.39 121.94 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 119.958 -1.714 . . . . 0.0 109.904 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.49 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 14.8 m-20 -106.29 -48.76 3.5 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 45' ' ' SER . 12.2 ptt85 -112.37 103.79 11.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.894 -1.129 . . . . 0.0 110.049 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.897 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -102.15 145.12 12.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 122.028 0.918 . . . . 0.0 110.316 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' GLY . 4.5 m-85 -120.26 -37.76 3.01 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.09 94.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.14 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.9 4.61 5.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -178.86 131.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -1.089 . . . . 0.0 109.101 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 75' ' ' THR . . . -144.59 -175.39 4.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.82 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.67 -140.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.39 -0.818 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 47.84 1.0 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 0.0 109.969 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -162.68 137.63 6.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.436 ' C ' ' HG2' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -85.05 78.57 9.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER 169.35 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.57 HG21 ' HB1' ' A' ' 69' ' ' ALA . 2.8 p -104.94 31.43 4.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.413 -0.805 . . . . 0.0 109.702 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -157.2 148.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.506 -0.746 . . . . 0.0 109.029 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -144.37 144.7 26.41 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.259 -0.901 . . . . 0.0 109.001 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.3 Cg_endo -78.98 117.82 3.96 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.488 2.125 . . . . 0.0 111.516 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.46 10.17 86.18 Favored Glycine 0 N--CA 1.506 3.356 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.135 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' THR . 1.2 p30 -55.58 131.34 46.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.596 -1.532 . . . . 0.0 109.502 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.881 ' HA ' HG22 ' A' ' 60' ' ' THR . 1.4 tt0 -80.2 56.16 2.38 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.278 -1.514 . . . . 0.0 108.034 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.814 HG12 HG22 ' A' ' 114' ' ' ILE . 2.5 mt -53.47 114.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -78.65 -47.34 17.23 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.646 -1.284 . . . . 0.0 110.199 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -112.68 177.83 4.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 108.585 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -158.99 92.59 1.11 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.928 -1.107 . . . . 0.0 110.369 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.498 ' HA3' HG23 ' A' ' 110' ' ' VAL . . . 60.86 -74.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -140.85 50.78 0.73 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.095 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -155.96 149.52 24.89 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -124.69 106.94 10.48 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.825 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.082 ' CE ' ' HB1' ' A' ' 98' ' ' ALA . 33.5 mmt -48.63 -67.39 0.27 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.634 -0.666 . . . . 0.0 109.74 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -47.79 -27.61 2.13 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.446 -0.902 . . . . 0.0 113.384 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.17 45.35 1.33 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.441 -2.264 . . . . 0.0 107.441 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -170.65 169.52 7.11 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.345 -1.091 . . . . 0.0 108.938 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.52 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -90.65 160.82 15.68 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.924 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.22 -69.55 0.11 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.929 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -50.87 67.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.095 -1.003 . . . . 0.0 109.793 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.967 ' O ' HD12 ' A' ' 101' ' ' ILE . 9.0 mm-40 -51.29 -45.56 62.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.978 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.082 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -54.33 -67.74 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 110.679 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 7.4 t-105 -53.97 -16.24 1.79 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.294 -0.879 . . . . 0.0 110.712 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.78 -48.78 11.18 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 110.955 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -53.22 -39.1 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.484 -1.385 . . . . 0.0 109.955 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 88' ' ' THR . 1.9 mp -62.64 -64.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.416 -0.802 . . . . 0.0 109.616 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 102' ' ' ILE . 5.6 mmmt -43.66 -30.5 0.63 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 109.801 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.37 -14.98 60.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 110.965 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.624 HD13 ' HD3' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -68.0 175.32 1.81 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.814 -1.178 . . . . 0.0 110.088 -179.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.624 ' HD3' HD13 ' A' ' 105' ' ' LEU . 36.8 Cg_endo -82.85 -179.16 4.29 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.918 2.412 . . . . 0.0 110.94 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.55 86.75 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.575 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HE3' ' A' ' 37' ' ' LYS . . . -145.86 -153.31 5.84 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.37 100.22 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.173 2.582 . . . . 0.0 111.561 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.913 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -87.55 110.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 13.1 m -88.15 129.13 35.41 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.13 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.96 154.43 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.72 94.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.041 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.4 pp -96.94 132.16 42.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.08 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.48 ' HB2' HG22 ' A' ' 30' ' ' VAL . 1.9 ttm180 -135.29 109.85 8.55 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ARG . 9.7 ttm180 -91.51 68.53 5.73 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.691 ' CD ' ' HB2' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -89.46 62.3 5.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 108.799 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.4 t 154.64 117.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -62.55 136.16 57.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.981 . . . . 0.0 109.188 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -122.02 -30.9 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' GLN . 1.0 OUTLIER 55.35 109.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.769 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -75.55 137.62 40.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.093 -1.004 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -123.21 -150.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.88 129.3 36.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.632 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 3.4 t -170.97 143.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 80.34 -8.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.764 . . . . 0.0 109.839 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' ALA . . . 45.0 -170.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 109.688 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.88 -72.37 1.03 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.01 37.45 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -1.145 . . . . 0.0 109.676 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 167.54 23.42 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.534 2.156 . . . . 0.0 110.436 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.72 79.04 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.205 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -92.81 93.7 8.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.711 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER 73.16 112.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.609 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.3 m -108.34 4.72 24.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 44.67 53.97 6.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.89 . . . . 0.0 109.573 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' ASP . 9.5 t -176.92 -152.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 8' ' ' THR . 7.3 m-20 -43.67 144.37 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -43.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 57.4 -162.36 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.498 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 47.1 -93.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 11' ' ' ALA . 37.6 m -60.19 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -114.52 19.54 16.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 t 45.2 48.38 10.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.94 . . . . 0.0 109.519 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.92 -164.6 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' SER . . . -168.99 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER 58.33 113.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.8 56.69 0.98 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.92 140.19 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 p -147.34 163.13 37.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 22' ' ' VAL . 7.6 p -121.46 59.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.89 36.09 0.85 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' ALA . 53.5 m 43.74 35.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 24' ' ' SER . 24.6 p 47.57 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' SER . . . -159.31 134.69 8.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -164.72 95.3 0.71 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.774 0.797 . . . . 0.0 109.573 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . . . -149.42 160.87 43.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.668 -0.645 . . . . 0.0 109.472 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.1 p -125.36 153.01 44.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.214 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 ' HB2' ' A' ' 115' ' ' ARG . 14.2 t -119.42 150.61 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 109.854 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.639 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.3 m -137.68 85.17 2.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.475 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -63.66 128.84 37.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.615 -179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -142.33 159.14 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.521 -178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -109.82 130.3 55.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.117 -0.989 . . . . 0.0 109.347 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.988 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -112.22 63.05 0.62 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.116 -0.99 . . . . 0.0 111.655 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 35' ' ' LEU . 7.2 mt-10 -10.81 112.41 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.107 0.48 . . . . 0.0 111.984 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 42' ' ' LEU . 7.4 mttm -77.68 83.67 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -131.75 -34.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.797 . . . . 0.0 109.225 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.9 m -66.29 -158.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.46 34.89 0.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 130.85 61.78 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.845 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.29 27.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.737 -0.861 . . . . 0.0 110.416 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 46.68 19.35 0.48 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.876 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -149.25 143.01 25.61 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.588 -1.536 . . . . 0.0 110.371 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -119.97 141.68 49.46 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.93 HD23 ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -94.12 139.35 31.1 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.306 -0.871 . . . . 0.0 111.55 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 45.1 mp0 -140.24 134.17 30.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.762 . . . . 0.0 109.776 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -157.09 -110.0 0.3 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 57' ' ' LYS . . . 155.86 113.97 0.46 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 118.671 -1.728 . . . . 0.0 111.442 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -45.06 138.53 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.258 . . . . 0.0 108.781 178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 56' ' ' ASP . . . -179.12 86.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.5 -1.333 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -107.96 42.13 1.41 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 109.228 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 mp -118.37 -33.6 4.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.744 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.95 15.28 3.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.068 -1.02 . . . . 0.0 110.178 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 56' ' ' ASP . . . 168.83 -93.18 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.953 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 14.7 p-10 172.64 -177.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.353 . . . . 0.0 109.586 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.55 87.29 11.52 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.39 -0.819 . . . . 0.0 109.161 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 60' ' ' THR . 36.3 Cg_endo -78.76 74.64 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.242 1.961 . . . . 0.0 110.498 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.775 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -45.66 123.57 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.947 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.3 p -123.85 157.67 33.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.901 -1.124 . . . . 0.0 109.916 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.989 HG21 HD11 ' A' ' 64' ' ' ILE . 30.7 mt -72.49 120.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.023 -1.673 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.1 m120 -110.56 -50.79 2.93 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.464 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.47 94.1 5.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.954 -1.091 . . . . 0.0 110.574 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.989 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -98.7 143.5 13.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.8 m-30 -108.54 -28.72 9.16 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.132 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 76.15 119.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.06 -57.92 0.18 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.61 113.54 20.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.159 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.01 174.36 4.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.836 . . . . 0.0 109.159 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.5 t -131.28 -147.07 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.543 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.14 -16.58 59.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.96 . . . . 0.0 109.273 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.94 161.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.799 . . . . 0.0 109.471 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -78.19 74.18 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.23 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 109.296 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' HD21 ' A' ' 35' ' ' LEU . 36.5 p -88.8 20.7 3.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 110.108 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 35' ' ' LEU . 2.4 m -131.67 156.35 42.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.267 -0.895 . . . . 0.0 108.963 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -147.15 134.28 10.16 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 108.964 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.69 113.14 3.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.119 1.88 . . . . 0.0 110.582 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.74 63.45 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.499 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -80.81 156.76 26.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.237 -1.743 . . . . 0.0 108.311 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.947 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tt0 -95.5 72.03 3.17 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.832 -1.167 . . . . 0.0 110.104 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.7 mt -66.87 122.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.777 -1.202 . . . . 0.0 109.048 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 90' ' ' MET . 41.9 mt -78.51 -39.38 38.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.685 -1.259 . . . . 0.0 111.268 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -150.35 178.55 8.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.398 -1.439 . . . . 0.0 110.743 -179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.999 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -134.15 -171.8 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.588 -0.695 . . . . 0.0 109.143 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.791 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -53.94 -18.3 8.55 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -163.41 46.82 0.32 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.105 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.48 139.87 4.8 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.959 -1.318 . . . . 0.0 108.383 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -129.22 112.94 14.43 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 109.034 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.93 ' SD ' HD23 ' A' ' 46' ' ' LEU . 23.7 mmt -49.49 -29.55 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.815 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.4 mm100 -71.71 155.62 40.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.01 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 1.055 ' O ' HD22 ' A' ' 93' ' ' LEU . . . 43.29 37.49 3.38 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.228 -1.545 . . . . 0.0 109.533 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.055 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -151.65 142.06 22.51 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.211 -1.17 . . . . 0.0 108.44 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -81.94 152.26 26.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.775 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -46.36 -57.31 4.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.105 -0.997 . . . . 0.0 110.143 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 7.3 m-85 -65.08 -55.83 16.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.768 -1.208 . . . . 0.0 109.515 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.843 ' O ' HD12 ' A' ' 101' ' ' ILE . 19.2 mm-40 -48.72 -41.59 32.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.57 -67.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 111.062 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.508 ' HA ' HD13 ' A' ' 102' ' ' ILE . 13.0 t-105 -57.33 -17.3 11.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.389 -0.819 . . . . 0.0 110.988 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 2.2 m-80 -81.3 -46.84 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.624 -1.297 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.92 -38.94 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.527 -1.358 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.105 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.6 mp -55.38 -63.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 102' ' ' ILE . 4.0 mmmt -42.58 -33.37 0.69 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.428 0.632 . . . . 0.0 110.107 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -15.34 61.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 0.0 110.84 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 ' HA3' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -72.0 176.33 2.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.823 -1.173 . . . . 0.0 110.046 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.679 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.58 176.51 8.46 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.575 2.184 . . . . 0.0 110.888 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 24.7 m-20 -96.54 84.48 3.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.337 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -144.56 -148.41 4.85 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.97 98.37 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.069 2.512 . . . . 0.0 111.159 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.4 OUTLIER -88.17 112.45 23.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -88.72 123.51 33.22 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.46 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.02 154.98 12.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.692 0.758 . . . . 0.0 110.114 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.73 90.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 114' ' ' ILE . 1.3 pp -89.74 130.57 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.846 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.844 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -121.32 111.13 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.96 105.51 17.66 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.605 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.567 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 7.1 mtpm? -69.41 164.36 23.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.19 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 1.1 p 67.89 119.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mp -53.41 111.89 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLN . 4.0 tt0 -153.41 31.68 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.84 23.13 5.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HE3' ' CB ' ' A' ' 126' ' ' ALA . 13.4 mtmt -92.94 162.46 14.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.64 2.15 38.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -108.03 26.15 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.472 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 86.3 m 60.39 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.532 ' CB ' ' HE3' ' A' ' 122' ' ' LYS . . . 61.85 141.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.525 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.65 174.8 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.29 -68.47 0.89 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -112.07 98.72 7.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.526 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.567 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 36.1 Cg_endo -76.64 162.24 33.1 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.273 1.982 . . . . 0.0 110.734 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.1 p-10 -177.57 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 4' ' ' LEU . 6.6 mp 58.56 18.35 5.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.91 . . . . 0.0 108.85 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -79.66 105.44 10.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.643 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.5 p -154.37 -53.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.247 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m -91.06 47.22 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.7 -13.53 15.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 10' ' ' SER . 4.0 p30 -100.09 139.07 36.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.477 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 74.34 -74.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.384 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' SER . . . 44.1 86.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' SER . . . -138.56 137.73 37.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER 72.16 90.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.658 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -39.98 66.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.6 -6.11 10.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.8 -171.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.87 166.58 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.611 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.0 p -83.66 146.94 27.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 0.0 109.351 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.55 44.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 109.672 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.6 p -169.94 161.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 109.39 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -68.41 148.63 50.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 22' ' ' VAL . 13.3 p -145.71 46.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 109.606 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 80.12 148.53 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.85 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 25' ' ' THR . 3.3 t -179.67 -42.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 109.104 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 24' ' ' SER . 1.6 p 52.32 176.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.528 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . . . -174.67 55.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 12.9 mt-10 65.63 96.83 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 173.87 -178.35 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 7.1 p -136.17 140.93 43.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.947 . . . . 0.0 109.34 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.944 HG22 ' HB2' ' A' ' 115' ' ' ARG . 24.1 t -123.52 146.91 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.838 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.0 m -137.89 86.9 2.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.717 HG23 HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -69.19 124.06 22.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -136.83 159.53 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.0 110.767 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.65 131.72 56.88 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -0.922 . . . . 0.0 109.395 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.629 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 12.3 mt -110.41 66.84 0.63 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.045 -1.034 . . . . 0.0 111.1 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 35' ' ' LEU . 13.9 pt-20 -21.75 99.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.216 0.531 . . . . 0.0 111.166 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 tttm -88.2 107.41 18.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 109.009 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 39' ' ' SER . 3.8 ptm -104.23 -13.23 16.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.284 -0.885 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER 163.98 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 174.37 -69.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 37' ' ' LYS . . . 137.16 63.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 52.34 10.7 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.251 -1.146 . . . . 0.0 110.975 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 55.88 11.67 4.56 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.839 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -142.33 159.37 42.36 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 120.64 -1.506 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -127.09 146.08 50.5 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.825 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -97.34 139.67 32.94 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.496 -0.752 . . . . 0.0 111.578 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 4.2 mm-40 -132.89 155.88 48.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 110.03 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 129.58 -110.57 1.08 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 62.46 -103.29 0.59 Allowed Glycine 0 N--CA 1.504 3.178 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.2 mttt -51.6 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.395 -1.062 . . . . 0.0 111.604 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 52.09 118.61 0.01 OUTLIER Glycine 0 N--CA 1.497 2.722 0 O-C-N 121.468 -0.77 . . . . 0.0 111.375 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' OG ' ' HA2' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -152.43 37.39 0.53 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.756 -1.438 . . . . 0.0 109.497 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.6 -86.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 54' ' ' HIS . 16.0 t60 -138.48 -3.61 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.06 55.88 0.01 OUTLIER Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -171.63 177.34 3.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.193 . . . . 0.0 109.477 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CE ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -114.46 83.82 9.04 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.255 -0.903 . . . . 0.0 110.414 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' O ' HG23 ' A' ' 60' ' ' THR . 38.6 Cg_endo -82.69 70.35 6.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.038 1.825 . . . . 0.0 110.164 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -43.93 112.88 0.44 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 58' ' ' PRO . 5.5 p -126.22 156.95 39.45 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.942 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 64' ' ' ILE . 29.2 mt -77.54 126.85 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.403 -1.436 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.547 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 2.7 p-10 -114.03 -56.44 2.39 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.17 94.2 7.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.882 . . . . 0.0 110.252 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.11 142.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.042 0.925 . . . . 0.0 110.311 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.78 168.34 9.25 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.08 60.15 0.82 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.099 -1.001 . . . . 0.0 109.396 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . -117.24 95.27 0.65 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 64.6 172.13 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.379 -1.071 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' ALA . . . 178.58 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.445 ' OG ' ' HG2' ' A' ' 36' ' ' GLU . 51.1 m 61.15 -163.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -103.77 39.59 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.92 . . . . 0.0 109.396 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.559 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.7 OUTLIER -112.25 152.62 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.473 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 74' ' ' GLU . 24.6 m -67.63 93.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.922 . . . . 0.0 109.549 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.2 OUTLIER 52.71 98.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 31.1 p -95.45 27.67 3.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.335 -0.853 . . . . 0.0 109.548 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -137.81 140.17 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.626 -0.672 . . . . 0.0 109.494 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -141.01 119.55 8.12 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.85 140.05 20.22 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.794 1.663 . . . . 0.0 110.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.11 4.5 90.5 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.183 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.032 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -82.04 145.67 30.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.285 -1.715 . . . . 0.0 109.573 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HA ' HG22 ' A' ' 60' ' ' THR . 8.1 tt0 -86.92 65.79 9.14 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 120.747 -1.221 . . . . 0.0 109.336 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.567 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.6 mt -58.52 120.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.027 -1.046 . . . . 0.0 110.218 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.669 HD11 ' NH2' ' A' ' 115' ' ' ARG . 6.8 mt -82.25 -42.72 18.51 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.177 . . . . 0.0 111.284 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -121.91 160.39 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.293 -1.504 . . . . 0.0 109.507 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -137.25 82.85 1.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.992 -1.067 . . . . 0.0 110.968 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 20.54 48.5 0.01 OUTLIER Glycine 0 N--CA 1.502 3.054 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 137.8 22.33 0.47 Allowed Glycine 0 N--CA 1.504 3.227 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.475 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.14 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -172.39 144.58 1.54 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.818 -1.401 . . . . 0.0 107.951 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.838 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -115.45 112.03 21.68 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 121.039 -1.038 . . . . 0.0 109.454 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.898 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -49.58 -27.22 4.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.178 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 92' ' ' GLY . 27.5 mt-30 -70.38 156.53 39.2 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.0 38.69 3.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 89' ' ' ALA . 13.0 mt -154.96 128.46 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.286 -1.126 . . . . 0.0 108.587 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -72.76 -179.19 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.043 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 96' ' ' PHE . 6.2 tmm_? -70.37 -58.57 3.6 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.935 -1.106 . . . . 0.0 108.804 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 47.8 p90 -65.66 -45.31 83.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.957 . . . . 0.0 109.801 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -60.26 -37.23 79.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.91 -1.119 . . . . 0.0 109.188 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -67.34 -62.07 1.6 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 110.623 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 12.8 t-105 -52.16 -16.28 0.76 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.403 -0.811 . . . . 0.0 110.934 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 68.2 m-20 -78.9 -51.5 9.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.553 -1.342 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.3 mp -51.48 -39.67 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.716 -1.24 . . . . 0.0 110.09 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.14 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.4 mp -58.54 -62.99 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.153 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -44.24 -30.58 0.82 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.653 0.739 . . . . 0.0 109.193 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.33 -5.04 59.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.621 . . . . 0.0 110.98 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -68.48 176.81 1.27 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.83 -1.169 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.3 Cg_endo -83.19 165.02 14.92 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.942 1.761 . . . . 0.0 110.639 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 25.8 m-20 -85.48 88.57 7.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 109.207 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -158.01 -144.43 3.94 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.44 96.54 1.08 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.763 2.308 . . . . 0.0 111.151 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -86.73 108.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 6.4 t -88.61 131.26 35.04 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.297 1.046 . . . . 0.0 110.476 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -114.18 155.92 15.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.717 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.32 90.23 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.032 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -89.52 130.17 39.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.628 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.944 ' HB2' HG22 ' A' ' 30' ' ' VAL . 10.0 ttp85 -130.14 107.66 9.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -101.1 131.51 47.0 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.071 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 26' ' ' ALA . 3.8 mttt -82.85 82.35 8.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.9 OUTLIER 53.0 -157.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 109.745 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.5 OUTLIER 74.74 72.55 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.182 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 121' ' ' SER . 4.0 pt20 -63.59 -18.31 63.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.426 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER 71.97 -81.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.59 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.39 146.02 30.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 109.541 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -73.41 -67.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.498 HG23 ' N ' ' A' ' 125' ' ' THR . 3.4 t -173.22 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.557 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 124' ' ' THR . 0.2 OUTLIER 46.28 -151.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 125' ' ' THR . . . -93.3 150.1 20.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.76 -78.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 59.95 -152.46 36.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -87.25 121.07 29.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.239 . . . . 0.0 109.312 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.532 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.6 128.71 9.63 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.479 2.12 . . . . 0.0 110.516 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 35.7 p-10 -75.27 -167.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.68 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 7' ' ' SER . 2.8 tp -149.76 111.97 4.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.68 -19.5 7.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -23.55 23.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 109.317 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.614 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 61.81 -172.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.512 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 t -60.49 140.68 57.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.91 . . . . 0.0 109.41 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.12 -161.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -156.96 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.08 112.74 25.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.13 102.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.657 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' ALA . 44.1 t -78.45 -69.3 0.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 42.73 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.81 109.7 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -0.831 . . . . 0.0 109.211 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . . . 48.67 -157.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.49 -74.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.3 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 t -91.33 33.81 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 66.6 t0 -109.24 62.21 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 20' ' ' VAL . 4.7 t -115.44 30.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.45 137.36 30.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 24' ' ' SER . 94.1 t -152.51 145.4 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.244 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.2 37.39 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 109.83 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 22' ' ' VAL . 9.6 t -131.63 -16.5 2.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.37 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.408 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER 48.92 42.59 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.953 -1.092 . . . . 0.0 109.143 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 49.87 72.54 0.31 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.893 . . . . 0.0 109.251 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 15.0 mt-10 -142.32 83.31 1.82 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.936 0.874 . . . . 0.0 109.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.828 ' HB1' ' HD3' ' A' ' 115' ' ' ARG . . . 70.23 161.23 0.22 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -138.1 140.72 40.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.552 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 115' ' ' ARG . 5.7 t -111.39 156.39 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.152 -0.967 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HB2' HD11 ' A' ' 114' ' ' ILE . 6.6 m -143.41 98.26 3.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.903 HG23 HG13 ' A' ' 113' ' ' VAL . 1.4 m -87.77 125.84 34.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -144.61 161.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 111.083 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.973 . . . . 0.0 109.072 178.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' OG1' ' A' ' 75' ' ' THR . 11.7 mt -107.78 63.25 0.62 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.042 -1.036 . . . . 0.0 111.166 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -13.32 101.03 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.631 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 106' ' ' PRO . 2.7 tttt -95.2 92.64 6.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.025 . . . . 0.0 109.117 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 3.0 ptm -126.37 8.29 7.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 172.4 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 179.96 -69.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.093 -1.005 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 116.85 62.4 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER 61.86 -1.64 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 111.543 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 45.95 19.78 0.39 Allowed Glycine 0 N--CA 1.484 1.839 0 O-C-N 120.416 -1.427 . . . . 0.0 109.772 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.762 ' HE1' HD13 ' A' ' 46' ' ' LEU . 1.2 p90 -142.69 146.54 34.49 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 120.537 -1.566 . . . . 0.0 110.187 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.8 t -112.34 149.7 32.08 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.848 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -102.36 143.3 32.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.125 -0.985 . . . . 0.0 110.659 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 8.1 mp0 -133.52 153.24 51.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.988 -1.07 . . . . 0.0 110.59 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 141.39 -121.48 1.88 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.603 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -159.39 -144.95 4.11 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 3.4 ptpt -77.63 53.45 1.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.755 -1.438 . . . . 0.0 110.359 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' CA ' ' O ' ' A' ' 57' ' ' LYS . . . 57.14 -87.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.9 m -165.35 142.2 5.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.48 -38.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 54' ' ' HIS . 36.1 t-80 -152.19 27.86 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.38 -97.46 0.11 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER 177.2 93.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.747 -1.443 . . . . 0.0 110.402 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -128.74 85.77 59.33 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.632 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' O ' HG23 ' A' ' 60' ' ' THR . 38.4 Cg_endo -82.01 93.75 0.93 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.02 1.813 . . . . 0.0 110.562 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -50.97 110.01 0.38 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.942 -1.099 . . . . 0.0 108.617 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.798 HG22 ' HA ' ' A' ' 81' ' ' GLU . 8.1 p -126.97 152.02 47.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.036 -1.04 . . . . 0.0 110.178 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 64' ' ' ILE . 50.1 mt -71.37 114.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.316 -1.49 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 8.6 m-20 -102.08 -27.7 12.77 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.916 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.95 104.44 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.537 -1.352 . . . . 0.0 109.828 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 61' ' ' ILE . 1.4 mt -106.58 143.78 16.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.142 -0.974 . . . . 0.0 110.598 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -112.12 169.97 8.48 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -108.2 101.87 11.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.07 -1.019 . . . . 0.0 109.139 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . 173.03 136.79 2.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 69.53 116.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.47 -179.47 1.88 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.686 ' H ' HG21 ' A' ' 75' ' ' THR . 0.8 OUTLIER -112.78 -160.71 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.751 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.11 46.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.856 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.863 ' HB3' HG22 ' A' ' 75' ' ' THR . 2.3 tt0 -118.63 132.64 56.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 72' ' ' GLN . 54.9 p -38.98 -43.12 0.94 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 0.0 110.149 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HG3' ' C ' ' A' ' 73' ' ' SER . 89.6 mt-10 -146.72 101.17 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 72' ' ' GLN . 1.9 p -89.91 23.57 2.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -130.75 176.77 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' CB ' ' HB2' ' A' ' 80' ' ' ASP . 25.3 mm-40 -149.11 103.55 3.35 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.453 -0.78 . . . . 0.0 108.905 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.65 123.38 6.92 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.964 1.776 . . . . 0.0 110.587 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.24 23.45 69.92 Favored Glycine 0 N--CA 1.507 3.375 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.12 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -92.35 155.78 17.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.322 . . . . 0.0 109.519 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 60' ' ' THR . 10.1 tp10 -93.0 93.78 8.53 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.745 -1.222 . . . . 0.0 110.037 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.793 HG23 HG22 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -85.04 126.37 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.491 -1.381 . . . . 0.0 109.618 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' SD ' ' A' ' 90' ' ' MET . 1.0 OUTLIER -82.4 -42.19 18.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.673 -1.267 . . . . 0.0 111.056 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -147.74 156.22 42.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.709 -1.244 . . . . 0.0 109.779 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.7 mp -110.46 -178.45 3.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -51.64 -16.65 2.71 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.692 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -158.18 49.69 0.42 Allowed Glycine 0 N--CA 1.503 3.143 0 C-N-CA 118.686 -1.721 . . . . 0.0 110.905 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -177.41 141.22 0.3 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -1.201 . . . . 0.0 108.193 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -123.75 119.95 31.26 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.168 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -61.88 -64.91 0.79 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.68 -0.637 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -37.86 -26.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.585 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.03 46.18 1.21 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -170.73 -170.74 0.93 Allowed 'General case' 0 C--N 1.31 -1.111 0 O-C-N 121.389 -1.065 . . . . 0.0 109.093 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.7 p -117.77 150.12 39.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -42.09 -57.44 2.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.225 -0.922 . . . . 0.0 110.721 -178.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 8.0 t80 -63.95 -60.24 3.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.83 -1.169 . . . . 0.0 109.856 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.957 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.4 mm-40 -49.35 -40.19 34.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.992 -1.067 . . . . 0.0 108.666 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.622 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -55.29 -70.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.377 -0.827 . . . . 0.0 110.44 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.458 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 10.2 t-105 -52.04 -16.14 0.7 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.383 -0.823 . . . . 0.0 111.272 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -82.76 -47.21 12.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.582 -1.324 . . . . 0.0 111.074 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -54.59 -41.97 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.456 -1.402 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -53.69 -63.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.311 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.58 -34.83 0.63 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.607 -0.683 . . . . 0.0 110.06 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 -20.01 57.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.497 -0.752 . . . . 0.0 111.122 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 101' ' ' ILE . 3.8 mm? -54.91 175.85 0.17 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.717 -1.24 . . . . 0.0 110.098 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.4 Cg_endo -81.96 -179.96 5.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.462 2.108 . . . . 0.0 110.278 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -97.58 99.18 10.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.366 -0.834 . . . . 0.0 109.447 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.97 -146.65 4.85 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.22 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.53 99.67 1.29 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.037 2.491 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.813 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -87.2 111.66 22.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -88.55 125.57 34.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.545 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 33' ' ' VAL . 1.1 pt -106.92 154.24 7.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -150.04 107.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.793 HG22 HG23 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -120.48 -179.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.946 -1.102 . . . . 0.0 109.625 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.828 ' HD3' ' HB1' ' A' ' 28' ' ' ALA . 7.4 tmm_? -150.91 102.58 2.99 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.681 ' HD2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.02 145.92 25.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 109.339 -178.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.58 113.43 21.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 118' ' ' SER . 0.0 OUTLIER 64.28 101.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.126 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 116' ' ' ARG . 0.5 OUTLIER 177.51 106.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.464 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.509 ' O ' ' CB ' ' A' ' 121' ' ' SER . 0.4 OUTLIER -58.55 -172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.204 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER 162.99 -63.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 109.375 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 126.78 30.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -172.72 82.62 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.2 p -73.2 131.09 41.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.443 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.75 -170.18 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.093 -1.005 . . . . 0.0 109.572 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -53.01 -54.71 31.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.712 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 126' ' ' ALA . . . 65.48 172.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 0.0 109.328 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.31 -75.44 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -113.61 174.37 5.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -1.114 . . . . 0.0 109.548 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.45 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 1' ' ' MET . 34.9 Cg_endo -77.39 -69.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.435 2.09 . . . . 0.0 110.803 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -154.02 163.84 39.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 109.653 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.72 -76.56 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.86 . . . . 0.0 109.486 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.93 -41.13 97.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 7' ' ' SER . 4.5 m 68.01 126.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.545 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 6' ' ' SER . 29.7 t 62.3 176.55 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.508 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 p -78.95 -33.5 45.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.92 163.81 23.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -63.14 -49.97 72.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 173.66 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.43 -51.59 2.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -92.76 -49.47 6.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.84 70.68 3.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -44.13 20.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.63 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.72 52.11 0.92 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 m -113.47 126.9 55.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.325 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.67 103.71 8.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' VAL . 25.7 m -50.14 141.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.366 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 22' ' ' VAL . 24.1 t -46.13 98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.413 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 23' ' ' GLU . 5.8 m -60.42 -156.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 22' ' ' VAL . 6.2 mt-10 46.62 70.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.498 ' O ' ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -145.02 75.85 1.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.927 . . . . 0.0 109.428 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 24' ' ' SER . 1.7 t 39.43 86.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 109.773 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.31 134.55 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.98 . . . . 0.0 109.851 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 121' ' ' SER . 3.3 mt-10 52.37 23.48 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.001 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -177.14 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 109.165 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 20.1 p -126.88 133.62 50.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.7 t -113.11 146.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 114' ' ' ILE . 3.6 m -142.49 87.61 2.02 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.46 127.08 31.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -0.78 . . . . 0.0 109.467 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -139.97 160.5 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -0.892 . . . . 0.0 110.325 -178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.56 130.73 56.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.091 -1.006 . . . . 0.0 110.416 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 110' ' ' VAL . 10.1 mt -103.01 162.79 12.65 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 6.6 mt-10 -105.03 104.4 14.13 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.372 -1.455 . . . . 0.0 109.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 20.6 tptm -79.93 119.5 22.87 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.053 -1.029 . . . . 0.0 108.887 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.8 mtm -131.73 -36.93 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.754 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.39 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 109.838 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . -156.91 29.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.357 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 43.32 62.59 2.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.858 HD22 HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER 43.9 20.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.267 -1.137 . . . . 0.0 110.615 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 54.15 12.63 3.07 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.866 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -141.4 141.36 33.77 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.424 -1.633 . . . . 0.0 109.882 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.5 p -114.62 139.82 49.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.865 HD22 HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.35 142.09 28.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.6 -0.688 . . . . 0.0 111.296 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 11.7 mp0 -131.33 156.24 45.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.412 -0.805 . . . . 0.0 109.643 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 154.03 -115.84 0.7 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 95' ' ' ARG . . . 129.51 145.4 5.86 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 118.485 -1.817 . . . . 0.0 110.935 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.652 ' HD2' HG23 ' A' ' 94' ' ' THR . 8.3 mtpm? -44.78 128.81 6.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.981 -1.305 . . . . 0.0 109.704 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.37 -134.94 8.09 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m 179.18 -70.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.71 -1.465 . . . . 0.0 109.337 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -120.85 36.88 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.059 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -134.93 -30.34 1.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.007 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 56' ' ' ASP . . . 156.6 45.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.3 p-10 43.06 -149.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -1.188 . . . . 0.0 109.871 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HE3' ' CG ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -109.98 86.3 4.83 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 0.0 110.275 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.79 ' O ' HG23 ' A' ' 60' ' ' THR . 36.7 Cg_endo -78.01 62.68 8.03 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.976 1.784 . . . . 0.0 109.466 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.6 OUTLIER -42.95 121.65 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 81' ' ' GLU . 16.9 p -126.32 155.25 42.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 110.077 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 64' ' ' ILE . 54.5 mt -74.28 120.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.038 -1.664 . . . . 0.0 109.532 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -104.2 -46.76 4.34 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.894 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 103.45 10.79 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.931 -1.106 . . . . 0.0 110.186 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.775 HD11 HG21 ' A' ' 61' ' ' ILE . 2.2 mt -101.83 146.24 10.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.923 0.868 . . . . 0.0 110.366 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -122.0 -66.12 1.06 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.293 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER 160.32 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -104.53 37.94 3.53 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' GLY . . . 46.87 -171.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.364 -1.08 . . . . 0.0 108.985 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.59 175.28 9.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.221 -0.924 . . . . 0.0 109.273 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' GLU . 5.0 m -101.32 -22.03 14.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 70' ' ' SER . 2.1 pp20? 171.84 40.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 109.303 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 131.59 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.048 -1.032 . . . . 0.0 109.987 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.79 152.42 22.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.382 -0.824 . . . . 0.0 108.846 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.66 46.74 3.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -94.97 34.5 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.338 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 3.5 m -144.36 169.63 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 108.942 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.31 146.32 19.82 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.0 109.628 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.74 101.37 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.603 2.202 . . . . 0.0 111.411 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 75.95 17.99 79.75 Favored Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.513 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.953 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -61.88 153.12 29.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.37 -1.665 . . . . 0.0 108.926 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.916 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -86.9 59.6 5.74 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.552 -1.342 . . . . 0.0 109.821 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 61' ' ' ILE . 2.2 mt -54.36 116.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 121.224 -0.923 . . . . 0.0 109.356 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.9 OUTLIER -80.93 -48.73 11.91 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.869 -1.145 . . . . 0.0 110.546 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -114.46 160.46 19.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.853 -1.155 . . . . 0.0 108.947 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -137.0 95.38 3.1 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.943 -1.098 . . . . 0.0 110.127 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 111' ' ' THR . . . 50.62 -85.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -119.98 55.8 0.61 Allowed Glycine 0 N--CA 1.502 3.09 0 C-N-CA 119.536 -1.316 . . . . 0.0 109.934 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.974 HG21 HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -167.81 150.42 5.76 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -122.5 118.74 29.02 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.329 -0.857 . . . . 0.0 108.833 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.725 ' HG3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.59 -62.97 1.43 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.43 -0.794 . . . . 0.0 109.759 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.453 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 2.1 mp0 -40.08 -32.28 0.16 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.808 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -111.26 47.06 1.08 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 101' ' ' ILE . 16.7 mt -163.16 146.21 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.652 HG23 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -69.79 -179.23 1.74 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.782 ' HA ' HD21 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -74.03 -60.49 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.498 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -67.06 -41.95 85.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.907 . . . . 0.0 109.884 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.956 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -59.17 -40.55 85.97 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.996 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.547 ' HB1' ' HE3' ' A' ' 90' ' ' MET . . . -61.32 -62.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.085 -1.01 . . . . 0.0 110.41 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -48.68 -22.84 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.41 -47.83 15.04 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.782 -1.198 . . . . 0.0 110.701 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -49.67 -39.7 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.514 -1.366 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.974 HD11 HG21 ' A' ' 88' ' ' THR . 1.4 mp -61.58 -58.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -40.39 -28.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.649 0.737 . . . . 0.0 109.196 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -80.41 -26.08 38.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.515 -0.741 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -53.99 176.64 0.12 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.737 -1.227 . . . . 0.0 109.447 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -81.73 175.52 9.32 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 121.882 1.721 . . . . 0.0 110.56 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 80.3 m-20 -96.06 90.38 5.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.31 -0.869 . . . . 0.0 109.674 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -156.86 -143.68 3.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.61 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.697 2.265 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.858 HG11 HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -86.1 118.64 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.426 ' H ' ' HA2' ' A' ' 86' ' ' GLY . 1.4 m -86.77 123.23 31.7 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.828 0.823 . . . . 0.0 110.302 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.2 pt -110.71 154.48 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -131.1 89.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.953 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.5 pp -89.27 130.41 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.694 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 30' ' ' VAL . 4.0 ttp85 -122.48 102.57 8.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG3' ' OD2' ' A' ' 80' ' ' ASP . 35.5 mtm-85 -89.32 162.61 15.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 108.922 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -126.81 130.03 49.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.717 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.24 151.26 23.6 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.29 -0.881 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 78.13 5.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.627 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.39 37.14 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.522 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.405 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -83.12 134.93 34.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -90.92 63.79 5.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.77 -30.33 2.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 125' ' ' THR . 12.6 t -47.78 136.15 11.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.875 . . . . 0.0 109.61 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 124' ' ' THR . 42.1 p 46.28 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.99 -36.43 64.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.13 -60.45 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.225 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -145.58 -170.2 14.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.78 -65.02 1.04 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.92 125.98 6.93 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.693 2.262 . . . . 0.0 110.148 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -176.07 -70.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.126 -0.984 . . . . 0.0 110.001 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.23 -39.99 16.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.961 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -72.94 -159.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.9 -174.52 3.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.124 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.459 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -158.19 -56.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.938 . . . . 0.0 109.405 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 7' ' ' SER . 18.0 p 53.03 57.87 5.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.408 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 23.9 p-10 -154.49 130.8 10.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.269 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.02 -52.61 2.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.81 31.8 18.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.411 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.76 44.25 17.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -131.48 2.36 4.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.81 -62.64 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.88 -163.02 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -81.27 -76.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.671 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 78.74 -50.35 0.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.869 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 m -118.69 171.02 8.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.967 . . . . 0.0 109.744 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.06 158.0 17.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 21' ' ' SER . 2.4 p -153.49 140.72 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.66 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 74.41 114.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.613 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 21' ' ' SER . 3.6 t 70.69 132.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.256 -0.902 . . . . 0.0 109.67 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.16 172.45 11.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.0 m -77.42 85.82 3.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 57.01 87.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.565 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -160.53 148.35 16.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER 65.74 97.08 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 65.51 157.33 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.54 129.12 21.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.088 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.2 t -107.22 152.53 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -143.21 88.62 2.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -68.86 128.71 37.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.816 . . . . 0.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -140.88 161.81 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.142 -0.974 . . . . 0.0 110.607 -178.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -114.63 135.98 53.54 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.202 -0.936 . . . . 0.0 109.086 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.4 mm? -114.63 65.15 0.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.883 -1.136 . . . . 0.0 111.215 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -14.52 105.84 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.228 0.537 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' CD ' HD11 ' A' ' 105' ' ' LEU . 2.8 tptp -80.02 131.84 35.88 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.455 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -119.81 -56.62 2.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.454 -0.779 . . . . 0.0 109.042 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.4 OUTLIER 167.8 57.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.786 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.29 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.059 . . . . 0.0 110.265 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.566 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 78.99 47.89 7.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.856 HD21 ' CG2' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 28.51 35.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.172 -0.605 . . . . 0.0 111.697 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 67.21 2.17 17.66 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.785 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.833 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -153.61 149.81 27.98 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.178 -1.778 . . . . 0.0 111.925 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.26 154.4 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.417 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -103.04 146.99 27.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.335 -0.853 . . . . 0.0 111.312 -178.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.513 ' HA ' ' NE ' ' A' ' 95' ' ' ARG . 72.8 mt-10 -145.34 150.83 37.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.644 -1.285 . . . . 0.0 111.131 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . 124.56 -113.39 1.98 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 57' ' ' LYS . . . 71.77 -139.38 28.59 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.526 -1.321 . . . . 0.0 109.894 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.9 pttt -45.78 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.252 . . . . 0.0 109.845 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.29 -98.74 2.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -147.54 -156.69 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 109.488 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.7 mm? -108.51 36.6 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.18 8.46 13.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . . . -178.73 -81.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER 169.12 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.284 . . . . 0.0 109.696 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HB2' ' HA2' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -115.31 84.24 11.35 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.0 109.898 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.908 ' O ' HG23 ' A' ' 60' ' ' THR . 40.2 Cg_endo -86.79 74.45 2.89 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.599 2.2 . . . . 0.0 111.265 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 95' ' ' ARG . 6.5 mp -46.83 121.6 3.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.595 -1.315 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 1.045 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.6 p -131.0 160.09 35.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 109.462 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.652 HG21 HD11 ' A' ' 64' ' ' ILE . 52.3 mt -75.39 116.72 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 119.999 -1.688 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.73 -41.92 5.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.284 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.33 95.2 5.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.804 -1.185 . . . . 0.0 110.573 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -98.35 144.66 11.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 0.0 109.477 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.6 m-85 -109.79 -59.26 1.94 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.096 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -136.04 123.05 21.46 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.079 -1.013 . . . . 0.0 109.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . -95.49 -143.99 15.75 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' SER . . . 55.58 104.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -1.128 . . . . 0.0 109.066 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.854 ' HB3' ' HB2' ' A' ' 72' ' ' GLN . . . -63.32 -165.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.98 . . . . 0.0 108.552 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -41.49 -55.96 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.204 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' GLN . 28.2 tt0 -131.08 -18.05 3.0 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.605 -0.684 . . . . 0.0 110.221 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.854 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -49.47 176.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 84.7 p -92.77 -74.0 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 73' ' ' SER . 2.4 mp0 -122.71 103.86 8.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' HD21 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -107.36 31.11 5.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -142.17 165.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.681 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -148.57 138.46 12.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.833 . . . . 0.0 108.771 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -79.53 105.62 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.238 1.959 . . . . 0.0 111.285 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.87 69.33 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.961 -1.114 . . . . 0.0 111.536 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -67.71 157.62 34.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.282 -1.717 . . . . 0.0 108.561 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.045 ' HA ' HG22 ' A' ' 60' ' ' THR . 5.1 tp10 -93.24 58.85 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.624 -1.298 . . . . 0.0 108.881 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' O ' ' CE ' ' A' ' 90' ' ' MET . 2.2 mt -53.86 129.14 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -41.27 22.38 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.789 -1.194 . . . . 0.0 110.917 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 88' ' ' THR . 4.4 pm0 -144.44 164.5 30.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.921 -1.112 . . . . 0.0 109.619 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -106.25 -173.55 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 108.732 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.573 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -68.88 -3.28 34.64 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 101' ' ' ILE . . . -155.47 27.9 0.61 Allowed Glycine 0 N--CA 1.501 3.015 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.697 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.901 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -168.27 153.1 6.4 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.668 -1.489 . . . . 0.0 108.035 178.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.42 128.2 40.84 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.929 ' HG2' HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -72.68 -61.75 1.7 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.511 -0.743 . . . . 0.0 110.663 -178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' MET . 11.2 mp0 -35.66 -27.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.611 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -115.62 47.79 1.0 Allowed Glycine 0 N--CA 1.48 1.622 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.596 ' CD2' ' CB ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -167.9 -164.07 0.53 Allowed 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.174 -1.192 . . . . 0.0 109.968 -177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 1.013 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.27 -65.34 1.02 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.227 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -63.3 -44.69 94.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.619 -1.301 . . . . 0.0 109.286 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 101' ' ' ILE . 55.2 mm-40 -50.7 -45.44 58.39 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.7 -68.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 111.074 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.518 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 22.5 t-105 -56.31 -12.61 1.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.183 -0.948 . . . . 0.0 110.897 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -81.78 -47.14 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 110.974 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.9 mp -56.41 -41.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 109.906 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 88' ' ' THR . 1.5 mp -54.46 -60.61 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.381 -0.825 . . . . 0.0 109.335 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -43.47 -36.0 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.912 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.79 -3.94 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.419 -0.801 . . . . 0.0 110.912 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -68.31 175.6 1.77 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.895 -1.128 . . . . 0.0 109.942 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.694 ' O ' HD22 ' A' ' 105' ' ' LEU . 34.9 Cg_endo -80.68 150.42 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.145 1.897 . . . . 0.0 111.246 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.58 85.46 1.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.106 -0.996 . . . . 0.0 109.146 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.38 -147.34 4.64 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.78 97.81 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 110.968 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' CG1' ' O ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -88.13 115.1 27.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.3 m -89.36 129.39 35.9 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.831 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.2 pt -114.42 155.78 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.24 96.13 2.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.018 -1.051 . . . . 0.0 108.447 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.776 HG21 ' NE2' ' A' ' 77' ' ' GLN . 1.4 pp -92.94 125.65 45.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.193 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.921 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -126.87 106.03 9.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 89.73 8.11 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.84 159.09 27.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.71 56.72 3.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 45.21 84.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -168.83 -156.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -163.26 -70.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 72.59 -59.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.32 -168.36 0.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.56 74.78 1.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -104.09 -179.29 3.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.396 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -94.76 -158.78 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . 173.35 109.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -111.65 114.09 3.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.29 68.35 0.54 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.299 -1.119 . . . . 0.0 109.258 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.434 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 36.6 Cg_endo -78.64 116.98 3.89 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.398 2.065 . . . . 0.0 110.154 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.31 -5.86 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -163.16 -161.37 0.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -47.1 -27.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 p -174.16 -173.63 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.576 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -175.4 34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.09 137.3 47.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -162.99 -151.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -76.28 -169.51 1.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.01 -62.6 1.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -0.906 . . . . 0.0 109.559 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.04 21.29 0.44 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.61 80.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -165.95 61.32 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.07 54.02 2.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -177.76 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.575 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 68.38 -59.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 179.74 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -112.47 162.24 15.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.913 . . . . 0.0 109.578 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 20' ' ' VAL . 9.3 t 65.76 30.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -78.75 121.17 24.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.397 -0.814 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.6 p 40.07 76.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.479 -0.763 . . . . 0.0 109.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -90.41 94.3 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 109.464 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER 75.97 175.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.481 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -152.77 150.67 29.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.308 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 27' ' ' GLU . . . -123.64 165.48 17.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 7.6 mt-10 150.99 102.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB2' ' HG2' ' A' ' 117' ' ' LYS . . . -177.32 145.65 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 109.685 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 70.3 p -114.54 146.36 40.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.01 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 115' ' ' ARG . 10.6 t -117.83 151.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.896 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 114' ' ' ILE . 4.7 m -142.36 88.96 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -69.01 129.98 41.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.448 -0.783 . . . . 0.0 110.041 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -140.9 154.78 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 110.306 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -109.85 134.46 52.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 178.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 112' ' ' ILE . 2.1 mm? -112.28 64.03 0.63 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.112 -0.993 . . . . 0.0 111.299 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 mt-10 -20.31 100.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.26 0.553 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.683 ' HB2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -90.49 132.31 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.564 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 1.1 mtp -137.03 76.6 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.208 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.5 t 59.45 53.0 5.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.96 . . . . 0.0 109.339 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.25 -63.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.388 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 132.53 51.12 0.09 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.046 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.2 OUTLIER 55.17 4.46 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.945 -1.327 . . . . 0.0 111.443 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 65' ' ' PHE . . . 69.39 -2.37 10.57 Favored Glycine 0 N--CA 1.482 1.7 0 O-C-N 120.632 -1.292 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 1.046 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 7.7 p90 -127.89 175.45 8.34 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 120.485 -1.597 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -128.9 148.16 50.89 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.93 HD21 ' CE ' ' A' ' 90' ' ' MET . 5.8 tp -110.43 138.92 46.19 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.183 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE1' ' ND2' ' A' ' 62' ' ' ASN . 17.8 mt-10 -122.85 155.92 35.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.648 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.585 ' HA3' ' HG ' ' A' ' 59' ' ' LEU . . . -153.21 123.38 1.42 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.235 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -87.59 57.38 4.44 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.387 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.0 tmtt? -44.53 116.44 1.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.001 -1.293 . . . . 0.0 109.145 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . 44.04 62.03 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -96.07 18.25 13.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mp 44.99 48.82 9.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.366 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -132.64 -25.41 1.9 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.879 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . 139.39 66.97 0.04 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.4 m-20 77.47 169.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.077 . . . . 0.0 109.367 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -118.29 86.32 27.11 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.195 -0.941 . . . . 0.0 109.761 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.993 ' O ' HG23 ' A' ' 60' ' ' THR . 37.1 Cg_endo -79.65 76.16 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.355 2.037 . . . . 0.0 110.51 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 90' ' ' MET . 1.6 mp -45.84 127.74 8.31 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 58' ' ' PRO . 37.6 p -140.99 158.46 43.9 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.758 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' A' ' 64' ' ' ILE . 87.0 mt -71.88 125.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 120.436 -1.415 . . . . 0.0 108.57 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 47' ' ' GLU . 1.9 m120 -106.29 -40.44 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.856 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 103.0 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.563 -1.335 . . . . 0.0 109.249 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -99.42 143.02 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.984 0.897 . . . . 0.0 110.611 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 1.1 m-85 -112.28 161.41 16.64 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.9 136.45 55.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.93 -170.09 12.24 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -110.51 18.97 19.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.032 -1.275 . . . . 0.0 109.491 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' ALA . . . 42.45 -168.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.734 -0.604 . . . . 0.0 109.646 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -132.39 -76.33 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.044 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.99 7.34 3.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.538 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.668 ' O ' HG23 ' A' ' 75' ' ' THR . 10.5 tt0 -129.68 128.65 42.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -50.93 143.57 9.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.358 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' CG ' ' C ' ' A' ' 73' ' ' SER . 1.8 pt-20 38.54 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.508 -0.745 . . . . 0.0 109.76 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 33' ' ' VAL . 22.3 p -90.46 21.34 3.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -137.04 154.53 31.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 O-C-N 121.354 -0.841 . . . . 0.0 109.014 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.753 ' CG ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -135.31 134.06 21.03 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 108.924 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.9 118.24 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.262 1.974 . . . . 0.0 111.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.82 26.47 64.77 Favored Glycine 0 N--CA 1.506 3.362 0 C-N-CA 120.002 -1.095 . . . . 0.0 111.436 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.946 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -85.78 155.4 21.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.438 -1.624 . . . . 0.0 109.271 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.988 ' HA ' HG22 ' A' ' 60' ' ' THR . 12.4 tt0 -91.66 61.47 4.24 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.627 -1.296 . . . . 0.0 109.784 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.81 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -60.27 128.94 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.065 -1.022 . . . . 0.0 109.17 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -85.89 -41.29 15.09 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.594 -1.316 . . . . 0.0 111.022 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.742 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -141.24 146.7 37.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.584 -1.322 . . . . 0.0 108.832 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.7 mp -106.62 170.95 7.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 108.735 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -37.9 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.461 -0.876 . . . . 0.0 110.934 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -148.55 51.08 0.56 Allowed Glycine 0 N--CA 1.503 3.119 0 C-N-CA 118.684 -1.722 . . . . 0.0 111.075 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.133 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -179.33 143.66 0.21 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.677 -1.484 . . . . 0.0 109.884 178.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.703 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -123.38 111.7 16.69 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.93 ' CE ' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 -0.69 14.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.01 . . . . 0.0 111.401 -177.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 0.5 OUTLIER -62.81 149.14 44.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.468 -1.395 . . . . 0.0 107.997 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.96 36.94 4.0 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 120.285 -1.509 . . . . 0.0 109.607 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -131.44 -168.74 2.06 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 120.955 -1.321 . . . . 0.0 109.086 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -128.14 171.35 12.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -60.02 -69.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 110.237 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -55.79 -51.46 67.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.096 -1.003 . . . . 0.0 109.345 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.98 ' O ' HD12 ' A' ' 101' ' ' ILE . 5.1 mt-10 -49.3 -49.56 43.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.203 -0.936 . . . . 0.0 109.112 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -56.57 -66.6 0.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.001 -1.062 . . . . 0.0 110.852 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.524 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 15.8 t-105 -57.78 -13.73 4.7 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.07 -1.019 . . . . 0.0 111.059 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.63 -46.27 14.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.648 -1.282 . . . . 0.0 110.96 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.98 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.8 mp -59.3 -39.31 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 110.536 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.133 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -55.69 -54.03 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 108.929 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -45.65 -34.33 3.41 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.628 0.728 . . . . 0.0 109.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.48 -1.58 53.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.54 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.845 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.23 175.72 1.21 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.742 ' O ' HD22 ' A' ' 105' ' ' LEU . 35.0 Cg_endo -80.87 170.07 15.79 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.422 2.081 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 7.1 m-20 -97.26 94.96 7.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -171.66 -142.01 3.56 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.0 95.91 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.808 2.338 . . . . 0.0 110.493 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.22 110.41 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.53 HG23 HG23 ' A' ' 34' ' ' THR . 0.7 OUTLIER -88.58 126.87 35.48 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 110.736 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -109.77 157.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -132.52 92.49 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 108.235 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.946 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.7 pp -89.76 131.23 37.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.576 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.904 ' HB2' HG22 ' A' ' 30' ' ' VAL . 20.9 ttp180 -127.71 109.36 11.59 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.04 177.04 6.56 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.258 -0.901 . . . . 0.0 109.707 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.605 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 mttt -151.35 175.09 12.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 3.7 t 78.09 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 109.71 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' A' ' 118' ' ' SER . 0.6 OUTLIER 79.89 141.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.499 -0.751 . . . . 0.0 109.534 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -110.06 14.81 22.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.835 . . . . 0.0 109.707 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.7 m -47.57 -25.82 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.27 121.28 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -71.01 -58.41 3.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.63 176.89 8.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.291 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -158.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.36 -166.81 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 50.35 22.11 0.94 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.59 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.79 -129.47 2.35 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.36 164.79 15.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.151 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.491 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.674 2.25 . . . . 0.0 110.34 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.07 169.44 0.42 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.565 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -61.88 153.49 28.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' SER . 1.7 m-80 -95.59 -88.19 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.298 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ASN . 3.2 m 51.41 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -11.36 60.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 109.307 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.4 m -80.26 125.35 29.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -175.22 -45.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -65.87 -67.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.21 100.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.41 113.75 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.18 39.16 4.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 101.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.3 m -155.45 -61.77 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.344 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.52 147.36 39.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -154.47 108.59 2.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER 63.47 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' C ' HG23 ' A' ' 20' ' ' VAL . 1.1 t0 72.44 129.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG23 ' C ' ' A' ' 19' ' ' ASP . 3.5 t 72.2 155.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.913 . . . . 0.0 109.643 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 22' ' ' VAL . 38.6 t -165.73 -163.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.131 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' N ' ' OG ' ' A' ' 21' ' ' SER . 12.2 p -44.87 135.02 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 0.0 109.231 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 24' ' ' SER . 16.0 tp10 -124.88 119.98 30.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 52.85 105.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.407 -0.808 . . . . 0.0 109.936 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 68.7 p -110.51 58.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 0.0 109.166 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -179.41 -166.37 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.307 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 5.2 mt-10 66.5 96.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.935 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.89 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.733 -0.604 . . . . 0.0 110.129 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.9 134.79 37.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 0.0 109.206 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 115' ' ' ARG . 12.1 t -116.31 151.41 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.687 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.8 m -140.75 87.49 2.12 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.549 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -71.53 131.62 43.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.371 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -150.08 159.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.031 . . . . 0.0 111.365 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -111.58 133.55 53.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.704 HD12 HD13 ' A' ' 112' ' ' ILE . 13.5 mt -112.52 66.17 0.64 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.814 -1.179 . . . . 0.0 111.459 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 35' ' ' LEU . 5.3 pt-20 -16.22 103.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.84 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -79.31 118.97 21.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.284 -0.885 . . . . 0.0 108.98 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.0 mmm -137.0 -35.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 0.0 109.978 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 30.7 p -162.55 165.58 25.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 110.052 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 67.08 -72.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.42 -0.8 . . . . 0.0 109.847 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.538 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 148.62 77.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 43.8 20.08 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.222 -1.164 . . . . 0.0 110.92 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 44.9 20.46 0.23 Allowed Glycine 0 N--CA 1.483 1.797 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.12 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.878 ' HE1' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -146.71 136.26 22.97 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.296 -1.708 . . . . 0.0 110.508 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -113.61 141.12 47.58 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.878 HD13 ' HE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -95.88 138.23 33.82 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.519 -0.738 . . . . 0.0 111.34 -179.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 65.0 mt-10 -153.15 155.32 36.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.086 . . . . 0.0 110.384 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.72 -117.57 0.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.674 ' O ' HD12 ' A' ' 59' ' ' LEU . . . -145.7 158.26 27.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.706 ' HD2' HG23 ' A' ' 94' ' ' THR . 1.5 ptmt -86.98 -12.02 48.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.656 -1.497 . . . . 0.0 111.3 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.6 ' CA ' ' HG3' ' A' ' 57' ' ' LYS . . . 122.77 14.79 4.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 70.5 m -150.52 74.24 1.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -1.111 . . . . 0.0 109.032 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -133.57 -73.59 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.214 -0.929 . . . . 0.0 109.684 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -139.85 -20.62 0.9 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.201 -0.937 . . . . 0.0 110.679 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' N ' ' HE3' ' A' ' 57' ' ' LYS . . . 157.01 -22.06 0.45 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.007 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' C ' ' HD3' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -141.18 92.38 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.447 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.639 ' CB ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.69 81.28 40.64 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -93.34 112.22 0.22 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.631 2.221 . . . . 0.0 111.469 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -68.11 118.13 10.85 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 1.01 HG22 ' HA ' ' A' ' 81' ' ' GLU . 32.0 p -138.2 160.66 38.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.176 . . . . 0.0 110.596 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 ' CG1' ' A' ' 64' ' ' ILE . 54.5 mt -68.87 124.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.258 -1.526 . . . . 0.0 109.852 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -104.82 -48.12 3.85 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.569 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -113.54 100.47 8.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.341 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.714 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -95.75 143.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.832 0.825 . . . . 0.0 109.808 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD2' ' HA2' ' A' ' 43' ' ' GLY . 3.2 m-30 -107.01 161.11 15.03 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.47 112.2 19.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.651 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.72 -44.19 0.52 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.93 114.93 28.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -1.174 . . . . 0.0 109.43 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -177.64 -173.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.156 -0.965 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -112.31 -156.46 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -117.4 35.76 4.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.455 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.8 OUTLIER -91.57 39.93 1.02 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.592 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 72' ' ' GLN . 51.7 p 47.94 84.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.806 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' SER . 41.2 mt-10 63.09 98.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.585 ' OG1' HD21 ' A' ' 35' ' ' LEU . 3.5 p -107.72 32.66 4.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.556 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -151.48 166.53 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.531 ' CB ' ' OD2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.77 140.88 14.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.202 -0.936 . . . . 0.0 109.22 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.9 Cg_endo -81.42 117.09 3.05 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.556 2.171 . . . . 0.0 111.545 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 25.64 74.17 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.34 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.858 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -79.98 155.69 27.54 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.429 -1.63 . . . . 0.0 108.551 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 60' ' ' THR . 16.1 tt0 -90.91 63.89 5.33 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.649 -1.282 . . . . 0.0 110.107 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 114' ' ' ILE . 2.0 mt -56.43 121.72 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 108.333 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 90' ' ' MET . 7.7 mt -78.92 -43.24 25.2 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.69 -1.257 . . . . 0.0 111.175 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 1.3 pm0 -150.13 157.14 42.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.699 -1.251 . . . . 0.0 110.553 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.852 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -101.71 -178.66 3.78 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.094 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.464 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -66.3 -6.18 32.18 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.44 27.44 1.08 Allowed Glycine 0 N--CA 1.503 3.165 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.097 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.28 144.56 4.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.686 -1.479 . . . . 0.0 108.729 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -130.25 127.25 39.19 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.777 ' HE3' ' HB2' ' A' ' 59' ' ' LEU . 1.4 mtp -67.58 -63.6 1.03 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.29 -0.881 . . . . 0.0 110.401 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 1.3 mm100 -34.5 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.624 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.666 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -112.42 48.29 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -167.05 -166.16 0.78 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.388 -1.066 . . . . 0.0 109.873 -177.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.706 HG23 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -113.64 175.16 5.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.797 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -67.86 -58.46 4.54 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.8 -1.187 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 45.9 m-85 -66.22 -50.72 62.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.861 -1.15 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.9 ' O ' HD12 ' A' ' 101' ' ' ILE . 67.9 mm-40 -49.73 -41.55 44.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.134 -0.979 . . . . 0.0 108.881 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -49.95 -69.56 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.102 -0.999 . . . . 0.0 109.971 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.612 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 13.8 t-105 -56.03 -13.88 2.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.248 -0.907 . . . . 0.0 111.069 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -81.39 -46.44 14.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.561 -1.337 . . . . 0.0 111.111 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.5 mp -58.04 -39.92 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.573 -1.329 . . . . 0.0 110.109 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.097 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -59.72 -59.41 4.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.136 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 102' ' ' ILE . 2.5 mmmm -42.34 -27.77 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.859 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -92.04 6.42 46.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.422 -0.799 . . . . 0.0 111.16 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -76.34 178.42 1.98 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 120.823 -1.173 . . . . 0.0 109.487 -179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 37.5 Cg_endo -83.5 177.36 6.42 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.827 2.351 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 4.2 m-20 -96.98 93.53 6.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 109.257 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.71 -148.78 5.52 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.599 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.06 97.78 1.16 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.214 2.61 . . . . 0.0 110.989 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.741 ' CG2' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.36 112.49 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 34' ' ' THR . 0.5 OUTLIER -88.62 128.79 35.59 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.78 0.8 . . . . 0.0 110.649 -177.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.704 HD13 HD12 ' A' ' 35' ' ' LEU . 1.1 pt -116.46 156.12 17.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.482 0.658 . . . . 0.0 109.742 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.449 ' CG2' ' NE2' ' A' ' 84' ' ' GLN . 2.1 t -134.73 110.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.858 HD13 ' OD2' ' A' ' 80' ' ' ASP . 1.4 pp -112.96 134.21 56.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.316 -0.865 . . . . 0.0 109.806 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.789 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.0 ttp180 -127.87 110.1 12.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 116' ' ' ARG . 5.8 ptt180 -95.68 103.78 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.685 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 61.28 6.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.006 -1.059 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.53 106.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.0 109.712 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 119' ' ' LEU . 3.1 tt -145.96 33.07 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.162 -0.962 . . . . 0.0 109.347 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 7.1 tt0 176.74 -30.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 48.79 -157.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' SER . 14.9 mttp 62.12 94.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.42 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 51.28 -157.71 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 125' ' ' THR . 38.2 p -136.76 -170.97 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.57 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 127' ' ' ALA . 27.0 p 47.59 40.7 12.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 63.09 -74.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 125' ' ' THR . . . -90.99 -149.1 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -158.91 -95.84 0.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -134.43 50.36 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -1.106 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.603 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 1' ' ' MET . 35.6 Cg_endo -78.49 82.82 2.37 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.484 2.123 . . . . 0.0 110.323 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER 169.48 51.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.268 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' ASN . 1.3 mt -174.77 -73.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 11.0 p30 40.91 37.99 0.6 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.525 -0.734 . . . . 0.0 110.046 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.23 -159.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 109.531 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.27 70.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.73 91.24 2.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 0.0 109.705 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 57.61 -173.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.708 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -97.34 -8.93 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.52 -72.48 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.569 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.76 -71.3 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.483 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -167.46 145.9 4.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.53 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.92 175.88 5.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.97 116.13 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.75 34.24 5.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.24 41.75 1.92 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.343 -0.848 . . . . 0.0 109.083 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -101.05 105.96 17.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.379 -0.826 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 20' ' ' VAL . 32.7 t70 -64.92 113.32 3.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER 58.24 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -86.11 -166.75 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.376 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.27 148.8 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -95.37 96.67 9.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -144.66 107.45 4.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.3 m -101.81 46.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.12 86.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.326 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -96.04 27.69 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 109.322 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . . . -44.56 121.12 2.5 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.636 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 1.0 OUTLIER -150.74 148.65 28.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.395 -0.816 . . . . 0.0 109.567 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 115' ' ' ARG . 26.7 t -112.79 150.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 109.183 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.6 m -134.38 83.31 2.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.493 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.888 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -71.97 120.93 18.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 108.874 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -144.14 163.0 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 111.161 -178.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.535 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -114.85 134.55 55.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 178.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.74 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.1 mm? -113.0 65.07 0.64 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.029 -1.045 . . . . 0.0 111.334 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.557 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.8 pt-20 -21.17 105.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.24 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' CD ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -78.72 117.31 19.74 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.248 -0.907 . . . . 0.0 108.956 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttp -147.08 -39.01 0.2 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.864 . . . . 0.0 109.178 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 40' ' ' ALA . 95.3 p -69.24 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.444 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' ' OG ' ' A' ' 39' ' ' SER . . . -174.01 39.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 148.26 40.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 37.07 28.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.56 -0.965 . . . . 0.0 110.234 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 49.51 21.07 2.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.998 ' CE2' HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -152.63 140.21 19.78 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.037 -1.272 . . . . 0.0 109.914 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 63' ' ' ARG . 3.8 t -128.4 156.25 43.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -141.43 162.64 34.98 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 116.179 -2.208 . . . . 0.0 114.071 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 9.1 mt-10 -147.22 155.7 42.31 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.172 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -151.09 -93.09 0.1 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 167.26 104.13 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.782 -1.675 . . . . 0.0 111.477 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 49' ' ' GLY . 4.9 tttt -28.96 131.7 0.05 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 122.016 -0.696 . . . . 0.0 109.866 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 57' ' ' LYS . . . -40.35 100.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -126.2 139.01 53.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 109.09 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER 59.2 -151.98 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.167 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.551 ' H ' HD23 ' A' ' 53' ' ' LEU . 18.2 p-80 -89.78 29.74 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.174 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -120.9 98.25 0.66 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 2.1 m-20 -49.28 -179.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.253 . . . . 0.0 109.26 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HG3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -110.1 82.77 2.68 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 110.736 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 60' ' ' THR . 37.3 Cg_endo -79.44 68.99 8.12 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.25 1.967 . . . . 0.0 110.206 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 95' ' ' ARG . 2.2 mp -41.61 132.57 2.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.886 HG22 ' HA ' ' A' ' 81' ' ' GLU . 22.0 p -128.81 153.46 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.109 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.807 HG21 HG13 ' A' ' 64' ' ' ILE . 76.6 mt -67.21 138.18 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 119.801 -1.812 . . . . 0.0 109.662 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.493 ' CG ' ' N ' ' A' ' 63' ' ' ARG . 1.8 p30 -115.98 -51.62 2.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.392 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 6.9 ptt180 -116.82 93.51 4.23 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.015 -1.053 . . . . 0.0 110.212 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.807 HG13 HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -95.09 155.62 3.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -123.55 101.34 7.27 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.275 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 108.803 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 68' ' ' ALA . . . 166.27 72.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . 168.47 -169.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.354 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 75' ' ' THR . . . 64.94 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p -162.77 42.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.52 -25.29 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 109.795 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -173.77 28.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' GLN . 24.6 p 47.92 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 110.03 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.4 mt-10 39.5 42.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.498 -0.751 . . . . 0.0 109.76 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.685 ' O ' HD21 ' A' ' 35' ' ' LEU . 3.2 p -91.61 26.55 2.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.456 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.0 157.48 3.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 121.606 -0.684 . . . . 0.0 109.237 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -148.33 145.64 20.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 109.065 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.04 131.67 10.06 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.519 2.146 . . . . 0.0 111.107 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.84 11.46 50.31 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.081 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' A' ' 82' ' ' ILE . 55.5 p-10 -61.63 146.95 47.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.022 -1.281 . . . . 0.0 109.39 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.886 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -90.89 75.65 6.39 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.406 -1.434 . . . . 0.0 110.004 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.642 HG12 HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -74.17 118.72 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.88 -1.138 . . . . 0.0 109.3 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.86 -46.54 21.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.626 -1.296 . . . . 0.0 110.335 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -129.1 150.51 50.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.601 -1.312 . . . . 0.0 109.278 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.998 HD21 ' CE2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -111.71 115.7 29.53 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 110' ' ' VAL . . . -20.4 83.64 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 121.8 7.24 8.11 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.947 HG21 HD11 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -167.52 144.61 4.42 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.982 -1.305 . . . . 0.0 108.816 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -120.66 140.65 51.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.051 ' CE ' ' HB2' ' A' ' 98' ' ' ALA . 5.5 tpp -88.52 -58.48 2.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.727 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.479 ' NE2' ' HE2' ' A' ' 57' ' ' LYS . 12.9 mm-40 -35.81 -27.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.71 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 1.017 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -116.5 47.76 1.0 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 106.536 -2.625 . . . . 0.0 106.536 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -162.8 -161.72 0.73 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.555 -0.967 . . . . 0.0 109.347 -177.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.552 ' O ' ' CE ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -126.29 161.75 27.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.827 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -54.9 -66.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.695 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.493 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -55.96 -50.22 71.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.005 . . . . 0.0 110.21 -178.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.04 ' O ' HD12 ' A' ' 101' ' ' ILE . 4.9 mm-40 -53.47 -42.99 67.77 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.861 -1.149 . . . . 0.0 108.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.051 ' HB2' ' CE ' ' A' ' 90' ' ' MET . . . -52.57 -69.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.626 ' HZ3' HD11 ' A' ' 42' ' ' LEU . 5.6 t-105 -55.73 -14.03 2.04 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.239 -0.913 . . . . 0.0 110.45 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -81.92 -49.77 9.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.302 . . . . 0.0 110.521 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.04 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.1 mp -55.21 -42.72 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.576 -1.327 . . . . 0.0 110.099 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.982 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.4 mp -55.81 -56.33 13.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 108.616 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' ILE . 10.6 mmtp -42.01 -35.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.505 0.669 . . . . 0.0 109.751 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.59 1.31 57.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 111.41 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.982 HD12 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -74.73 175.28 4.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.781 -1.2 . . . . 0.0 110.363 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.57 ' N ' HD22 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -83.13 122.43 3.31 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 122.786 2.324 . . . . 0.0 111.658 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.12 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 109.736 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' PRO . . . -150.96 -151.2 5.51 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.9 95.71 1.08 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.978 2.452 . . . . 0.0 110.796 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.674 HG11 HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -87.25 111.92 22.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 11.9 t -88.05 134.86 33.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.138 0.97 . . . . 0.0 110.685 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.74 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.1 pt -118.8 153.84 21.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.888 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.18 99.42 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.1 pp -109.96 146.92 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.532 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.742 ' HB2' HG22 ' A' ' 30' ' ' VAL . 14.0 ttt180 -130.6 114.71 15.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 85.36 6.2 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.698 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -72.03 90.48 1.17 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 109.236 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 119' ' ' LEU . 1.4 t 59.37 -163.42 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 118' ' ' SER . 2.3 mp 60.91 113.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -106.32 4.82 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.628 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.92 178.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.684 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 92.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.53 -167.6 0.11 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -141.55 -47.19 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.493 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 124' ' ' THR . 81.2 m 65.2 87.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.386 -0.822 . . . . 0.0 109.714 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.03 165.62 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.937 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.18 118.71 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.269 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.62 152.88 47.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.97 114.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 109.628 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.378 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.586 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 36.5 Cg_endo -78.83 -48.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.313 2.009 . . . . 0.0 109.883 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 72.5 m-20 62.69 -83.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 0.0 109.568 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER -173.24 145.27 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 177.6 165.26 0.63 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -51.19 173.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.305 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.75 91.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p -105.99 -33.45 7.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.181 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -72.3 99.75 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.86 118.23 9.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -117.52 163.42 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.01 -44.12 6.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.5 t -169.5 161.19 9.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.632 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.28 -64.29 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.877 . . . . 0.0 109.487 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 t -157.6 59.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.23 -27.46 13.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . -77.15 -167.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 69.45 -148.67 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.415 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.65 82.55 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 t -87.79 154.63 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.394 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 141.63 49.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.85 175.47 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 66.7 mt-10 60.6 169.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 24' ' ' SER . 38.7 p 52.33 77.68 0.15 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 p -127.76 -76.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.89 40.92 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.524 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 49.49 23.39 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -0.886 . . . . 0.0 109.578 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.91 170.34 1.21 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 37.9 p -120.26 138.05 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 115' ' ' ARG . 39.7 t -119.46 144.92 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.998 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.5 m -138.19 87.98 2.28 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 HG23 HG13 ' A' ' 113' ' ' VAL . 2.0 m -70.03 128.09 35.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.588 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -145.45 161.49 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 110.683 -178.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.6 OUTLIER -120.71 133.13 55.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 110.271 178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 110' ' ' VAL . 4.1 mm? -100.76 161.67 13.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 0.3 OUTLIER -108.69 104.14 13.37 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 108.786 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 106' ' ' PRO . 4.9 ttpp -81.96 128.37 34.0 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.564 ' HG3' ' N ' ' A' ' 39' ' ' SER . 12.2 ptp -135.71 -37.05 0.76 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' A' ' 38' ' ' MET . 0.2 OUTLIER 177.33 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 178.05 -30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 110.223 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 102.26 68.77 0.81 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.97 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.08 21.91 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.258 -1.142 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 56.56 9.74 3.73 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.97 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.6 p90 -143.84 154.96 43.92 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.657 -1.496 . . . . 0.0 109.911 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.415 ' OG ' ' CB ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -117.45 151.76 36.4 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.829 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -107.3 145.13 33.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 111.388 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 7.5 mt-10 -116.19 157.55 24.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' CA ' ' HG ' ' A' ' 59' ' ' LEU . . . -146.8 118.12 1.0 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . -71.93 56.96 1.4 Allowed Glycine 0 N--CA 1.499 2.841 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.62 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HB3' HG22 ' A' ' 94' ' ' THR . 2.8 ptmt -36.47 104.15 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.573 -0.957 . . . . 0.0 109.708 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 52' ' ' SER . . . -113.18 -109.73 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 14.3 m -167.05 -148.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.683 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.97 -17.56 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.859 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -125.7 32.84 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.932 . . . . 0.0 109.579 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 56' ' ' ASP . . . -130.18 -42.42 0.21 Allowed Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.595 -1.288 . . . . 0.0 109.98 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 1.5 m-20 61.45 126.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -1.219 . . . . 0.0 108.761 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -120.81 89.37 45.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.077 . . . . 0.0 110.833 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 37.4 Cg_endo -79.82 85.38 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.337 2.025 . . . . 0.0 108.511 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 95' ' ' ARG . 1.9 mp -44.61 151.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.083 -1.01 . . . . 0.0 110.111 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.727 HG22 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -148.64 158.82 44.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.568 -0.708 . . . . 0.0 110.205 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.84 HG21 HD11 ' A' ' 64' ' ' ILE . 52.5 mt -80.24 117.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.072 -1.643 . . . . 0.0 109.177 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' OE2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -115.13 -0.04 13.43 Favored 'General case' 0 N--CA 1.509 2.498 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.11 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.415 ' CB ' ' OG ' ' A' ' 45' ' ' SER . 1.4 mtt-85 -150.57 86.53 1.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.253 -1.53 . . . . 0.0 109.356 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 61' ' ' ILE . 1.3 mt -95.31 145.52 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.006 0.908 . . . . 0.0 110.195 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.2 m-85 -109.74 -61.22 1.67 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.013 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 68' ' ' ALA . 23.0 tttt -133.04 109.46 9.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 109.641 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.831 ' HA2' HG21 ' A' ' 76' ' ' VAL . . . -66.61 74.12 0.15 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -70.76 164.42 25.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -1.167 . . . . 0.0 109.616 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.52 130.18 5.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.439 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.2 m -78.98 -12.62 60.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.47 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.73 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.547 ' HB2' ' CG2' ' A' ' 75' ' ' THR . 0.9 OUTLIER -142.71 161.39 38.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 109.636 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -92.73 103.5 15.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 73' ' ' SER . 0.3 OUTLIER 64.71 84.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 72' ' ' GLN . 64.7 p -92.39 25.26 3.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.187 -0.946 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' HA2' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -140.49 158.81 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.58 -0.7 . . . . 0.0 109.28 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.537 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -150.74 142.65 15.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.345 -0.847 . . . . 0.0 109.296 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.78 117.6 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.41 2.073 . . . . 0.0 110.257 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 3.77 87.42 Favored Glycine 0 N--CA 1.504 3.207 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.991 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 60' ' ' THR . 17.0 p30 -58.24 137.51 57.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.552 -1.557 . . . . 0.0 109.361 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.8 tt0 -84.39 64.48 8.39 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.562 -1.337 . . . . 0.0 108.778 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.8 mt -60.93 120.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.069 -1.02 . . . . 0.0 109.214 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.602 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.7 mm? -79.83 -39.14 31.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.488 -1.382 . . . . 0.0 111.354 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.771 ' NE2' HG21 ' A' ' 113' ' ' VAL . 15.5 pm0 -146.47 156.01 42.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.395 -1.441 . . . . 0.0 110.107 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG22 ' A' ' 88' ' ' THR . 3.2 mp -114.59 -179.23 3.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.374 -0.829 . . . . 0.0 109.646 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.931 ' HA2' HG22 ' A' ' 111' ' ' THR . . . -46.12 -21.18 0.62 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 101' ' ' ILE . . . -158.44 42.26 0.5 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 118.743 -1.694 . . . . 0.0 110.941 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -167.72 141.29 3.42 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.864 -1.374 . . . . 0.0 108.848 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' LEU . . . -117.75 122.08 42.52 Favored 'General case' 0 C--N 1.291 -1.948 0 O-C-N 121.26 -0.9 . . . . 0.0 109.016 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.578 ' CG ' ' HB2' ' A' ' 59' ' ' LEU . 9.8 mmt -59.65 -65.7 0.63 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.546 -0.721 . . . . 0.0 111.13 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 90' ' ' MET . 28.4 mm-40 -35.57 -28.17 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.923 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 1.03 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -117.21 48.08 0.97 Allowed Glycine 0 N--CA 1.482 1.743 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -161.29 139.39 9.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.403 -1.057 . . . . 0.0 110.237 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.8 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -80.81 165.26 22.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -48.62 -62.33 1.56 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.682 -1.261 . . . . 0.0 111.353 -178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -63.01 -51.95 64.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -178.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.015 ' O ' HD12 ' A' ' 101' ' ' ILE . 13.8 mm-40 -52.79 -41.24 63.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.923 -1.11 . . . . 0.0 108.833 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -60.8 -68.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 110.906 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -55.55 -14.25 1.98 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.365 -0.835 . . . . 0.0 110.901 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 92.7 m-20 -82.62 -49.07 10.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 110.771 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -53.77 -42.81 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.63 -1.294 . . . . 0.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.5 mp -54.18 -60.06 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.08 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' ILE . 8.5 mtpp -41.91 -35.18 0.8 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.581 0.705 . . . . 0.0 109.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 101' ' ' ILE . . . -65.8 -28.87 69.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.496 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 3.5 mm? -55.19 175.5 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 105' ' ' LEU . 36.6 Cg_endo -83.81 176.64 6.76 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.602 2.202 . . . . 0.0 110.662 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 3.9 m-20 -96.41 90.22 5.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.567 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -159.0 -140.21 2.86 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.45 98.5 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.781 2.32 . . . . 0.0 110.665 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.77 HG11 HD22 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.55 117.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.931 HG22 ' HA2' ' A' ' 86' ' ' GLY . 9.8 t -87.63 138.57 31.35 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.134 0.969 . . . . 0.0 110.94 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.1 pt -126.19 154.68 35.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG21 ' NE2' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -134.18 95.7 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.998 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.5 pp -93.79 129.83 43.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.407 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.688 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -128.22 99.08 5.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -89.09 128.98 35.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.174 -0.954 . . . . 0.0 109.656 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.79 169.49 13.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.266 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.63 173.42 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 109.152 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' O ' ' CG ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER -168.9 67.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 109.598 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -109.11 29.82 7.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.378 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -132.07 150.78 52.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.358 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -95.92 145.4 25.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.301 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 178.66 95.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.643 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.91 124.6 37.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 126' ' ' ALA . 55.2 m -156.75 131.33 8.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 125' ' ' THR . . . 44.24 58.72 3.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 109.543 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.36 39.32 2.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.897 . . . . 0.0 109.267 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.71 -33.95 5.37 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 -151.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.494 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.494 -179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.26 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.818 2.346 . . . . 0.0 110.601 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ASN . 2.8 m-20 -127.67 125.31 39.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.925 . . . . 0.0 109.658 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -65.17 79.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' ASP . 2.2 m-20 -146.5 -71.69 0.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.958 . . . . 0.0 109.606 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.23 -176.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 t -61.01 -42.51 98.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 109.22 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 47.22 80.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 56.13 -118.03 1.17 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.07 157.05 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.753 -1.217 . . . . 0.0 109.397 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.75 3.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.97 . . . . 0.0 109.334 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.61 -176.91 6.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.548 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.35 -164.43 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 -173.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 161.22 5.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 56.94 168.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.373 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 130.06 55.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 109.312 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' SER . 29.2 t0 67.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 21' ' ' SER . 29.4 m -69.41 142.19 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 4.4 t 75.25 134.93 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.581 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.7 m -153.65 120.08 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.464 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER 74.64 138.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 109.263 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.05 106.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 29.7 m -79.55 -63.96 1.29 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.48 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 25' ' ' THR . . . 173.1 76.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.249 -0.907 . . . . 0.0 109.498 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 8.3 mt-10 67.03 103.36 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.688 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 117' ' ' LYS . . . -44.48 172.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p -124.45 135.67 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.428 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 115' ' ' ARG . 27.7 t -95.15 148.95 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 109.07 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 114' ' ' ILE . 2.7 m -130.15 84.59 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.446 -0.784 . . . . 0.0 109.724 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -74.26 120.7 20.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 108.689 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -141.29 161.29 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.982 . . . . 0.0 111.412 -178.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -116.92 129.38 56.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 108.753 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 112' ' ' ILE . 3.2 mm? -103.38 61.55 0.77 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.772 -1.205 . . . . 0.0 110.933 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.3 mt-10 -18.42 97.4 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.295 0.569 . . . . 0.0 111.471 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.82 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.32 133.39 36.62 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 39' ' ' SER . 34.4 mtt -132.74 -35.8 1.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 38' ' ' MET . 30.1 t 176.4 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.08 -66.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.761 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 37' ' ' LYS . . . 138.53 64.14 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 HG21 ' A' ' 102' ' ' ILE . 0.1 OUTLIER 48.25 15.93 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -1.085 . . . . 0.0 110.849 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 65' ' ' PHE . . . 52.3 14.33 2.16 Favored Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 2.1 p90 -147.36 148.94 31.87 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.496 -1.59 . . . . 0.0 110.482 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -106.77 161.15 14.92 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HG ' HD23 ' A' ' 59' ' ' LEU . 9.4 tp -118.45 140.46 49.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.976 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' LEU . 25.1 mt-10 -118.69 156.59 29.02 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' LEU . . . -151.13 118.51 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . -73.41 55.66 1.98 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 119.224 -1.465 . . . . 0.0 109.495 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 50' ' ' LYS . 8.0 pttp -54.31 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -1.197 . . . . 0.0 109.825 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 144.87 100.07 0.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 56' ' ' ASP . 7.5 m -136.48 -132.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 108.777 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -46.59 8.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.778 -1.201 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 8.95 1.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 109.914 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.32 67.64 0.09 OUTLIER Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 8.2 m-20 -130.32 78.05 1.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -1.176 . . . . 0.0 109.446 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -125.67 90.59 50.24 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.252 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 36.6 Cg_endo -78.16 86.05 1.72 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.977 . . . . 0.0 109.715 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.721 HD13 ' CB ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -45.35 133.37 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.986 . . . . 0.0 109.052 -179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.789 HG22 ' HA ' ' A' ' 81' ' ' GLU . 3.2 p -141.58 155.06 45.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.955 . . . . 0.0 110.993 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' CD1' HD11 ' A' ' 82' ' ' ILE . 96.5 mt -76.42 123.39 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.355 -1.465 . . . . 0.0 110.531 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB3' ' CD ' ' A' ' 47' ' ' GLU . 10.9 p-10 -105.78 -20.51 13.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.684 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER -134.46 105.53 6.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.322 -1.486 . . . . 0.0 109.606 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -108.67 144.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.195 -0.94 . . . . 0.0 110.4 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 7.0 m-30 -105.71 171.24 7.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.279 0.561 . . . . 0.0 109.594 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.92 76.12 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 68' ' ' ALA . . . -109.92 -14.85 12.78 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 71.08 116.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -1.032 . . . . 0.0 109.531 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.754 ' HB3' ' CG2' ' A' ' 75' ' ' THR . . . -95.48 121.28 37.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' GLU . 1.8 p 48.54 -100.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER 168.31 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.085 -1.01 . . . . 0.0 109.724 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' GLU . 2.4 pt20 -101.96 65.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.283 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 56.7 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mm-40 -109.75 160.36 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 108.979 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.782 ' HA ' HG11 ' A' ' 33' ' ' VAL . 81.0 p -135.45 -93.07 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 110.137 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.4 m -78.47 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.56 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -149.17 142.91 16.43 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.201 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.76 134.18 10.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.46 12.04 63.11 Favored Glycine 0 N--CA 1.505 3.234 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.072 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.88 ' OD2' HG21 ' A' ' 114' ' ' ILE . 14.7 p-10 -71.98 146.57 47.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.819 -1.401 . . . . 0.0 108.959 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.789 ' HA ' HG22 ' A' ' 60' ' ' THR . 39.5 tt0 -92.34 85.07 5.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.619 -1.301 . . . . 0.0 109.253 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.068 HG23 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -78.33 130.36 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.401 -1.437 . . . . 0.0 109.341 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -79.02 -41.14 29.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.631 -1.293 . . . . 0.0 109.877 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -150.3 149.38 30.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.671 -1.268 . . . . 0.0 109.191 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.714 HD22 ' CD1' ' A' ' 102' ' ' ILE . 5.6 mp -98.15 175.22 6.17 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.83 -1.169 . . . . 0.0 108.566 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.39 60.83 0.43 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 148.85 9.06 0.17 Allowed Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.099 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.888 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -166.73 154.84 9.95 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.284 -1.715 . . . . 0.0 108.481 179.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.894 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -117.3 145.67 43.84 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.531 -0.731 . . . . 0.0 109.23 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.751 ' HE3' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -85.7 -66.09 0.94 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.922 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -35.18 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.265 -0.897 . . . . 0.0 112.867 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 1.058 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.8 44.93 1.4 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.241 -2.344 . . . . 0.0 107.241 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.058 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.3 OUTLIER -154.01 -172.49 4.23 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.332 -1.099 . . . . 0.0 109.448 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -125.99 166.79 16.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -53.25 -71.67 0.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.016 -1.053 . . . . 0.0 110.609 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.469 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 76.3 t80 -63.36 -44.73 93.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 110.744 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.943 ' CG ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.74 -28.09 68.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.184 -1.407 . . . . 0.0 109.373 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 94' ' ' THR . . . -69.45 -61.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.688 -1.258 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 12.2 t-105 -55.24 -14.54 1.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.519 -0.738 . . . . 0.0 110.923 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 96' ' ' PHE . 3.7 m-80 -82.37 -48.66 10.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.275 . . . . 0.0 110.776 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.2 mp -51.98 -41.15 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.531 -1.355 . . . . 0.0 109.831 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.888 ' CD1' HG21 ' A' ' 88' ' ' THR . 2.0 mp -61.3 -56.19 19.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.129 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -43.5 -33.83 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.553 -0.717 . . . . 0.0 109.846 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.52 37.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.765 ' C ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -71.1 177.26 1.59 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.817 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 35.3 Cg_endo -83.03 170.21 12.46 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.041 1.828 . . . . 0.0 110.361 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.63 87.87 4.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.742 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -155.85 -140.95 3.09 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.8 95.62 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.442 2.095 . . . . 0.0 110.676 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -86.67 108.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 7.6 t -88.4 137.91 31.9 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.181 0.991 . . . . 0.0 110.997 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -125.1 155.27 33.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.32 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -139.78 109.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.068 HG22 HG23 ' A' ' 82' ' ' ILE . 1.3 pp -122.54 146.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.912 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.474 ' HB2' HG22 ' A' ' 30' ' ' VAL . 9.0 ttp-105 -119.29 108.7 14.94 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -102.17 138.4 39.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.042 -1.036 . . . . 0.0 109.584 -178.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.631 ' CG ' ' HB2' ' A' ' 28' ' ' ALA . 2.9 mttm -108.11 176.48 5.12 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.474 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 12.0 p -46.36 118.45 1.95 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.691 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 mt -118.58 154.12 33.13 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -143.88 -52.25 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.676 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -130.85 39.18 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 109.847 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 121' ' ' SER . 6.9 pttm 41.66 -162.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.347 -0.846 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 114.62 21.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.477 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 t -85.94 154.78 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -127.93 -34.42 2.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 127' ' ' ALA . . . -134.68 -91.65 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . 176.31 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.528 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.63 78.43 0.36 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 170.6 14.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.412 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.39 -65.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.516 2.144 . . . . 0.0 110.563 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -124.64 -93.82 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.62 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 109.577 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.38 88.59 2.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 54.52 86.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.1 OUTLIER 71.34 177.92 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.51 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.04 -38.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 9' ' ' ASP . 48.6 p-10 -92.69 69.88 4.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.229 -0.92 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -48.42 11.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.226 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.12 -171.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.442 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.55 135.72 48.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.458 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t 54.33 177.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.13 37.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.79 -42.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.544 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -88.02 18.3 4.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 64.71 27.6 13.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.633 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.27 168.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.548 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 16.7 t0 -59.15 165.61 2.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.601 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 21' ' ' SER . 46.7 t -95.3 147.74 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.65 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER 76.85 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 109.574 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 22' ' ' VAL . 12.7 m -84.66 126.45 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.503 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' A' ' 19' ' ' ASP . 27.9 tp10 -90.28 61.46 5.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.516 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -102.35 41.81 1.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.722 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.7 t -72.52 169.94 15.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -103.34 -172.5 2.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 23.8 mt-10 64.44 97.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.11 -0.994 . . . . 0.0 109.433 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 62.02 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -150.47 144.6 25.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 31' ' ' CYS . 2.3 t -97.44 158.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.386 -0.822 . . . . 0.0 109.048 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 114' ' ' ILE . 12.3 m -144.5 89.5 2.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 110.104 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 113' ' ' VAL . 1.8 m -79.87 127.43 32.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 108.864 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG23 HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -145.06 161.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.025 -1.047 . . . . 0.0 111.181 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -118.37 135.73 54.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 177.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD11 HG13 ' A' ' 76' ' ' VAL . 10.9 mt -119.73 67.36 0.81 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.194 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' C ' ' O ' ' A' ' 35' ' ' LEU . 4.2 pt-20 -10.26 113.58 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.168 0.509 . . . . 0.0 111.672 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HG2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.82 81.65 5.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.174 -0.954 . . . . 0.0 109.599 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' MET . 3.6 ttm -135.5 5.19 3.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m -105.07 -63.73 1.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 109.284 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . 165.1 45.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.977 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 120.44 53.49 0.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.903 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 42.3 22.45 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.25 -1.147 . . . . 0.0 110.42 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 57.4 9.71 4.89 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.903 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.7 p90 -144.42 153.14 41.62 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 120.624 -1.515 . . . . 0.0 110.166 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 47' ' ' GLU . 1.6 t -121.0 142.94 49.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.561 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.844 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -95.2 138.16 33.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -0.861 . . . . 0.0 111.796 -178.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 13.5 mp0 -140.46 139.95 35.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 108.997 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . -159.84 -103.3 0.19 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 57' ' ' LYS . . . 174.03 104.69 0.18 Allowed Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.787 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 1.051 ' HB3' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -47.37 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -1.12 . . . . 0.0 109.782 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . 158.9 103.04 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.722 ' HB3' HD23 ' A' ' 53' ' ' LEU . 40.0 m -50.12 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -1.15 . . . . 0.0 109.704 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD23 ' HB3' ' A' ' 52' ' ' SER . 0.1 OUTLIER -129.53 -0.78 4.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.653 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.424 ' CE1' HD12 ' A' ' 53' ' ' LEU . 12.4 m-70 -105.53 26.3 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.257 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 51' ' ' GLY . . . 166.98 74.74 0.03 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.2 p30 -38.99 141.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.439 -1.036 . . . . 0.0 109.598 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -112.54 84.5 6.39 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.409 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' O ' HG23 ' A' ' 60' ' ' THR . 37.8 Cg_endo -81.43 72.63 6.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.427 2.085 . . . . 0.0 109.889 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -44.38 130.09 6.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 108.962 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 81' ' ' GLU . 6.7 p -128.65 157.28 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.117 -0.99 . . . . 0.0 109.446 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.911 HG21 HD11 ' A' ' 64' ' ' ILE . 23.5 mt -73.36 127.22 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 119.838 -1.789 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 4.9 m-20 -115.45 -52.52 2.65 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.626 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -99.86 94.79 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.959 -1.088 . . . . 0.0 110.22 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.911 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -100.18 143.41 13.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.296 -0.877 . . . . 0.0 110.239 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.4 m-85 -108.55 -45.97 3.76 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.4 tttt 73.96 126.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.66 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.74 -62.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.59 149.34 39.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -1.136 . . . . 0.0 109.184 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.23 175.93 9.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 71' ' ' GLU . 89.0 p -96.3 -100.07 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' N ' ' OG ' ' A' ' 70' ' ' SER . 15.6 pm0 -124.08 33.01 5.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.251 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.771 ' HB3' HG22 ' A' ' 75' ' ' THR . 3.7 tt0 -130.93 132.34 45.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.446 -0.784 . . . . 0.0 109.097 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 72' ' ' GLN . 11.3 m -44.36 -47.75 9.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 6.2 pm0 -133.55 106.77 7.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.118 -0.989 . . . . 0.0 109.693 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.857 ' OG1' HD21 ' A' ' 35' ' ' LEU . 69.3 p -96.77 27.78 3.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.861 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -143.11 152.69 16.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 109.36 179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.68 ' HG3' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -148.54 137.15 11.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.864 . . . . 0.0 109.004 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 123' ' ' GLU . 36.8 Cg_endo -81.16 119.33 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.329 2.019 . . . . 0.0 111.205 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.19 15.54 71.74 Favored Glycine 0 N--CA 1.504 3.2 0 C-N-CA 119.804 -1.188 . . . . 0.0 112.118 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.69 ' CG ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -78.23 154.3 31.16 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.064 -1.845 . . . . 0.0 108.456 179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.951 ' HA ' HG22 ' A' ' 60' ' ' THR . 26.9 tt0 -90.15 59.62 4.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.751 -1.218 . . . . 0.0 110.0 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 61' ' ' ILE . 1.9 mt -51.54 120.56 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 90' ' ' MET . 2.0 mm? -89.77 -47.67 7.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.891 -1.131 . . . . 0.0 110.428 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.06 151.83 40.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.727 -1.233 . . . . 0.0 109.216 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.772 ' CD1' HG22 ' A' ' 112' ' ' ILE . 1.4 tp -116.92 -174.89 2.67 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 108.866 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.47 -30.47 2.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.519 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.04 56.89 0.31 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.115 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -170.62 147.91 2.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.283 -1.127 . . . . 0.0 108.337 179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . . . -115.94 107.8 15.44 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.086 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.553 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -49.55 -24.59 2.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.39 -0.819 . . . . 0.0 109.558 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 19.8 mt-30 -69.14 154.77 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.42 37.82 3.66 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.232 -1.542 . . . . 0.0 109.284 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -147.66 129.19 14.98 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.356 -1.084 . . . . 0.0 108.63 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 1.051 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.73 174.87 7.03 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 108.842 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.861 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -62.62 -58.14 8.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.826 -1.171 . . . . 0.0 110.113 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.11 -52.39 55.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.761 -1.212 . . . . 0.0 109.111 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.023 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.2 mm-40 -48.34 -48.24 36.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.013 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.08 -69.24 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 110.04 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.502 ' CH2' ' O ' ' A' ' 44' ' ' PHE . 9.1 t-105 -52.67 -18.46 1.8 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.255 -0.903 . . . . 0.0 110.714 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -79.51 -47.32 15.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.686 -1.259 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.3 mp -54.58 -41.38 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.678 -1.264 . . . . 0.0 109.721 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.115 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.9 mp -60.75 -57.55 11.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 109.286 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -43.54 -28.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.775 . . . . 0.0 109.349 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.71 -2.05 58.22 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.595 -0.691 . . . . 0.0 111.109 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.026 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -69.79 176.63 1.63 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.184 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 105' ' ' LEU . 35.8 Cg_endo -80.71 163.62 21.07 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.379 2.052 . . . . 0.0 110.696 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.14 81.05 8.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.129 -0.982 . . . . 0.0 109.085 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -150.65 -138.66 2.89 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.44 98.75 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.594 2.196 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -87.21 105.08 14.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.836 HG23 HG23 ' A' ' 34' ' ' THR . 1.0 OUTLIER -88.68 127.99 35.59 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.98 0.895 . . . . 0.0 110.536 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.772 HG22 ' CD1' ' A' ' 85' ' ' LEU . 1.1 pt -109.37 155.08 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.35 104.24 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.69 HD12 ' CG ' ' A' ' 80' ' ' ASP . 4.9 pt -110.31 175.08 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 122.701 1.239 . . . . 0.0 111.862 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -152.43 122.95 7.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.445 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -123.46 105.9 10.18 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.697 -1.252 . . . . 0.0 109.294 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -66.68 85.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 117' ' ' LYS . 0.9 OUTLIER 59.67 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.666 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.5 tp -122.04 134.02 54.79 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.174 -0.954 . . . . 0.0 109.56 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -69.49 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.95 . . . . 0.0 109.345 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 122' ' ' LYS . 29.7 t -82.73 -173.32 4.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.173 -0.954 . . . . 0.0 109.275 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 121' ' ' SER . 3.9 ptmm? -138.87 170.13 16.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' HB2' ' HD3' ' A' ' 78' ' ' PRO . 2.7 tt0 -56.17 117.07 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.79 145.37 31.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 109.081 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 -174.35 4.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.633 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 108.69 20.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -158.46 95.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.12 134.79 12.49 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -55.1 -18.39 5.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.571 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' A' ' 1' ' ' MET . 35.9 Cg_endo -78.35 -13.92 14.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.796 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 25.9 t70 -102.62 -94.73 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.889 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 6.3 tp 76.45 73.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.194 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 4' ' ' LEU . 15.3 p30 40.56 57.91 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.576 -0.702 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 7' ' ' SER . 3.7 m -75.48 -141.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.882 . . . . 0.0 109.37 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' SER . 0.9 OUTLIER 74.86 132.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 7' ' ' SER . 33.2 p 45.42 54.82 7.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.24 74.98 0.37 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 p -128.42 14.07 6.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.1 124.92 25.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.59 -77.46 0.57 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -99.14 110.91 23.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.29 173.63 12.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.2 -157.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ALA . . . -162.16 84.98 0.58 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . 177.99 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.1 t -55.08 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.6 m-20 -119.19 49.36 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER 37.96 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.141 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 p -117.88 30.27 7.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.153 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.63 38.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.512 -0.742 . . . . 0.0 109.384 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' SER . 3.5 pt-20 174.6 89.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.159 -0.963 . . . . 0.0 109.61 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER 66.65 94.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 74.5 p -110.81 17.47 20.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 25' ' ' THR . . . 65.06 127.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 mt-10 62.69 95.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 174.47 139.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' ARG . 25.6 p -127.56 144.14 51.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.07 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 115' ' ' ARG . 25.6 t -119.07 148.65 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -0.927 . . . . 0.0 109.845 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.8 m -139.41 88.86 2.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -71.73 127.59 33.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.855 . . . . 0.0 109.771 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -143.52 162.66 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.077 -1.015 . . . . 0.0 110.775 -178.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.61 133.88 53.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 69' ' ' ALA . 1.5 mm? -111.62 62.08 0.62 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.242 -0.911 . . . . 0.0 111.634 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -13.53 110.52 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 CA-C-O 121.187 0.518 . . . . 0.0 111.386 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.714 ' CE ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -78.45 99.68 6.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.157 -0.964 . . . . 0.0 109.71 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtt -150.77 31.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.612 -0.68 . . . . 0.0 109.236 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 m -141.54 -143.39 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.13 -5.82 59.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 110.041 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 156.72 76.1 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 41.31 23.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.315 -1.109 . . . . 0.0 110.479 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 55.73 10.37 3.28 Favored Glycine 0 N--CA 1.484 1.899 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.485 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.894 ' CE1' HD13 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -142.24 153.08 43.67 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.43 -1.629 . . . . 0.0 110.345 179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.3 t -123.47 141.45 51.98 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.894 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -96.85 136.73 36.98 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.166 -0.959 . . . . 0.0 111.585 -178.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' ' HB2' ' A' ' 62' ' ' ASN . 35.8 mt-10 -152.87 156.46 39.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.715 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 95' ' ' ARG . . . 179.17 -100.73 0.14 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . 176.39 103.71 0.17 Allowed Glycine 0 N--CA 1.495 2.62 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.185 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -47.31 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.237 . . . . 0.0 108.592 178.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -44.12 97.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -116.59 -65.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.9 -131.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -127.45 33.64 4.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.979 -1.075 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -119.67 -70.29 0.32 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 170.62 176.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 0.0 109.65 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -113.34 84.45 7.58 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 60' ' ' THR . 37.3 Cg_endo -80.27 79.48 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.29 1.994 . . . . 0.0 110.516 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HG ' ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -46.35 135.22 8.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 108.122 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 81' ' ' GLU . 5.5 p -141.09 158.08 44.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 HD11 ' A' ' 64' ' ' ILE . 16.1 mt -75.63 126.34 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 119.994 -1.691 . . . . 0.0 110.099 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 3.6 m-80 -115.41 -52.26 2.66 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.628 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 91.85 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.09 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -96.61 144.47 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.925 0.869 . . . . 0.0 109.72 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 2.8 m-30 -107.82 160.24 15.89 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.668 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 106.34 16.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.37 125.98 0.84 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 46.23 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.418 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . 46.49 42.7 11.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 48.12 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -111.33 -9.36 14.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 109.95 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 73' ' ' SER . 61.0 mt-30 -103.27 39.41 1.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.454 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 72' ' ' GLN . 8.0 t 67.41 56.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER 70.18 96.05 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.499 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' HD21 ' A' ' 35' ' ' LEU . 1.4 t -103.4 30.78 4.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.206 -0.934 . . . . 0.0 109.739 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HB ' HD13 ' A' ' 64' ' ' ILE . 3.1 m -134.47 165.81 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.855 . . . . 0.0 108.955 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.611 ' NE2' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -150.6 140.93 14.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.139 -0.975 . . . . 0.0 109.66 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 37.2 Cg_endo -82.32 99.0 0.94 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.267 1.978 . . . . 0.0 110.829 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 85.17 9.92 79.07 Favored Glycine 0 N--CA 1.504 3.21 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.847 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.922 ' OD2' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -56.93 149.88 17.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.176 -1.779 . . . . 0.0 108.801 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.861 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.6 OUTLIER -85.58 57.86 4.71 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.648 -1.283 . . . . 0.0 109.708 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 114' ' ' ILE . 2.2 mt -55.52 118.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.109 -0.994 . . . . 0.0 108.561 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' MET . 0.2 OUTLIER -84.94 -44.92 12.69 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.71 -1.244 . . . . 0.0 111.302 -178.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.45 158.9 28.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.764 -1.21 . . . . 0.0 109.324 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.911 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -121.25 -171.8 2.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.108 -0.995 . . . . 0.0 108.717 179.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -50.3 -22.42 5.11 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.15 49.63 0.26 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.008 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.038 HG21 ' CD1' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -165.53 139.65 4.69 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.984 -1.304 . . . . 0.0 109.086 178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -109.52 106.75 16.6 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.788 0.804 . . . . 0.0 109.15 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.939 ' HE2' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -50.19 -61.41 2.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.805 -0.559 . . . . 0.0 110.481 -179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mt-30 -40.52 -28.78 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.119 -0.988 . . . . 0.0 113.002 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.957 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -111.55 48.32 0.95 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.957 HD22 ' O ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -157.14 144.7 18.9 Favored 'General case' 0 C--N 1.309 -1.178 0 O-C-N 121.653 -0.91 . . . . 0.0 109.657 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -71.62 177.31 4.16 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HD2' ' N ' ' A' ' 48' ' ' GLY . 1.4 tpp180 -67.37 -57.67 6.18 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.765 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -70.49 -48.76 54.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.658 -1.276 . . . . 0.0 109.309 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.788 ' O ' HD12 ' A' ' 101' ' ' ILE . 6.3 mm-40 -52.34 -29.08 21.93 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.182 -0.949 . . . . 0.0 110.167 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.939 ' HB1' ' HE2' ' A' ' 90' ' ' MET . . . -66.81 -63.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.91 -1.119 . . . . 0.0 110.859 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.669 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 10.3 t-105 -54.43 -13.54 0.96 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.437 -0.789 . . . . 0.0 111.457 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -81.32 -48.62 11.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.582 -1.324 . . . . 0.0 110.897 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.4 mp -51.77 -40.65 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.639 -1.288 . . . . 0.0 110.112 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.038 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.1 mp -60.63 -66.94 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 108.823 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -41.32 -28.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.76 -0.587 . . . . 0.0 110.414 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -84.92 4.04 35.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 111.007 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.828 HD22 ' O ' ' A' ' 102' ' ' ILE . 0.9 OUTLIER -81.33 179.96 1.71 Allowed Pre-proline 0 C--N 1.297 -1.701 0 O-C-N 121.007 -1.058 . . . . 0.0 109.671 -179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 105' ' ' LEU . 36.2 Cg_endo -78.84 169.91 18.82 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.689 2.26 . . . . 0.0 111.407 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.64 88.02 4.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.301 -0.874 . . . . 0.0 109.849 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' ' 37' ' ' LYS . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -82.15 99.78 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.905 2.403 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.637 HG23 ' H ' ' A' ' 86' ' ' GLY . 0.9 OUTLIER -88.7 118.2 33.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.59 127.51 35.9 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.721 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.672 HD11 ' CD2' ' A' ' 35' ' ' LEU . 1.4 pt -109.09 154.27 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -134.22 96.18 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.824 -1.172 . . . . 0.0 108.105 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 pp -95.8 134.92 31.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.615 0.721 . . . . 0.0 109.503 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -133.31 98.2 4.18 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -89.86 149.23 22.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.595 -178.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -135.79 120.56 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 75.48 178.02 0.2 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.46 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 174.19 7.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.7 8.65 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER 53.42 36.38 22.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.1 OUTLIER 70.16 -77.84 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -138.03 159.45 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.509 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.2 p -137.27 51.8 1.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 39.4 p -65.3 -155.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 66.68 -179.47 0.21 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.94 31.57 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . -109.49 99.69 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.5 m-20 65.19 -150.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -1.163 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.56 85.3 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.455 2.103 . . . . 0.0 110.287 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 64.81 93.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mt 57.15 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 6' ' ' SER . 44.8 m-80 -79.39 -73.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.534 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER 167.97 -68.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.428 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER 68.47 49.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 ' CB ' ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER 74.45 133.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 10' ' ' SER . 2.9 t0 -134.41 170.19 16.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER 168.77 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.3 54.3 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.24 91.58 2.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.895 . . . . 0.0 109.365 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -107.84 146.97 31.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.63 -168.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.17 -0.957 . . . . 0.0 109.435 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 p -103.04 -59.48 1.7 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.216 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.33 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.2 49.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.85 58.66 4.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.436 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 0.6 OUTLIER 51.57 40.9 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.943 . . . . 0.0 109.531 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 19' ' ' ASP . 4.8 m 39.51 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.581 -0.7 . . . . 0.0 109.739 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.19 111.24 15.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.408 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.99 103.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -66.81 138.15 57.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.21 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' OG1' ' A' ' 25' ' ' THR . 68.8 m -68.87 -74.33 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.748 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.403 ' OG1' ' C ' ' A' ' 24' ' ' SER . 0.1 OUTLIER 60.2 59.94 2.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.187 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' O ' ' CB ' ' A' ' 27' ' ' GLU . . . -133.52 84.55 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.2 mt-10 147.62 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 27' ' ' GLU . . . 152.56 -179.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 116' ' ' ARG . 1.7 p -126.8 127.06 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 115' ' ' ARG . 40.7 t -108.12 149.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.988 -1.07 . . . . 0.0 110.242 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 33' ' ' VAL . 25.9 t -137.86 86.31 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 113.19 11.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -135.2 164.39 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.173 -0.955 . . . . 0.0 110.43 -178.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -115.87 135.65 53.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.745 -1.222 . . . . 0.0 110.485 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.602 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 3.1 mm? -107.55 61.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.378 -0.826 . . . . 0.0 111.02 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' C ' ' O ' ' A' ' 35' ' ' LEU . 1.7 pt-20 -14.4 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.281 0.562 . . . . 0.0 111.443 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 108' ' ' GLY . 16.5 tttt -83.76 116.99 22.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.9 mtm -114.17 -50.12 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.89 45.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.76 23.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 42' ' ' LEU . . . 46.15 50.98 11.93 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.967 ' CD1' HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER 51.45 12.39 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.34 -1.094 . . . . 0.0 111.021 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 65' ' ' PHE . . . 47.21 16.1 0.25 Allowed Glycine 0 N--CA 1.482 1.727 0 O-C-N 120.906 -1.121 . . . . 0.0 111.159 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.905 ' HE1' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -134.92 150.48 50.41 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 120.1 -1.824 . . . . 0.0 109.772 179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -128.17 147.4 50.56 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.666 ' HG ' HD13 ' A' ' 82' ' ' ILE . 8.3 mp -102.92 146.05 28.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 112.18 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 11.7 mm-40 -137.43 155.59 49.17 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.644 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.46 -121.85 2.64 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.184 -2.367 . . . . 0.0 107.184 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . -168.57 -156.58 10.53 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.619 ' CE ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.18 108.54 19.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.602 -1.528 . . . . 0.0 110.19 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . 28.54 -112.75 0.03 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.525 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.9 m -154.18 58.08 0.71 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 108.789 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.619 HD23 ' CE ' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -54.65 -49.08 71.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.287 -179.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.61 13.63 3.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.007 . . . . 0.0 110.082 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' O ' ' CG ' ' A' ' 56' ' ' ASP . . . -157.95 -110.91 0.3 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' CG ' ' O ' ' A' ' 55' ' ' GLY . 4.9 m-20 -162.1 84.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.348 . . . . 0.0 109.032 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -123.16 85.4 51.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.093 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -83.86 159.83 13.96 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.391 2.061 . . . . 0.0 109.689 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.87 HD11 ' SD ' ' A' ' 90' ' ' MET . 6.4 mp -90.06 135.41 33.67 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 108.619 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 3.9 p -151.56 152.16 32.54 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.331 -1.347 . . . . 0.0 111.327 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.836 HG13 HD11 ' A' ' 82' ' ' ILE . 90.9 mt -80.18 122.65 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.433 -1.417 . . . . 0.0 109.441 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -101.66 -46.96 4.78 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.426 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -123.11 104.37 9.15 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.04 -1.038 . . . . 0.0 110.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.821 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.2 mt -99.71 144.04 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.812 0.815 . . . . 0.0 109.39 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.6 m-30 -106.72 -58.07 1.98 Allowed 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.812 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -146.25 127.8 15.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA3' ' CG2' ' A' ' 76' ' ' VAL . . . -94.71 -113.18 2.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . 60.36 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -1.122 . . . . 0.0 109.588 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.69 ' HB2' ' CG2' ' A' ' 75' ' ' THR . . . -76.71 -172.86 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 71' ' ' GLU . 50.3 m -63.66 -27.99 69.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' SER . 2.0 mt-10 179.3 45.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -136.64 50.42 2.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 74' ' ' GLU . 1.2 p 45.93 -156.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' N ' ' OG ' ' A' ' 73' ' ' SER . 4.0 pm0 -61.38 135.22 57.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.09 -1.006 . . . . 0.0 109.672 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.69 ' CG2' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.43 41.97 3.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.416 -0.803 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -146.34 158.62 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.112 . . . . 0.0 109.664 179.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -151.21 136.7 10.65 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.59 136.69 13.95 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.345 2.03 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.19 6.44 32.83 Favored Glycine 0 N--CA 1.505 3.269 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.027 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.819 ' OD2' HG21 ' A' ' 114' ' ' ILE . 25.3 p-10 -60.98 147.68 42.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.862 -1.375 . . . . 0.0 108.636 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -91.6 88.32 6.7 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.448 -1.408 . . . . 0.0 109.711 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.836 HD11 HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -84.31 121.58 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.367 -1.458 . . . . 0.0 110.031 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -51.75 7.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.822 -1.174 . . . . 0.0 109.36 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -128.56 166.24 19.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.29 -0.881 . . . . 0.0 108.91 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.967 HD21 ' CD1' ' A' ' 42' ' ' LEU . 15.9 tp -142.85 125.32 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 110.028 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 39.96 -91.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -116.76 51.45 0.73 Allowed Glycine 0 N--CA 1.503 3.145 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.255 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.928 HG21 HD11 ' A' ' 102' ' ' ILE . 1.1 t -160.49 139.06 10.21 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -1.22 . . . . 0.0 109.251 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -134.77 114.59 12.8 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.872 ' HG3' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.72 -44.86 61.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.307 -177.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' MET . 1.9 mp0 -36.56 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.175 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -114.44 47.49 1.04 Allowed Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.189 -2.765 . . . . 0.0 106.189 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.843 HD23 ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -160.92 0.18 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.417 ' OG1' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -117.61 162.69 17.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 0.0 109.047 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.699 ' NH2' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -55.19 -52.09 64.44 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.262 -0.898 . . . . 0.0 111.332 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -63.05 -48.83 76.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.633 -1.292 . . . . 0.0 110.062 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.022 ' O ' HD12 ' A' ' 101' ' ' ILE . 24.8 mt-10 -49.36 -44.88 45.12 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.752 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -48.2 -69.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.617 -0.677 . . . . 0.0 111.677 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CE3' ' HA ' ' A' ' 99' ' ' TRP . 2.8 t-105 -57.15 -18.71 16.33 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.106 -0.996 . . . . 0.0 110.936 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -80.93 -47.35 13.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.687 -1.258 . . . . 0.0 110.38 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.022 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.4 mp -53.05 -41.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.809 -1.182 . . . . 0.0 110.586 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.928 HD11 HG21 ' A' ' 88' ' ' THR . 2.9 mt -64.33 -58.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 102' ' ' ILE . 3.8 mtpp -42.34 -28.41 0.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.266 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -86.88 -2.02 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 111.546 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -83.99 178.33 2.47 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.62 -1.3 . . . . 0.0 109.713 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.676 ' HD2' HD12 ' A' ' 105' ' ' LEU . 36.7 Cg_endo -81.89 174.95 9.76 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.449 ' OD1' ' HE3' ' A' ' 37' ' ' LYS . 25.1 m-20 -96.71 94.05 7.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.168 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -153.42 -143.53 3.7 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.07 96.36 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.649 2.233 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.51 112.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 4.4 m -87.83 127.55 35.34 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.97 0.891 . . . . 0.0 110.472 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 33' ' ' VAL . 1.3 pt -105.96 152.72 7.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.08 88.62 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.819 HG21 ' OD2' ' A' ' 80' ' ' ASP . 1.3 pp -102.02 139.56 22.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.057 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.476 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -115.66 110.19 18.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -94.68 -179.41 4.86 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 108.912 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.05 83.76 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.031 -1.043 . . . . 0.0 109.412 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 p -169.17 146.44 3.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 67.33 3.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.574 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' SER . 4.4 tt0 -106.62 20.52 18.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLN . 1.5 p -44.83 140.19 2.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.259 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -119.29 -92.32 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' N ' ' CG ' ' A' ' 122' ' ' LYS . 1.4 pt-20 -156.03 29.03 0.36 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.02 67.34 0.98 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.7 p -135.12 149.57 50.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.07 -20.8 61.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.404 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . 49.37 69.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.627 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.52 140.75 5.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.29 28.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -1.108 . . . . 0.0 109.239 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.499 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.11 -8.35 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.24 . . . . 0.0 110.438 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.652 ' O ' HD22 ' A' ' 4' ' ' LEU . 5.4 m-20 -69.24 -24.48 64.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -131.38 -41.83 1.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.475 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' LEU . 14.2 p30 41.87 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.428 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 0.5 OUTLIER 62.33 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.423 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -55.35 176.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.364 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 -162.44 0.82 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.127 -0.983 . . . . 0.0 109.443 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -68.82 74.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.4 120.61 33.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.01 123.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.398 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.64 -65.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 14' ' ' ALA . 1.4 t -138.41 -91.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . 57.02 49.51 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.166 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -91.31 87.32 6.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -138.78 -77.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.219 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' ALA . . . 64.72 16.73 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER 65.43 -73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.406 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER 43.64 70.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.4 135.76 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.39 103.51 10.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.474 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.81 146.52 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 2.0 pt-20 -80.13 129.33 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.717 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.95 116.48 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.151 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -137.98 -176.52 4.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -0.954 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -175.02 120.01 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -165.86 95.09 0.6 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.581 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.97 127.28 32.07 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.609 -0.682 . . . . 0.0 109.167 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -149.33 142.84 25.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.988 . . . . 0.0 110.128 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 115' ' ' ARG . 2.6 t -91.74 160.85 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.825 . . . . 0.0 109.225 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 8.4 m -144.04 88.09 1.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.73 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.4 HG23 HG13 ' A' ' 113' ' ' VAL . 1.1 m -86.45 122.33 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.952 . . . . 0.0 109.052 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.656 HG11 ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -141.85 153.46 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.989 -1.069 . . . . 0.0 111.497 -178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -111.91 129.21 56.24 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.086 HD23 HD11 ' A' ' 112' ' ' ILE . 2.2 mm? -109.73 60.94 0.6 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.706 -1.246 . . . . 0.0 111.278 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' C ' ' O ' ' A' ' 35' ' ' LEU . 2.4 mp0 -13.07 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.375 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' CG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -77.61 137.08 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.096 -1.002 . . . . 0.0 109.667 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 39' ' ' SER . 5.6 mtt -144.29 40.24 1.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.51 -0.743 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 38' ' ' MET . 0.2 OUTLIER 74.55 77.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.275 -179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.85 -49.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 117.54 51.29 0.35 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.787 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER 38.1 26.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.0 110.706 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 45.93 17.14 0.17 Allowed Glycine 0 N--CA 1.487 2.035 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.014 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.945 ' CE1' HD13 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -141.04 147.82 39.24 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.186 -1.773 . . . . 0.0 110.463 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.02 137.01 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.945 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -93.74 141.36 28.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.391 -0.818 . . . . 0.0 111.315 -178.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 34.1 mt-10 -132.97 154.45 50.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.351 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' N ' ' HG3' ' A' ' 95' ' ' ARG . . . 145.43 -123.4 1.89 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.561 ' CA ' ' HB2' ' A' ' 95' ' ' ARG . . . -161.06 -152.0 6.45 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 120.853 -1.381 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.857 ' HB3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -95.95 93.84 7.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.32 . . . . 0.0 109.413 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.63 113.22 1.95 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.81 -74.39 0.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.271 . . . . 0.0 109.733 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.0 -80.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -92.46 24.97 3.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 56' ' ' ASP . . . -97.77 -47.37 2.12 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER 78.36 57.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.996 . . . . 0.0 110.265 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.559 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -127.49 86.8 57.67 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.999 -1.063 . . . . 0.0 110.052 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -87.67 114.06 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.547 2.165 . . . . 0.0 110.47 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -61.88 118.69 7.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 108.217 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.833 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.1 p -130.53 157.87 41.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 0.0 110.313 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.842 HG21 HD11 ' A' ' 64' ' ' ILE . 21.5 mt -76.36 120.87 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.22 -1.55 . . . . 0.0 110.296 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' CG ' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m120 -109.28 -49.94 3.06 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.476 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 98.14 7.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.871 -1.143 . . . . 0.0 110.25 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.842 HD11 HG21 ' A' ' 61' ' ' ILE . 1.2 mt -97.11 145.94 8.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.866 0.841 . . . . 0.0 109.881 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 6.3 m-85 -109.74 170.65 7.93 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.611 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -118.59 90.52 3.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.69 58.02 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -154.48 -177.94 6.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -1.109 . . . . 0.0 109.401 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB2' HD13 ' A' ' 35' ' ' LEU . . . 55.33 167.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.503 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 1.1 p -72.73 -96.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 109.187 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 72' ' ' GLN . 15.2 pm0 -82.02 50.54 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 108.853 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.814 ' HG2' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -38.42 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.54 -0.725 . . . . 0.0 110.339 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -123.22 -33.33 3.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 73' ' ' SER . 3.6 mt-10 -167.07 33.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.656 ' HA ' HG11 ' A' ' 33' ' ' VAL . 24.6 p -88.71 22.84 2.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.807 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 64' ' ' ILE . 33.6 m -151.66 156.29 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -150.77 137.05 11.04 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.79 122.95 4.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.267 1.978 . . . . 0.0 110.662 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.51 10.39 83.48 Favored Glycine 0 N--CA 1.503 3.147 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.617 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 60' ' ' THR . 0.2 OUTLIER -80.52 153.31 28.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.255 -1.733 . . . . 0.0 108.615 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.833 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 tt0 -92.16 75.53 5.4 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.145 . . . . 0.0 111.116 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.735 HG23 HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -63.25 124.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.265 . . . . 0.0 108.587 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 90' ' ' MET . 0.5 OUTLIER -88.51 -35.99 16.67 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.502 -1.374 . . . . 0.0 111.954 -178.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HG2' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -135.94 165.49 25.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.382 -1.449 . . . . 0.0 109.079 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.671 ' HB2' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.68 -169.91 2.24 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 108.882 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . -43.95 -26.08 0.76 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA3' HD11 ' A' ' 105' ' ' LEU . . . -170.68 42.26 0.19 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.655 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.706 ' CG2' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -151.67 128.58 10.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.618 -1.519 . . . . 0.0 108.0 178.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . . . -101.78 114.06 27.8 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.641 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 mmt -49.07 -71.06 0.07 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -42.2 -27.47 0.14 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.943 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -110.7 45.3 1.34 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' OG1' ' A' ' 88' ' ' THR . 0.7 OUTLIER -171.93 147.4 2.16 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.33 -1.1 . . . . 0.0 109.406 -178.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -69.71 168.94 13.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.598 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -60.14 -56.57 20.02 Favored 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.317 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.98 -52.01 64.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.049 -1.032 . . . . 0.0 109.319 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.845 ' O ' HD12 ' A' ' 101' ' ' ILE . 17.8 mm-40 -51.37 -45.31 62.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.2 -0.937 . . . . 0.0 108.927 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.641 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -55.16 -67.05 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.941 ' CZ3' HG21 ' A' ' 102' ' ' ILE . 8.8 t-105 -58.23 -11.57 2.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.201 -0.937 . . . . 0.0 110.637 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -82.7 -47.65 11.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.605 -1.309 . . . . 0.0 111.142 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 97' ' ' GLU . 4.0 mp -56.8 -40.31 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.283 -1.511 . . . . 0.0 109.335 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.941 HG21 ' CZ3' ' A' ' 99' ' ' TRP . 0.7 OUTLIER -52.74 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 102' ' ' ILE . 9.3 mmtp -42.07 -32.97 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.29 57.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.509 -0.744 . . . . 0.0 111.363 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -68.32 176.65 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.622 -1.299 . . . . 0.0 109.723 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.858 ' HD2' HD23 ' A' ' 105' ' ' LEU . 36.5 Cg_endo -81.8 178.5 6.46 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.66 2.24 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.01 91.81 5.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.5 -143.59 3.73 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.92 96.8 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.443 2.095 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -87.82 119.0 34.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.8 134.66 39.82 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.565 -177.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.086 HD11 HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -116.34 95.96 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 32' ' ' THR . 1.9 t -89.93 119.74 37.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -129.18 -176.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.706 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -152.51 106.74 3.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 63.67 7.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.879 -1.138 . . . . 0.0 108.732 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.47 168.98 9.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.736 . . . . 0.0 109.386 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.8 p -168.04 154.14 7.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 0.0 109.899 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' GLN . 1.7 mm? 65.65 88.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.793 . . . . 0.0 109.594 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 19.6 tp60 175.11 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 109.095 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER 64.07 73.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.806 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 169.87 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG2' ' HA3' ' A' ' 128' ' ' GLY . 7.9 mt-10 -78.17 114.39 17.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.0 -66.71 0.51 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 126' ' ' ALA . 3.4 m -124.11 171.58 9.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.534 ' H ' HG22 ' A' ' 125' ' ' THR . . . 59.55 -154.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.664 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.22 83.69 2.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.522 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 123' ' ' GLU . . . -63.08 137.68 43.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.78 -70.07 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.472 -179.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -27.1 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.703 2.269 . . . . 0.0 110.323 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -147.52 -149.87 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.62 42.88 1.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -100.04 146.03 27.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -147.24 -43.21 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.641 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -66.64 88.63 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.413 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.29 -55.76 2.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 t70 63.58 37.38 10.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.656 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' ALA . 44.4 p -152.0 179.89 8.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' SER . . . 59.58 155.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.46 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.25 -75.49 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p 55.22 -175.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.5 37.44 1.36 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t -79.8 60.18 3.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.473 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.88 28.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.37 -62.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m 55.91 86.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.26 43.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 20' ' ' VAL . 17.7 t -95.28 30.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -85.54 143.91 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.403 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.4 145.39 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.39 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 24' ' ' SER . 9.8 tt0 -77.08 79.61 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.576 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 25' ' ' THR . 1.1 m 169.07 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 24' ' ' SER . 76.3 p -156.84 144.81 19.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.83 149.8 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.332 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.9 mt-10 46.27 26.86 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 108.931 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLU . . . 70.44 164.96 0.27 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.687 -0.633 . . . . 0.0 109.339 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.5 p -125.65 130.53 51.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.456 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 115' ' ' ARG . 53.3 t -106.32 145.6 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.772 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.901 ' SG ' HD11 ' A' ' 114' ' ' ILE . 1.6 m -134.3 84.14 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 HG13 ' A' ' 113' ' ' VAL . 1.2 m -66.41 126.92 30.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.501 -0.749 . . . . 0.0 109.226 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -139.32 157.04 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -112.33 134.04 54.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.984 -1.072 . . . . 0.0 109.283 178.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.765 HD11 HG13 ' A' ' 76' ' ' VAL . 14.9 mt -119.76 67.16 0.81 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.237 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' C ' ' O ' ' A' ' 35' ' ' LEU . 3.0 pt-20 -5.64 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.24 0.543 . . . . 0.0 111.733 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HE2' HG23 ' A' ' 102' ' ' ILE . 7.5 mttt -78.98 127.2 31.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.122 -0.986 . . . . 0.0 109.989 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.1 mtp -150.74 -75.98 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 109.233 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.2 p -141.54 159.34 42.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.877 . . . . 0.0 109.373 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . 76.75 -3.12 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.693 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 67.84 86.75 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' CZ ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.1 24.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 53.86 12.14 2.49 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.823 ' CZ ' HD12 ' A' ' 42' ' ' LEU . 1.1 p90 -142.71 146.58 34.5 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.434 -1.627 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 p -115.53 139.89 49.66 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.774 HD13 ' CE1' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -94.39 142.52 27.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.378 -0.826 . . . . 0.0 111.258 -178.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 5.4 mp0 -130.3 131.51 45.45 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.409 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . 158.95 -127.74 1.91 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 57' ' ' LYS . . . 64.1 -61.54 0.06 OUTLIER Glycine 0 N--CA 1.513 3.783 0 O-C-N 121.086 -1.243 . . . . 0.0 110.207 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 48' ' ' GLY . 1.6 ptmm? -93.05 57.03 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 109.281 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' LYS . . . -41.47 -82.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.57 ' O ' HD22 ' A' ' 53' ' ' LEU . 58.1 m -151.33 -91.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.153 . . . . 0.0 109.466 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -141.77 10.72 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -104.05 -18.62 14.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.581 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 57' ' ' LYS . . . 103.85 -19.62 43.6 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.086 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -68.23 111.32 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.025 -1.28 . . . . 0.0 109.704 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' HB2' ' CA ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -130.5 90.17 41.79 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' O ' HG23 ' A' ' 60' ' ' THR . 37.9 Cg_endo -81.9 78.58 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.25 1.967 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -43.17 123.25 2.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 81' ' ' GLU . 1.6 p -130.26 157.9 41.25 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.251 -0.905 . . . . 0.0 109.305 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.844 HG21 HD11 ' A' ' 64' ' ' ILE . 80.3 mt -75.66 122.27 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 119.963 -1.711 . . . . 0.0 110.584 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -105.09 -46.4 4.27 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.653 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -113.77 103.32 11.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.908 -1.12 . . . . 0.0 110.209 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.844 HD11 HG21 ' A' ' 61' ' ' ILE . 1.1 mt -102.72 143.81 14.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.957 0.884 . . . . 0.0 110.31 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -110.27 170.26 8.2 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -103.16 135.58 44.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.118 -0.989 . . . . 0.0 109.607 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.94 -29.9 4.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' O ' HD22 ' A' ' 35' ' ' LEU . . . -77.54 89.73 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -1.218 . . . . 0.0 109.611 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -178.44 159.9 1.23 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.154 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 t -169.65 28.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.61 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -141.88 -41.68 0.35 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -160.15 176.21 12.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.475 -0.765 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.51 39.63 0.92 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 74' ' ' GLU . 7.5 tt0 -160.76 45.68 0.2 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.185 -0.947 . . . . 0.0 109.246 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 33' ' ' VAL . 61.2 p -92.07 25.32 2.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.765 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -154.53 163.96 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.975 ' OE1' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -149.97 142.0 15.37 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 36.7 Cg_endo -79.91 125.13 5.86 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.66 2.24 . . . . 0.0 112.077 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 63.18 18.3 60.28 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.54 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -69.01 147.45 51.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.849 -1.383 . . . . 0.0 108.583 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 60' ' ' THR . 0.7 OUTLIER -86.86 63.72 8.11 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.618 -1.301 . . . . 0.0 110.124 -179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 61' ' ' ILE . 13.4 mt -56.8 126.25 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.87 -1.144 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 90' ' ' MET . 6.5 mp -89.56 -38.18 14.16 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.588 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -150.4 149.37 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 109.986 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.992 ' HB2' HG22 ' A' ' 88' ' ' THR . 5.1 mp -107.77 174.83 5.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 110' ' ' VAL . . . -44.34 -24.17 0.58 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA3' ' HG ' ' A' ' 105' ' ' LEU . . . -152.17 53.51 0.47 Allowed Glycine 0 N--CA 1.503 3.118 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.02 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.2 t -177.8 149.35 0.59 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.1 -1.235 . . . . 0.0 108.879 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -134.21 120.44 20.03 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE3' ' HB3' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -72.73 -9.48 58.68 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.915 -178.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.8 mt-30 -71.14 152.54 43.33 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 91' ' ' GLN . . . 43.18 40.43 4.45 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 89' ' ' ALA . 7.8 mt -156.99 148.86 22.66 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.324 -1.104 . . . . 0.0 108.394 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.444 ' OG1' ' HG3' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -89.36 -166.62 1.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 109.715 -179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.699 ' HA ' HD21 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -79.27 -64.94 1.07 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.08 -1.012 . . . . 0.0 109.667 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 10.4 m-85 -59.35 -37.25 77.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.894 -1.129 . . . . 0.0 109.775 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.818 ' O ' HD12 ' A' ' 101' ' ' ILE . 25.9 mm-40 -61.26 -47.66 85.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 109.653 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -66.93 -56.01 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 110.513 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.605 ' HA ' HD13 ' A' ' 102' ' ' ILE . 6.5 t-105 -56.27 -22.78 32.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.824 . . . . 0.0 111.262 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -77.79 -47.29 19.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.432 -1.417 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 97' ' ' GLU . 2.7 mp -52.01 -37.73 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.504 -1.373 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.02 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.8 mp -57.55 -62.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.468 -0.77 . . . . 0.0 108.949 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -44.71 -38.69 4.57 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.864 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.34 73.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.701 -0.624 . . . . 0.0 110.896 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD13 ' HD3' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -54.92 174.73 0.21 Allowed Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.961 -179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.626 ' HD3' HD13 ' A' ' 105' ' ' LEU . 37.0 Cg_endo -84.15 -179.04 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.9 2.4 . . . . 0.0 110.602 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -95.91 85.5 4.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.774 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.64 -150.82 5.49 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.24 100.45 1.37 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.806 2.337 . . . . 0.0 110.513 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -87.75 106.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 2.7 m -87.94 123.59 32.83 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.914 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -105.51 156.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -130.35 95.46 2.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.975 HG21 ' OE1' ' A' ' 77' ' ' GLN . 1.4 pp -94.93 127.15 47.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 121.36 -0.837 . . . . 0.0 109.467 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.821 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.62 105.24 8.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.437 ' C ' ' HG2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -95.74 -167.68 1.64 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.438 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 116' ' ' ARG . 5.0 pttt 177.82 157.39 0.4 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.69 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -80.11 131.82 35.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.955 -1.091 . . . . 0.0 109.367 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.37 -164.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -81.04 -87.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.599 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' SER . 0.3 OUTLIER 75.44 130.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.523 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -63.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 t -164.38 43.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -56.14 177.03 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 109.205 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -110.48 106.59 15.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.793 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -109.95 170.51 8.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.29 65.55 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 130' ' ' SER . 1.3 p30 -134.07 129.91 36.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 109.466 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 129' ' ' ASP . 49.6 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.371 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 1' ' ' MET . 34.7 Cg_endo -78.3 -60.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 110.674 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 60.1 m-20 60.12 -174.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.311 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mt -101.59 121.85 42.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.459 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -148.54 -43.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.46 154.71 19.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -82.51 166.46 19.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 9' ' ' ASP . 12.3 p -84.25 -169.93 2.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 8' ' ' THR . 8.7 m-20 62.65 165.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.85 22.55 12.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.48 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.41 -57.41 1.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.517 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.96 116.69 22.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.724 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.2 156.27 41.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.28 40.03 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.77 132.21 46.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.304 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.61 -63.11 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.644 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.41 66.21 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 109.303 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.9 m -60.47 160.81 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.63 94.76 2.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.363 -0.836 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 t -80.73 135.53 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.05 157.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.288 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.94 103.19 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.153 -0.967 . . . . 0.0 109.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.19 99.52 9.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.293 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.82 158.39 16.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.594 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -161.7 58.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' GLU . . . -122.6 30.8 6.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 26' ' ' ALA . 4.8 mt-10 -150.4 88.29 1.49 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.081 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . 58.58 158.49 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.75 135.19 48.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 115' ' ' ARG . 4.5 t -107.32 153.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.564 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 m -141.95 86.62 1.99 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 HG23 HG13 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -68.79 125.79 27.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.948 . . . . 0.0 108.861 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -140.68 159.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 111.557 -178.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -110.26 132.08 54.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 76' ' ' VAL . 11.6 mt -120.35 69.09 0.86 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.824 -1.172 . . . . 0.0 111.059 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.592 ' C ' ' O ' ' A' ' 35' ' ' LEU . 33.8 mt-10 -10.74 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.053 0.454 . . . . 0.0 111.129 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HG3' ' CG1' ' A' ' 110' ' ' VAL . 6.1 mtpt -75.38 92.47 2.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 110.158 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 39' ' ' SER . 41.6 mtp -131.75 -179.5 5.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 38' ' ' MET . 8.8 t 67.41 -128.83 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.98 -1.075 . . . . 0.0 109.443 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.96 5.26 9.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.729 -1.232 . . . . 0.0 110.191 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 43' ' ' GLY . . . 170.34 65.88 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.109 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.06 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER 40.3 23.78 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.269 -1.136 . . . . 0.0 110.67 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 41' ' ' GLY . . . 62.64 5.6 9.33 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.266 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 1.06 ' CE2' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -134.16 156.53 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.489 -1.595 . . . . 0.0 110.264 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -129.6 143.57 50.88 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -101.92 143.1 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' CG ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 mm-40 -134.52 139.03 45.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 58' ' ' PRO . . . 108.6 -170.32 14.75 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 57' ' ' LYS . . . 135.98 -77.36 0.36 Allowed Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.877 -1.367 . . . . 0.0 111.07 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.47 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.272 -1.134 . . . . 0.0 110.614 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.32 107.12 0.23 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 m -126.41 -72.22 0.66 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.242 . . . . 0.0 109.693 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.91 -68.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.753 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -77.35 -7.41 56.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.65 63.49 0.61 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.72 114.33 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.738 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 50' ' ' LYS . 10.1 ptpt -129.44 90.35 44.56 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 110.731 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 37.6 Cg_endo -83.55 152.6 13.5 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.511 2.141 . . . . 0.0 109.917 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.999 HD21 ' CB ' ' A' ' 90' ' ' MET . 2.9 mp -58.29 123.9 17.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.132 -0.98 . . . . 0.0 110.446 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -155.32 155.91 34.55 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.09 -1.444 . . . . 0.0 112.519 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.756 HG21 ' CG1' ' A' ' 64' ' ' ILE . 78.1 mt -91.22 132.59 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.306 -1.497 . . . . 0.0 108.791 177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' CG ' ' CG ' ' A' ' 47' ' ' GLU . 1.1 p-10 -111.28 -55.25 2.52 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.516 -0.74 . . . . 0.0 111.83 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -103.4 91.01 3.88 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.096 -1.002 . . . . 0.0 110.65 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.756 ' CG1' HG21 ' A' ' 61' ' ' ILE . 1.1 mt -95.57 143.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.161 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 2.4 m-30 -107.21 169.85 8.32 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.716 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -100.55 98.91 9.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.263 -0.898 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 68' ' ' ALA . . . 140.96 -160.84 26.75 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 67' ' ' GLY . . . 44.18 52.26 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -152.52 155.1 36.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.425 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 t -68.16 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.2 24.85 11.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 74' ' ' GLU . 4.0 mt-30 -83.48 141.69 31.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 109.415 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -46.01 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.703 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 72' ' ' GLN . 10.1 mp0 49.94 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.65 HG23 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -99.97 31.19 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 108.999 179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.858 HG13 HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.28 160.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.087 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.533 ' CG ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -144.62 145.0 26.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 108.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.7 113.32 3.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.413 2.075 . . . . 0.0 110.917 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 79.27 7.91 88.16 Favored Glycine 0 N--CA 1.504 3.191 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.676 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 60' ' ' THR . 0.9 OUTLIER -63.14 158.7 19.17 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.13 -1.806 . . . . 0.0 108.696 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 19.4 tt0 -89.32 75.79 7.66 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.755 -1.216 . . . . 0.0 110.667 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.807 HG12 HG22 ' A' ' 114' ' ' ILE . 2.4 mt -80.26 120.69 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.66 -1.275 . . . . 0.0 108.545 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.784 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.9 mm? -81.96 -40.58 22.01 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.374 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 85' ' ' LEU . 2.2 pt20 -144.36 173.17 12.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.503 -1.373 . . . . 0.0 110.042 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.052 ' HB3' HG22 ' A' ' 88' ' ' THR . 4.6 tt -120.48 168.53 11.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 85' ' ' LEU . . . -45.33 -24.29 0.95 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 85' ' ' LEU . . . -148.34 45.75 0.72 Allowed Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.163 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 1.086 HG21 ' CD1' ' A' ' 102' ' ' ILE . 1.8 t -169.38 137.73 1.9 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.969 -1.312 . . . . 0.0 109.049 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 84' ' ' GLN . . . -136.21 129.63 31.92 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 120.533 -1.354 . . . . 0.0 107.748 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.999 ' CB ' HD21 ' A' ' 59' ' ' LEU . 23.7 ttm -87.72 -47.82 8.35 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.144 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' OE1' ' HB3' ' A' ' 83' ' ' LEU . 1.8 mp0 -35.73 -31.21 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.906 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.198 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 90' ' ' MET . . . -113.3 49.09 0.87 Allowed Glycine 0 N--CA 1.482 1.725 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 90' ' ' MET . 0.2 OUTLIER -169.13 -161.01 0.29 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.661 -0.905 . . . . 0.0 109.045 -177.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' CG ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -124.73 158.37 33.42 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 109.678 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 1.9 ttp180 -45.83 -69.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.397 -0.815 . . . . 0.0 111.109 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -48.37 80.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.179 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 101' ' ' ILE . 41.7 mm-40 -53.37 -41.4 65.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.101 -0.999 . . . . 0.0 109.32 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.78 ' HB2' ' HG3' ' A' ' 90' ' ' MET . . . -64.29 -66.05 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.659 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 7.1 t-105 -54.28 -19.48 5.39 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.416 -0.802 . . . . 0.0 110.724 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.37 -47.88 13.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.698 -1.251 . . . . 0.0 110.967 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 97' ' ' GLU . 3.0 mp -49.39 -37.97 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.604 -1.31 . . . . 0.0 109.72 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.086 ' CD1' HG21 ' A' ' 88' ' ' THR . 1.7 mp -59.47 -63.64 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -44.71 -27.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.578 0.704 . . . . 0.0 109.8 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.45 0.55 37.18 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 110.85 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.715 HD23 ' HD2' ' A' ' 106' ' ' PRO . 0.2 OUTLIER -92.69 176.42 2.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.975 -1.078 . . . . 0.0 109.747 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.715 ' HD2' HD23 ' A' ' 105' ' ' LEU . 35.5 Cg_endo -81.07 -179.75 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.545 2.163 . . . . 0.0 110.965 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -96.34 93.61 6.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.786 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 36' ' ' GLU . . . -145.68 -156.88 7.04 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.37 98.8 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.788 2.325 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.9 HG23 ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -88.76 110.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 1.1 m -87.75 129.75 35.07 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.978 0.894 . . . . 0.0 110.44 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -113.92 157.97 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.581 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -129.67 101.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.807 HG22 HG12 ' A' ' 82' ' ' ILE . 1.5 pp -108.04 132.59 55.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.153 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.856 ' HB2' HG22 ' A' ' 30' ' ' VAL . 5.9 ttp-105 -126.2 111.68 14.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.8 136.36 41.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.38 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 93.12 4.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.049 -1.032 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.8 p -74.84 -164.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.456 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 119' ' ' LEU . 10.9 mp -47.97 140.04 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.513 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -162.52 -59.89 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.43 88.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.466 -0.771 . . . . 0.0 109.244 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -83.42 53.55 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.651 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 124' ' ' THR . 27.3 mt-10 -85.0 -34.94 22.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.2 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.528 ' CB ' ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER 77.0 42.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.392 -0.817 . . . . 0.0 109.97 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.59 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 23.3 m -45.46 -64.02 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.168 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 125' ' ' THR . . . 68.95 12.6 8.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.65 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 125' ' ' THR . . . -103.29 160.12 14.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.528 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ALA . . . 51.56 95.85 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.11 142.3 31.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.387 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 stop_ save_